跳到正文
MarketHOT
English
摘要
SEC · EDGAR 财务披露·· 12 天前AI 评分59

Silver Point Specialty Lending Fund披露截至2026年9月30日的季度及九个月业绩与投资组合情况

Silver Point Specialty Lending Fund (0001646614) (Filer)

AI 导读

Silver Point Specialty Lending Fund的10-Q节选披露,截至2026年9月30日投资公允价值为11.607亿美元,净资产为6.395亿美元,每股NAV为26.90美元,低于2025年末的27.96美元。

正文

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2026

OR

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM ________ TO ________.

Commission File Number: 000-56533

SILVER POINT SPECIALTY LENDING FUND

(Exact Name of Registrant as Specified in its Charter)

Maryland

47-1577585

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer
Identification No.)

Two Greenwich Plaza, Suite 1

Greenwich, Connecticut

06830

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (203) 542-4200

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange on which registered

None

Not applicable

Not applicable

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☒

Smaller reporting company

☐

Emerging growth company

☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 6, 2026, the registrant had 23,885,536 common shares of beneficial interest, $0.001 par value per share, outstanding. Common shares outstanding excludes shares issued pursuant to the registrant's dividend reinvestment plan as of October 31, 2026 since the issuance price is not yet finalized at this time.


Silver Point Specialty Lending Fund

Table of Contents

Page

PART I

CONSOLIDATED FINANCIAL INFORMATION

1

Item 1

Consolidated Financial Statements

1

Consolidated Statements of Assets and Liabilities as of September 30, 2026 (Unaudited) and December 31, 2025

1

Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and 2025 (Unaudited)

2

Consolidated Statements of Changes in Net Assets for the three and nine months ended September 30, 2026 and 2025 (Unaudited)

3

Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 2025 (Unaudited)

5

Consolidated Schedules of Investments as of September 30, 2026 (Unaudited) and December 31, 2025

6

Notes to Consolidated Financial Statements (Unaudited)

28

Item 2

Management’s Discussion and Analysis of Financial Condition and Results of Operations

54

Item 3

Quantitative and Qualitative Disclosures About Market Risk

67

Item 4

Controls and Procedures

68

PART II

OTHER INFORMATION

69

Item 1

Legal Proceedings

69

Item 1A

Risk Factors

69

Item 2

Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities

69

Item 3

Defaults Upon Senior Securities

69

Item 4

Mine Safety Disclosures

69

Item 5

Other Information

69

Item 6

Exhibits

70

Signatures

71


PART I— CONSOLIDATED FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

Silver Point Specialty Lending Fund

Consolidated Statements of Assets and Liabilities

September 30,
2026

December 31,
2025

(Unaudited)

Assets

Investments, at fair value:

Non-controlled, non-affiliated investments (amortized cost of $1,138,411,250 and $1,157,779,432, respectively)

$

1,096,390,452

$

1,133,651,175

Non-controlled, affiliated investments (amortized cost of $39,635,723 and $23,603,860, respectively)

51,115,296

30,263,217

Controlled investments (amortized cost of $35,988,496 and $40,671,939, respectively)

13,187,231

19,832,346

Total investments, at fair value (amortized cost of $1,214,035,469 and $1,222,055,231, respectively)

1,160,692,979

1,183,746,738

Cash and cash equivalents (cash equivalents of $12,434,159 and $11,056,883, respectively)

16,255,600

14,006,888

Restricted cash and cash equivalents (restricted cash equivalents of $25,549,979 and $12,954,969, respectively)

29,138,160

17,888,102

Foreign cash held at banks (cost of $1,279,014 and $2,165,557, respectively)

1,279,014

2,163,174

Receivable for unsettled transactions

1,804,851

5,351,693

Interest receivable

10,909,211

8,223,819

Foreign currency forward contracts, at fair value

961,348

65,048

Interest rate swaps, at fair value

1,595,422

1,144,580

Due from broker

1,906,248

1,773,780

Deferred financing costs

1,278,044

1,785,354

Other assets

10,265,100

313,017

Total assets

$

1,236,085,977

$

1,236,462,193

Liabilities

Debt (Note 6) (net of unamortized debt issuance costs of $1,480,776 and $2,448,150, respectively)

$

558,394,058

$

599,743,222

Payable for unsettled transactions

17,193,445

21,204,629

Interest payable

6,669,718

5,352,673

Management fees payable to an affiliate (Note 3)

1,622,621

1,506,894

Income incentive fee payable to an affiliate (Note 3)

2,625,477

2,501,126

Interest rate swaps, at fair value

13,277

226,331

Foreign currency forward contracts, at fair value

2,511

177,236

Dividend payable

5,706,332

5,310,097

Other liabilities

1,785,228

4,734,054

Accrued expenses

2,564,186

1,870,812

Total liabilities

596,576,853

642,627,074

Commitments and contingencies (Note 8)

Net assets

Common shares $0.001 par value, unlimited shares authorized; 23,776,383 and 21,240,388 shares issued and outstanding, respectively

23,776

21,240

Paid-in-capital in excess of par

724,559,915

654,483,442

Distributable earnings (losses)

(85,074,567

)

(60,669,563

)

Total net assets

639,509,124

593,835,119

Total liabilities and net assets

$

1,236,085,977

$

1,236,462,193

Net asset value per share

$

26.90

$

27.96

The accompanying notes are an integral part of these consolidated financial statements.

1


Silver Point Specialty Lending Fund

Consolidated Statements of Operations

(Unaudited)

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2026

2025

2026

2025

Investment income:

Non-controlled/non-affiliated investments:

Interest income (excluding payment-in-kind (“PIK”) interest)

$

30,638,985

$

25,434,795

$

90,419,991

$

75,443,660

PIK interest income

1,009,378

749,981

2,721,057

3,260,987

Dividend income

48,099

—

128,264

—

Other income

92,759

18,959

776,669

49,053

Non-controlled/affiliated investments:

Interest income (excluding PIK interest)

97,979

139,255

169,735

424,044

PIK interest income

497,470

371,402

1,183,086

851,959

Controlled investments:

Interest income (excluding PIK interest)

87,100

122,783

273,094

443,636

PIK interest income

32,924

27,628

93,567

80,962

Total investment income

32,504,694

26,864,803

95,765,463

80,554,301

Expenses:

Interest and financing expenses

7,983,529

7,726,432

24,601,097

22,001,250

Management fee (Note 3)

2,028,276

1,721,287

5,953,449

4,217,662

Income incentive fee (Note 3)

2,625,477

2,030,684

7,529,540

6,750,047

Incentive compensation clawback (Note 3)

—

—

—

(1,522,386

)

Professional fees

704,264

519,464

2,121,923

2,186,622

Administration fees

635,648

543,696

2,007,693

1,497,260

Trustee fees

65,625

87,500

196,875

262,500

Other general and administrative expenses

373,676

388,175

1,469,648

1,335,044

Total expenses

14,416,495

13,017,238

43,880,225

36,727,999

Management fee waiver (Note 3)

(405,655

)

(344,258

)

(1,190,690

)

(568,954

)

Net expenses

14,010,840

12,672,980

42,689,535

36,159,045

Net investment income

18,493,854

14,191,823

53,075,928

44,395,256

Net gain (loss):

Net realized gain (loss):

Non-controlled/non-affiliated investments

(12,532,174

)

121,626

(16,660,558

)

(11,328,621

)

Non-controlled/affiliated investments

—

(38,676

)

—

175,063

Foreign currency transactions

(85,217

)

(97,849

)

(165,442

)

75,770

Foreign currency forward contracts

(500,058

)

(163,707

)

1,862,999

(2,347,438

)

Interest rate swaps

(84,444

)

4,941

(278,395

)

15,217

Total net realized gain (loss)

(13,201,893

)

(173,665

)

(15,241,396

)

(13,410,009

)

Net change in unrealized appreciation (depreciation):

Non-controlled/non-affiliated investments

3,499,945

(795,032

)

(17,892,541

)

947,663

Non-controlled/affiliated investments

166,443

(268,761

)

4,820,216

2,623,234

Controlled investments

(554,652

)

140,779

(1,961,672

)

(3,253,405

)

Translation of assets and liabilities in foreign currencies

71,936

(24,555

)

166,273

53,846

Foreign currency forward contracts

1,213,457

837,661

1,071,025

(94,397

)

Interest rate swaps

835,994

17,897

1,230,358

(236,759

)

Total net change in unrealized appreciation (depreciation)

5,233,123

(92,011

)

(12,566,341

)

40,182

Net gain (loss)

(7,968,770

)

(265,676

)

(27,807,737

)

(13,369,827

)

Net increase (decrease) in net assets resulting from operations

$

10,525,084

$

13,926,147

$

25,268,191

$

31,025,429

Net investment income per share (Basic and Dilutive)

$

0.78

$

0.75

$

2.33

$

2.39

Earnings per share (Basic and Dilutive)

$

0.45

$

0.74

$

1.11

$

1.67

Weighted average shares outstanding

23,615,974

18,844,679

22,821,203

18,610,157

The accompanying notes are an integral part of these consolidated financial statements.

2


Silver Point Specialty Lending Fund

Consolidated Statements of Changes in Net Assets

(Unaudited)

Shares

Par Amount

Paid-in-Capital in Excess of Par

Distributable Earnings (Losses)

Total Net Assets

Balance at December 31, 2025:

21,240,388

$

21,240

$

654,483,442

$

(60,669,563

)

$

593,835,119

Net increase (decrease) in net assets resulting from operations:

Net investment income (loss)

—

—

—

16,942,662

16,942,662

Net realized gains (losses) on investments and foreign currency transactions

—

—

—

(3,985,169

)

(3,985,169

)

Net change in unrealized gains (losses) on investments and foreign currency translation

—

—

—

(7,975,779

)

(7,975,779

)

Increase (decrease) in net assets resulting from capital share transactions:

Issuance of common shares

1,074,758

1,075

29,998,925

—

30,000,000

Dividends to shareholders:

Shares issued in connection with dividend reinvestment plan

289,820

290

8,089,564

—

8,089,854

Dividends declared from distributable earnings

—

—

—

(15,947,981

)

(15,947,981

)

Balance at March 31, 2026:

22,604,966

$

22,605

$

692,571,931

$

(71,635,830

)

$

620,958,706

Net increase (decrease) in net assets resulting from operations:

Net investment income (loss)

—

—

—

17,639,412

17,639,412

Net realized gains (losses) on investments and foreign currency transactions

—

—

—

1,945,666

1,945,666

Net change in unrealized gains (losses) on investments and foreign currency translation

—

—

—

(9,823,685

)

(9,823,685

)

Increase (decrease) in net assets resulting from capital share transactions:

Issuance of common shares

547,581

548

14,999,452

—

15,000,000

Dividends to shareholders:

Shares issued in connection with dividend reinvestment plan

304,232

304

8,334,156

—

8,334,460

Dividends declared from distributable earnings

—

—

—

(16,683,506

)

(16,683,506

)

Balance at June 30, 2026:

23,456,779

$

23,457

$

715,905,539

$

(78,557,943

)

$

637,371,053

Net increase (decrease) in net assets resulting from operations:

Net investment income (loss)

—

—

—

18,493,854

18,493,854

Net realized gains (losses) on investments and foreign currency transactions

—

—

—

(13,201,893

)

(13,201,893

)

Net change in unrealized gains (losses) on investments and foreign currency translation

—

—

—

5,233,123

5,233,123

Increase (decrease) in net assets resulting from capital share transactions:

Issuance of common shares

—

—

—

—

—

Dividends to shareholders:

Shares issued in connection with dividend reinvestment plan

319,604

319

8,654,376

—

8,654,695

Dividends declared from distributable earnings

—

—

—

(17,041,708

)

(17,041,708

)

Balance at September 30, 2026:

23,776,383

$

23,776

$

724,559,915

$

(85,074,567

)

$

639,509,124

The accompanying notes are an integral part of these consolidated financial statements.

3


Silver Point Specialty Lending Fund

Consolidated Statements of Changes in Net Assets

(Unaudited)

Shares

Par Amount

Paid-in-Capital in Excess of Par

Distributable Earnings (Losses)

Total Net Assets

Balance at December 31, 2024:

18,453,726

$

18,454

$

553,593,317

$

(8,698,777

)

$

544,912,994

Net increase (decrease) in net assets resulting from operations:

Net investment income (loss)

—

—

—

15,642,045

15,642,045

Net realized gains (losses) on investments and foreign currency transactions

—

—

—

(2,262,938

)

(2,262,938

)

Net change in unrealized gains (losses) on investments and foreign currency translation

—

—

—

(3,151,907

)

(3,151,907

)

Increase (decrease) in net assets resulting from capital share transactions:

Issuance of common shares

—

—

—

—

—

Dividends to shareholders:

Shares issued in connection with dividend reinvestment plan

—

—

—

—

—

Dividends declared from distributable earnings

—

—

—

(12,917,608

)

(12,917,608

)

Balance at March 31, 2025:

18,453,726

$

18,454

$

553,593,317

$

(11,389,185

)

$

542,222,586

Net increase (decrease) in net assets resulting from operations:

Net investment income (loss)

—

—

—

14,561,388

14,561,388

Net realized gains (losses) on investments and foreign currency transactions

—

—

—

(10,973,406

)

(10,973,406

)

Net change in unrealized gains (losses) on investments and foreign currency translation

—

—

—

3,284,100

3,284,100

Increase (decrease) in net assets resulting from capital share transactions:

Issuance of common shares

329,746

330

9,509,701

—

9,510,031

Dividends to shareholders:

Shares issued in connection with dividend reinvestment plan

—

—

—

—

—

Dividends declared from distributable earnings

—

—

—

(17,346,502

)

(17,346,502

)

Balance at June 30, 2025:

18,783,472

$

18,784

$

563,103,018

$

(21,863,605

)

$

541,258,197

Net increase (decrease) in net assets resulting from operations:

Net investment income (loss)

—

—

—

14,191,823

14,191,823

Net realized gains (losses) on investments and foreign currency transactions

—

—

—

(173,665

)

(173,665

)

Net change in unrealized gains (losses) on investments and foreign currency translation

—

—

—

(92,011

)

(92,011

)

Increase (decrease) in net assets resulting from capital share transactions:

Issuance of common shares

—

—

—

—

—

Dividends to shareholders:

—

Shares issued in connection with dividend reinvestment plan

244,829

245

7,085,116

—

7,085,361

Dividends declared from distributable earnings

—

—

—

(23,101,906

)

(23,101,906

)

Balance at September 30, 2025:

19,028,301

$

19,029

$

570,188,134

$

(31,039,364

)

$

539,167,799

The accompanying notes are an integral part of these consolidated financial statements.

4


Silver Point Specialty Lending Fund

Consolidated Statements of Cash Flows

(Unaudited)

For the Nine Months Ended September 30,

2026

2025

Cash flows from operating activities

Net increase (decrease) in net assets resulting from operations

$

25,268,191

$

31,025,429

Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities

Net amortization/accretion of premium/discount on investments

(7,902,188

)

(5,209,181

)

Amortization of deferred financing costs and debt issuance costs

1,474,685

1,242,291

Payments for purchase of investments

(261,458,342

)

(385,645,607

)

Proceeds from sales, paydowns and resolutions of investments

264,710,709

183,936,349

Interest paid-in-kind

(3,997,710

)

(4,193,908

)

Net realized (gain) loss from investments

16,660,558

11,153,558

Net change in unrealized (appreciation) depreciation from investments

15,033,997

(317,492

)

Net change in unrealized (appreciation) depreciation from foreign currency forward contracts

(1,071,025

)

94,397

Net change in unrealized (appreciation) depreciation from interest rate swaps

(1,230,358

)

236,759

Net change in unrealized (appreciation) depreciation on effectively hedged interest rate swaps and debt

(5,744

)

(40,928

)

Net (increase) decrease in operating assets and increase (decrease) in operating liabilities

Receivable for unsettled transactions

3,546,842

6,975,301

Interest receivable

(2,678,657

)

309,382

Incentive compensation clawback

—

7,025,114

Due from broker

(132,468

)

190,050

Other assets

(9,952,083

)

(8,766,694

)

Due to broker

—

(1,920,000

)

Payable for unsettled transactions

(4,011,184

)

34,475,781

Interest payable

1,317,045

428,400

Management fees payable to an affiliate

115,727

347,359

Income incentive fee payable to an affiliate

124,351

(824,106

)

Interest rate swaps accrual, net

(44,333

)

(56,576

)

Other liabilities

395,041

(113,127

)

Accrued expenses

694,105

18,010

Net cash provided by (used in) operating activities

36,857,159

(129,629,439

)

Cash flows from financing activities

Proceeds from debt borrowings

141,900,000

152,792,625

Principal debt payments

(183,600,000

)

(65,374,938

)

Payment of deferred financing costs and debt issuance costs

—

(1,357,103

)

Issuance of common shares

45,000,000

9,510,031

Dividends paid in cash

(24,198,682

)

(31,819,146

)

Payments of other liabilities

(3,343,867

)

—

Net cash provided by (used in) financing activities

(24,242,549

)

63,751,469

Net increase (decrease)

12,614,610

(65,877,970

)

Beginning of period balance(1)

34,058,164

99,176,269

End of period balance(1) (Note 2)

$

46,672,774

$

33,298,299

(1) Including cash and cash equivalents, restricted cash and cash equivalents and foreign cash held at banks

Supplemental cash flow information

Cash paid during the period for interest

$

21,859,444

$

20,428,063

Reinvestment of dividends during the period

$

25,079,009

$

7,085,361

Dividends payable

$

5,706,332

$

14,461,509

The accompanying notes are an integral part of these consolidated financial statements.

5


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

September 30, 2026 (Unaudited)

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(17)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

Non-Controlled/Non-Affiliated Investments

1st Lien/Secured Loans

United States of America

Accela Inc/US⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Software & Services

S+4.75%, 0.75% Floor

8.65%

9/1/2023

9/2/2030

$

11,324,143

$11,196,894

$11,273,705

1.76%

Accela Inc/US⁽⁷⁾⁽⁸⁾

1st Lien Delayed Draw Term Loan

Software & Services

S+4.75%, 0.75% Floor

8.65

4/11/2025

9/2/2030

1,341,923

1,331,957

1,335,946

0.21

Accela Inc/US⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Revolver

Software & Services

S+4.75%, 0.75% Floor (0.50% on unfunded)

0.50

9/1/2023

9/2/2030

2,242,023

(15,884)

(15,926)

(0.00)

Accurate Background LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Business Services

S+6.26%, 1.00% Floor

10.34

10/18/2021

3/26/2029

18,993,788

18,179,685

18,730,525

2.93

ADMI Corp (aka Aspen Dental)

1st Lien Term Loan

Healthcare Providers & Services

S+3.38%, 0.50% Floor

7.39

9/24/2026

12/23/2027

2,362,716

2,250,487

2,222,442

0.35

ADMI Corp (aka Aspen Dental)

1st Lien Term Loan

Healthcare Providers & Services

S+5.75%

9.65

9/24/2026

12/23/2027

7,819,306

7,457,663

7,379,470

1.15

ADMI Corp (aka Aspen Dental)

1st Lien Term Loan

Healthcare Providers & Services

S+3.75%, 0.50% Floor

7.77

9/28/2026

12/23/2027

1,565,879

1,495,415

1,474,542

0.23

Allentown LLC⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Healthcare Equipment & Supplies

S+7.15%, 1.00% Floor (1.00% PIK)

10.91

4/22/2022

4/22/2027

11,591,022

11,534,010

11,188,234

1.75

Allentown LLC⁽⁷⁾

1st Lien Delayed Draw Term Loan

Healthcare Equipment & Supplies

S+7.15%, 1.00% Floor (1.00% PIK)

10.91

4/22/2022

4/22/2027

1,728,258

1,735,460

1,668,201

0.26

Allentown LLC⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Healthcare Equipment & Supplies

P+6.00%, 1.00% Floor (0.50% on unfunded) (1.00% PIK)

13.00

4/22/2022

4/22/2027

1,174,971

462,987

427,480

0.07

Alpine Acquisition Corp II⁽⁷⁾⁽¹⁶⁾

1st Lien Term Loan

Transportation & Logistics

S+5.25%, 1.00% Floor

9.15

1/14/2026

1/14/2031

707,745

707,745

572,854

0.09

Alpine Acquisition Corp II⁽⁷⁾⁽¹⁶⁾

1st Lien Term Loan

Transportation & Logistics

S+5.00%, 1.00% Floor

8.90

1/14/2026

1/14/2031

530,233

530,233

481,624

0.08

Alpine Acquisition Corp II⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Delayed Draw Term Loan

Transportation & Logistics

S+4.75%, 1.00% Floor (0.50% on unfunded)

0.50

1/14/2026

1/14/2031

53,094

(456)

(1,369)

(0.00)

Alpine Acquisition Corp II⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Revolver

Transportation & Logistics

S+4.75%, 1.00% Floor (0.50% on unfunded)

0.50

1/14/2026

1/14/2031

212,377

(9,107)

(5,587)

(0.00)

Amerijet Holdings Inc⁽⁷⁾

1st Lien Term Loan

Transportation & Logistics

11.50% (12.00% PIK)

11.50

12/19/2023

6/30/2027

7,333,027

7,327,060

8,174,125

1.28

Amerijet Holdings Inc⁽⁷⁾⁽¹⁶⁾

1st Lien Term Loan

Transportation & Logistics

S+7.26%, 1.00% Floor

11.08

12/28/2021

6/30/2027

12,775,842

12,698,577

11,921,139

1.86

Amerijet Holdings Inc⁽⁷⁾⁽¹⁶⁾

1st Lien Revolver

Transportation & Logistics

S+7.26%, 1.00% Floor (0.50% on unfunded)

11.08

12/28/2021

6/30/2027

2,536,322

2,526,026

2,364,106

0.37

Aprimo Inc⁽⁷⁾⁽⁸⁾⁽¹⁵⁾

1st Lien Term Loan

Software & Services

S+6.19%, 0.75% Floor

10.09

5/26/2022

5/26/2028

2,149,832

2,136,428

2,127,756

0.33

Artisan Bidco Inc⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Technology

S+7.00%, 1.00% Floor

10.74

11/7/2023

11/7/2029

4,080,261

4,010,526

4,032,010

0.63

Artisan Bidco Inc⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Technology

E+7.00%, 1.00% Floor

9.31

11/7/2023

11/7/2029

€

6,975,535

7,369,886

7,808,122

1.22

Artisan Bidco Inc⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Technology

S+7.00%, 1.00% Floor (0.50% on unfunded)

10.73

11/7/2023

11/7/2029

1,170,535

1,035,331

1,038,902

0.16

Atlas Sand Co LLC⁽⁷⁾⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Oilfield Services

9.51%

9.51

3/5/2025

3/1/2032

5,784,787

5,739,028

5,726,940

0.90

Azurite Intermediate Holdings Inc⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Software & Services

S+6.00%, 0.75% Floor

9.90

3/19/2024

3/19/2031

2,108,913

2,085,302

2,024,952

0.32

Azurite Intermediate Holdings Inc⁽⁷⁾⁽⁹⁾

1st Lien Delayed Draw Term Loan

Software & Services

S+6.00%, 0.75% Floor

9.90

3/19/2024

3/19/2031

4,792,983

4,743,609

4,602,631

0.72

Azurite Intermediate Holdings Inc⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Revolver

Software & Services

S+6.00%, 0.75% Floor (0.50% on unfunded)

0.50

3/19/2024

3/19/2031

770,731

(7,373)

(31,141)

(0.00)

BayMark Health Services Inc⁽⁷⁾⁽¹⁶⁾

1st Lien Term Loan

Healthcare Providers & Services

S+6.50%, 2.00% Floor

10.40

9/30/2026

2/28/2031

5,193,489

5,041,063

5,116,626

0.80

BayMark Health Services Inc⁽⁷⁾

1st Lien Term Loan

Healthcare Providers & Services

S+5.00%, 2.00% Floor

8.90

9/30/2026

9/30/2030

363,861

348,461

358,585

0.06

BEL USA LLC⁽⁷⁾⁽¹¹⁾⁽¹⁴⁾⁽¹⁶⁾

1st Lien Term Loan

E-Commerce

S+9.15%, 2.50% Floor

12.82

12/13/2018

6/2/2026

8,821,421

8,719,947

838,463

0.13

BEL USA LLC⁽⁷⁾

1st Lien Term Loan

E-Commerce

S+9.15%, 2.50% Floor

12.82

1/13/2026

6/2/2026

223,491

223,491

222,277

0.03

The accompanying notes are an integral part of these consolidated financial statements.

6


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

September 30, 2026 (Unaudited)

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(17)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

Bending Spoons US Inc⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Technology

S+5.63%, 1.00% Floor

9.39%

2/19/2025

3/7/2031

$

14,824,181

$14,581,196

$14,805,652

2.32%

ChemCat AcquisitionCo LLC (Ketjen)⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Specialty Chemicals

S+4.75%

8.82

6/30/2026

3/2/2033

6,463,557

6,210,511

6,437,315

1.01

Circle Graphics Inc⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

E-Commerce

S+3.25%, 4.00% Floor

7.27

6/30/2025

3/31/2029

10,602,410

10,241,389

9,484,157

1.48

Circle Graphics Inc⁽⁷⁾⁽¹⁶⁾

1st Lien Term Loan

E-Commerce

S+3.75%, 4.00% Floor (S+3.75% PIK)

7.77

6/30/2025

3/31/2029

10,711,823

8,340,100

5,935,957

0.93

Contractual Buyer, LLC (dba Kodiak Solutions)⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Healthcare Technology

S+4.50%, 0.75% Floor

8.32

10/10/2023

10/10/2030

3,424,661

3,369,545

3,378,693

0.53

Contractual Buyer, LLC (dba Kodiak Solutions)⁽⁷⁾

1st Lien Delayed Draw Term Loan

Healthcare Technology

S+4.50%, 0.75% Floor

8.32

1/22/2026

10/10/2030

16,630

16,487

16,406

0.00

Contractual Buyer, LLC (dba Kodiak Solutions)⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Revolver

Healthcare Technology

S+4.50%, 0.75% Floor (0.50% on unfunded)

0.50

10/10/2023

10/10/2029

401,425

(5,769)

(4,731)

(0.00)

Coupa Holdings LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Software & Services

S+5.25%, 0.75% Floor

9.07

2/27/2023

2/27/2030

10,118,253

9,972,876

9,850,059

1.54

Coupa Holdings LLC⁽⁷⁾⁽⁸⁾

1st Lien Delayed Draw Term Loan

Software & Services

S+5.25%, 0.75% Floor

9.07

2/27/2023

2/27/2030

921,900

907,301

897,464

0.14

Coupa Holdings LLC⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Software & Services

S+5.25%, 0.75% Floor (0.50% on unfunded)

9.07

2/27/2023

2/27/2029

707,659

464,670

457,673

0.07

CP Atlas Buyer Inc (American Bath)⁽⁸⁾

1st Lien Term Loan

Building Products

S+5.25%

9.15

7/1/2025

7/8/2030

18,315,016

17,612,767

14,976,536

2.34

Crewline Buyer Inc⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Software & Services

S+6.75%, 1.00% Floor

10.57

11/8/2023

11/8/2030

9,501,470

9,346,340

9,190,111

1.44

Crewline Buyer Inc⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Revolver

Software & Services

S+6.75%, 1.00% Floor (0.50% on unfunded)

0.50

11/8/2023

11/8/2030

989,736

(14,089)

(32,657)

(0.01)

Databricks Inc⁽⁷⁾⁽⁸⁾⁽¹⁶⁾

1st Lien Term Loan

Software & Services

S+4.50%

8.27

12/19/2024

1/3/2031

2,193,577

2,185,753

2,203,448

0.34

Databricks Inc⁽⁶⁾⁽⁷⁾⁽¹⁶⁾

1st Lien Delayed Draw Term Loan

Software & Services

S+4.50% (1.00% on unfunded)

1.00

12/19/2024

1/5/2032

13,716,358

—

61,724

0.01

Elessent Clean Technologies Inc⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Specialty Chemicals

S+6.00%, 1.00% Floor

9.95

11/15/2024

11/15/2029

2,424,328

2,391,321

2,431,663

0.38

Elessent Clean Technologies Inc⁽⁶⁾⁽⁷⁾⁽¹³⁾

1st Lien Revolver

Specialty Chemicals

S+6.00%, 1.00% Floor (0.50% on unfunded)

0.50

11/15/2024

11/15/2029

241,448

(3,017)

731

0.00

FR Vision Holdings, Inc. (CHA Consulting)⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Professional Services

S+5.00%, 0.75% Floor

8.73

1/19/2024

1/20/2031

2,489,152

2,455,421

2,446,462

0.38

FR Vision Holdings, Inc. (CHA Consulting)⁽⁷⁾⁽⁸⁾

1st Lien Delayed Draw Term Loan

Professional Services

S+5.00%, 0.75% Floor

8.73

1/19/2024

1/20/2031

731,116

720,498

718,577

0.11

FR Vision Holdings, Inc. (CHA Consulting)⁽⁶⁾⁽⁷⁾

1st Lien Delayed Draw Term Loan

Professional Services

S+5.00%, 0.75% Floor (1.00% on unfunded)

8.73

9/26/2025

1/20/2031

556,894

66,927

59,943

0.01

FR Vision Holdings, Inc. (CHA Consulting)⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Professional Services

S+5.00%, 0.75% Floor (0.50% on unfunded)

8.73

1/19/2024

1/20/2030

185,747

49,796

49,545

0.01

G-3 Chickadee Purchaser, LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Specialty Chemicals

S+5.75%, 1.00% Floor

9.57

10/31/2025

10/31/2031

5,876,954

5,775,359

5,806,430

0.91

GC Bison Acquisition, LLC (Midland Industries)⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Industrial Products & Services

S+6.00%, 1.00% Floor

9.76

9/1/2023

9/4/2029

11,152,761

11,034,609

11,044,904

1.73

GC Bison Acquisition, LLC (Midland Industries)⁽⁷⁾⁽⁸⁾

1st Lien Delayed Draw Term Loan

Industrial Products & Services

S+6.00%, 1.00% Floor

10.07

2/27/2026

9/3/2029

275,114

270,295

272,453

0.04

GC Bison Acquisition, LLC (Midland Industries)⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Revolver

Industrial Products & Services

S+6.00%, 1.00% Floor (0.50% on unfunded)

0.50

9/1/2023

9/4/2029

1,063,447

(10,353)

(11,709)

(0.00)

GI Apple Midco LLC (Atlas Technical)⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Professional Services

S+6.75%, 1.00% Floor

10.65

4/19/2023

4/19/2030

10,718,681

10,563,265

10,542,276

1.65

GI Apple Midco LLC (Atlas Technical)⁽⁷⁾⁽⁸⁾

1st Lien Delayed Draw Term Loan

Professional Services

S+6.75%, 1.00% Floor

10.65

4/19/2023

4/19/2030

205,655

203,960

202,277

0.03

GI Apple Midco LLC (Atlas Technical)⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Professional Services

S+6.75%, 1.00% Floor (0.50% on unfunded)

10.65

4/19/2023

4/19/2029

1,345,718

1,069,040

1,069,268

0.17

Gibson Brands Inc⁽⁹⁾

1st Lien Term Loan

Consumer Brands

S+5.26%, 0.75% Floor

8.99

2/16/2024

8/11/2028

9,232,258

9,017,441

8,982,480

1.40

Gopher Resource LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Environmental Solutions

S+5.75%, 1.00% Floor (2.50% PIK)

9.82

10/4/2024

10/4/2029

16,848,431

16,538,859

16,732,558

2.62

Gopher Resource LLC⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Environmental Solutions

S+5.75%, 1.00% Floor (0.50% on unfunded)

9.61

10/4/2024

10/4/2029

1,341,763

961,121

970,556

0.15

The accompanying notes are an integral part of these consolidated financial statements.

7


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

September 30, 2026 (Unaudited)

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(17)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

Guava Buyer LLC (dba AVI-SPL)⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Technology Hardware & Equipment

S+5.50%, 1.00% Floor

9.24%

8/12/2025

8/12/2032

$

17,388,316

$17,084,109

$17,379,622

2.72%

Guava Buyer LLC (dba AVI-SPL)⁽⁶⁾⁽⁷⁾

1st Lien Delayed Draw Term Loan

Technology Hardware & Equipment

S+5.50%, 1.00% Floor (1.00% on unfunded)

9.25

8/12/2025

8/12/2032

2,063,073

876,161

900,331

0.14

Guava Buyer LLC (dba AVI-SPL)⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Technology Hardware & Equipment

S+5.50%, 1.00% Floor (0.50% on unfunded)

9.25

8/12/2025

8/12/2030

2,074,483

521,135

541,786

0.08

Hawk Parent Holdings LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Financial Services

S+5.50%, 1.00% Floor

9.40

6/11/2026

6/1/2032

20,092,691

19,556,457

19,731,023

3.09

Igloo Group Parent Inc⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Technology

S+5.00%, 1.00% Floor

9.07

12/23/2025

12/23/2031

18,136,781

17,146,961

17,248,079

2.70

Industrial Service Solutions WC, Inc.⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Industrial Products & Services

S+4.45%, 0.75% Floor

8.52

2/6/2026

2/7/2033

10,733,333

10,637,315

10,540,133

1.65

Industrial Service Solutions WC, Inc.⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Industrial Products & Services

S+4.50%, 0.75% Floor (0.50% on unfunded)

9.37

2/6/2026

2/7/2033

1,871,345

575,613

557,037

0.09

INEOS US Petrochem LLC

1st Lien Term Loan

Specialty Chemicals

S+4.25%

8.25

5/5/2026

3/29/2029

10,303,354

9,674,665

8,778,679

1.37

Iron Oak Energy Solutions LLC⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Energy

S+5.50%, 3.00% Floor

9.23

6/1/2026

6/1/2033

5,801,595

5,661,093

5,673,960

0.89

IXS Holdings Inc⁽⁸⁾

1st Lien Term Loan

Automobiles & Components

S+5.50%, 1.00% Floor

9.32

8/15/2025

9/5/2029

5,763,540

5,587,175

5,749,132

0.90

Jennmar Intermediate III LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Industrial Products & Services

S+5.00%

9.26

12/16/2025

12/16/2030

20,193,656

19,614,938

19,981,623

3.12

LA Specialty Produce Co LLC(dba Vesta Foodservice)⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Food & Beverage

S+4.50%, 0.75% Floor

8.23

4/1/2026

4/1/2033

6,949,729

6,883,230

6,932,355

1.08

LA Specialty Produce Co LLC(dba Vesta Foodservice)⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Delayed Draw Term Loan

Food & Beverage

S+4.50%, 0.75% Floor (1.00% on unfunded)

1.00

4/1/2026

4/1/2033

1,737,432

(8,068)

(4,344)

(0.00)

LA Specialty Produce Co LLC(dba Vesta Foodservice)⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Revolver

Food & Beverage

S+4.50%, 0.75% Floor (0.50% on unfunded)

0.50

4/1/2026

4/1/2033

1,003,850

(9,320)

(7,529)

(0.00)

LAC Acquisition LLC d/b/a Lighthouse Autism Center⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Healthcare Providers & Services

S+11.15%, 3.00% Floor (5.50% PIK)

14.91

7/23/2021

7/23/2027

20,423,325

20,372,969

17,747,949

2.78

LAC Acquisition LLC d/b/a Lighthouse Autism Center⁽⁶⁾⁽⁷⁾⁽¹²⁾

1st Lien Revolver

Healthcare Providers & Services

S+11.15%, 3.00% Floor (0.50% on unfunded)

0.50

4/3/2024

7/23/2027

500,000

—

(65,498)

(0.01)

Learning Care Group US No 2

1st Lien Term Loan

Education

S+4.00%, 0.50% Floor

7.78

5/12/2025

8/11/2028

12,125,607

11,300,213

9,046,206

1.41

LeVecke Real Estate Holdings, LLC⁽⁷⁾⁽⁸⁾⁽¹¹⁾⁽¹⁴⁾

1st Lien Delayed Draw Term Loan

Real Estate Development & Management

S+7.75%, 3.75% Floor

11.75

12/1/2022

8/31/2026

4,523,100

4,523,100

3,781,538

0.59

Likewize Corp⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Insurance & Insurance Services

S+5.75%, 0.50% Floor

9.50

8/15/2024

8/27/2029

18,362,247

18,044,401

16,721,121

2.61

LVF Holdings Inc⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Food & Beverage

S+5.50%

9.27

2/24/2025

2/24/2032

15,857,995

15,210,537

14,746,836

2.31

Mercury Bidco LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Technology

S+5.75%, 1.00% Floor

9.82

5/31/2023

5/31/2030

17,297,773

17,086,651

16,226,000

2.54

Mercury Bidco LLC⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Revolver

Technology

S+5.75%, 1.00% Floor (0.50% on unfunded)

0.50

5/31/2023

5/31/2029

1,981,556

(15,936)

(97,349)

(0.02)

Meta Buyer LLC⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Consumer Products

S+5.25%, 0.75% Floor

9.00

12/22/2025

12/22/2031

3,630,385

3,598,036

3,598,303

0.56

Meta Buyer LLC⁽⁷⁾

1st Lien Term Loan

Consumer Products

E+5.25%, 0.75% Floor

7.56

12/22/2025

12/22/2031

€

5,046,856

5,857,045

5,667,603

0.89

Meta Buyer LLC⁽⁷⁾

1st Lien Term Loan

Consumer Products

BBSY+5.25%, 0.75% Floor

9.76

12/22/2025

12/22/2031

AU$

3,819,489

2,501,868

2,629,736

0.41

Meta Buyer LLC⁽⁶⁾⁽⁷⁾⁽⁹⁾

1st Lien Delayed Draw Term Loan

Consumer Products

S+5.25%, 0.75% Floor (1.00% on unfunded)

9.00

12/22/2025

12/22/2031

3,383,676

1,586,558

1,579,107

0.25

Meta Buyer LLC⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Consumer Products

S+5.25%, 0.75% Floor (0.50% on unfunded)

9.20

1/21/2026

12/22/2031

1,479,569

428,379

428,562

0.07

Michael Baker International LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Professional Services

S+4.50%, 0.75% Floor

8.40

12/30/2025

12/1/2028

18,038,713

17,553,158

17,533,629

2.74

MMS BidCo LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾⁽¹⁶⁾

1st Lien Term Loan

Healthcare Providers & Services

S+5.375%, 1.00% Floor

9.04

6/30/2022

6/30/2029

9,030,448

8,985,861

8,992,810

1.41

Mounty US Holdings⁽⁷⁾⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Software & Services

S+5.75%, 1.00% Floor

9.47

5/17/2024

5/17/2030

6,813,260

6,728,358

6,561,169

1.03

Mounty US Holdings⁽⁶⁾⁽⁷⁾⁽¹⁰⁾⁽¹²⁾⁽¹³⁾

1st Lien Revolver

Software & Services

S+5.75%, 1.00% Floor (0.50% on unfunded)

0.50

5/17/2024

5/17/2030

995,726

(13,159)

(36,842)

(0.01)

The accompanying notes are an integral part of these consolidated financial statements.

8


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

September 30, 2026 (Unaudited)

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(17)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

National Dentex Corp⁽⁷⁾⁽¹¹⁾⁽¹⁴⁾⁽¹⁶⁾

1st Lien Term Loan

Healthcare Providers & Services

S+10.10%, 1.00% Floor (1.00% PIK)

14.00%

10/26/2020

9/30/2026

$

13,896,457

$11,554,228

$3,347,656

0.52%

National Dentex Corp⁽⁷⁾⁽¹¹⁾⁽¹⁴⁾⁽¹⁶⁾

1st Lien Delayed Draw Term Loan

Healthcare Providers & Services

S+10.10%, 1.00% Floor (1.00% PIK)

14.00

10/26/2020

9/30/2026

6,994,520

5,813,679

1,684,980

0.26

National Dentex Corp⁽⁷⁾⁽¹¹⁾⁽¹⁴⁾⁽¹⁶⁾

1st Lien Delayed Draw Term Loan

Healthcare Providers & Services

S+12.10%, 1.00% Floor (S+12.10% PIK)

16.00

10/29/2024

9/30/2026

3,397,562

580,738

818,473

0.13

National Dentex Corp⁽⁷⁾⁽¹¹⁾⁽¹⁴⁾⁽¹⁶⁾

1st Lien Delayed Draw Term Loan

Healthcare Providers & Services

S+10.10%, 1.00% Floor (1.00% PIK)

14.00

4/4/2024

9/30/2026

1,112,271

898,936

267,946

0.04

National Dentex Corp⁽⁷⁾⁽¹¹⁾⁽¹⁴⁾

1st Lien Delayed Draw Term Loan

Healthcare Providers & Services

S+10.10%, 1.00% Floor (1.00% PIK)

14.00

9/24/2025

9/30/2026

1,922,081

1,747,123

1,922,081

0.30

National Dentex Corp⁽⁶⁾⁽⁷⁾⁽¹¹⁾⁽¹⁴⁾

1st Lien Revolver

Healthcare Providers & Services

S+9.10%, 1.00% Floor (0.50% on unfunded) (1.00% PIK)

13.00

10/26/2020

9/30/2026

1,777,755

1,475,733

413,392

0.06

NetSPI Midco Corporation⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Professional Services

S+6.25%, 1.00% Floor

10.12

5/31/2024

5/31/2029

6,911,607

6,827,965

6,738,817

1.05

NetSPI Midco Corporation⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Professional Services

S+6.25%, 1.00% Floor (0.50% on unfunded)

10.62

5/31/2024

5/31/2029

767,956

298,998

287,984

0.05

NP Gaming Acquisition LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Gaming & Entertainment

S+6.50%, 1.00% Floor

10.23

4/21/2026

4/21/2031

14,297,413

13,963,422

13,967,095

2.18

NP Gaming Acquisition LLC⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Revolver

Gaming & Entertainment

S+6.50%, 1.00% Floor (0.50% on unfunded)

0.50

4/21/2026

4/21/2031

742,723

(16,911)

(17,159)

(0.00)

PaperWorks Industries Holding Corp.⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Paper & Packaging

S+7.00%, 1.00% Floor

10.82

6/30/2023

6/30/2029

19,368,122

18,944,918

18,648,892

2.92

Pelican Power Borrower LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾⁽²⁰⁾

1st Lien Term Loan

Power Generation

S+5.50%, 2.00% Floor

9.26

8/30/2024

8/29/2030

27,988,900

26,805,254

28,380,740

4.44

Peloton Interactive Inc⁽⁸⁾⁽¹⁰⁾

1st Lien Term Loan

Fitness & Leisure

S+5.50%

9.40

5/23/2024

5/30/2029

21,846,315

21,973,502

21,832,715

3.41

Peraton Corp

1st Lien Term Loan

Technology

S+3.75%, 0.75% Floor

7.67

7/28/2026

2/1/2028

12,000,280

11,412,490

11,160,260

1.75

Quirch Foods Holdings LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Food & Beverage

S+6.50%, 1.00% Floor

10.31

11/24/2025

11/12/2030

11,631,010

11,509,252

11,537,962

1.80

Quirch Foods Holdings LLC⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Delayed Draw Term Loan

Food & Beverage

S+6.50%, 1.00% Floor (1.00% on unfunded)

1.00

11/24/2025

11/12/2030

1,209,254

(6,320)

(9,674)

(0.00)

Radiate Holdco LLC⁽⁸⁾

1st Lien Term Loan

Telecommunications

S+4.00%, 1.00% Floor

7.90

10/23/2025

6/26/2029

5,000,250

4,940,169

4,990,900

0.78

Radiate Holdco LLC⁽⁸⁾

1st Lien Delayed Draw Term Loan

Telecommunications

S+4.00%, 1.00% Floor

7.90

10/23/2025

6/26/2029

5,000,250

4,989,281

4,990,900

0.78

Rayonier AM Products Inc⁽⁷⁾⁽⁸⁾⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Paper & Packaging

S+7.50%, 3.00% Floor

11.57

10/28/2024

10/29/2029

10,668,478

10,491,671

10,425,538

1.63

Recorded Books Inc (RB Media)⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Media: Diversified & Production

S+5.00%, 0.75% Floor

8.76

8/31/2023

9/3/2030

8,630,042

8,524,008

8,454,760

1.32

Recorded Books Inc (RB Media)⁽⁶⁾⁽⁷⁾

1st Lien Delayed Draw Term Loan

Media: Diversified & Production

S+5.00%, 0.75% Floor (1.00% on unfunded)

9.07

8/15/2025

9/3/2030

390,213

363,136

361,319

0.06

Recorded Books Inc (RB Media)⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Media: Diversified & Production

S+5.00%, 0.75% Floor (0.50% on unfunded)

8.82

8/31/2023

8/31/2029

987,009

706,741

700,292

0.11

Resistance Holdings Inc⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Pharmaceuticals & Life Sciences

S+5.00%, 1.00% Floor

9.07

3/16/2026

3/14/2031

14,351,923

14,152,282

14,237,107

2.23

Resistance Holdings Inc⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Revolver

Pharmaceuticals & Life Sciences

S+5.00%, 1.00% Floor (0.38% on unfunded)

0.38

3/16/2026

3/14/2031

1,258,941

(16,824)

(10,072)

(0.00)

RKG Newco LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Consumer Products

S+5.50%, 1.00% Floor

9.25

2/2/2026

2/2/2033

18,143,804

17,813,883

17,813,683

2.79

RKG Newco LLC⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Consumer Products

S+5.50%, 1.00% Floor (0.50% on unfunded)

9.30

2/2/2026

2/2/2033

1,417,346

456,223

456,084

0.07

SBP Holdings LP⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Industrial Products & Services

S+5.00%, 1.00% Floor

8.90

3/27/2023

3/27/2028

5,146,457

5,085,456

5,104,722

0.80

SBP Holdings LP⁽⁶⁾⁽⁷⁾

1st Lien Delayed Draw Term Loan

Industrial Products & Services

S+5.00%, 1.00% Floor (1.00% on unfunded)

8.86

11/30/2023

3/27/2028

1,670,760

1,097,785

1,096,983

0.17

SBP Holdings LP⁽⁷⁾⁽⁹⁾

1st Lien Delayed Draw Term Loan

Industrial Products & Services

S+5.00%, 1.00% Floor

8.58

3/27/2023

3/27/2028

740,655

732,314

734,649

0.11

SBP Holdings LP⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Delayed Draw Term Loan

Industrial Products & Services

S+5.00%, 1.00% Floor (1.00% on unfunded)

1.00

8/19/2024

3/27/2028

1,429,513

(2,956)

(11,362)

(0.00)

SBP Holdings LP⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Revolver

Industrial Products & Services

S+5.00%, 1.00% Floor (0.50% on unfunded)

0.50

3/27/2023

3/27/2028

838,328

(6,360)

(6,846)

(0.00)

The accompanying notes are an integral part of these consolidated financial statements.

9


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

September 30, 2026 (Unaudited)

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(17)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

Shrieve Chemical Co LLC⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Specialty Chemicals

S+6.00%, 1.00% Floor

9.90%

10/30/2024

10/30/2030

$

6,676,436

$6,578,274

$6,610,092

1.03%

Shrieve Chemical Co LLC⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Specialty Chemicals

S+6.00%, 1.00% Floor (0.50% on unfunded)

9.90

10/30/2024

10/30/2030

539,828

168,509

170,986

0.03

Sintec Media NYC Inc⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Software & Services

S+7.00%, 1.00% Floor

11.03

6/21/2023

6/21/2029

11,502,896

11,315,830

11,192,947

1.75

Sintec Media NYC Inc⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Software & Services

S+7.00%, 1.00% Floor (0.50% on unfunded)

10.99

6/21/2023

6/21/2029

1,164,025

950,314

933,999

0.15

Smarsh Inc⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Software & Services

S+5.00%, 0.75% Floor

9.07

2/18/2022

2/18/2029

4,253,705

4,217,267

4,109,767

0.64

Smarsh Inc⁽⁶⁾⁽⁷⁾

1st Lien Delayed Draw Term Loan

Software & Services

S+5.00%, 0.75% Floor (1.00% on unfunded)

9.07

2/18/2022

2/18/2029

472,634

96,363

88,932

0.01

Smarsh Inc⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Software & Services

S+5.00%, 0.75% Floor (0.50% on unfunded)

8.80

2/18/2022

2/18/2029

236,317

114,628

108,586

0.02

Southeastern Grocers LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Staples Retail

S+7.50%, 1.00% Floor

11.57

9/19/2025

9/19/2030

9,837,080

9,587,513

11,776,076

1.84

SP PF Buyer LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Specialty Retail

S+7.00%, 1.00% Floor

10.82

10/15/2024

10/13/2029

18,702,452

18,343,939

18,324,468

2.87

Spectrum Group Buyer Inc (Pixelle)⁽⁸⁾

1st Lien Term Loan

Paper & Packaging

S+6.50%, 0.75% Floor

10.32

5/11/2022

5/19/2028

5,887,507

5,757,366

5,448,034

0.85

Speedstar Holding LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Automobiles & Components

S+6.00%, 1.00% Floor

9.75

7/2/2024

7/22/2029

14,408,533

14,342,059

11,345,346

1.77

Speedstar Holding LLC⁽⁷⁾

1st Lien Delayed Draw Term Loan

Automobiles & Components

S+6.00%, 1.00% Floor

9.85

7/2/2024

7/22/2029

1,573,561

1,566,775

1,239,029

0.19

Stryten Energy Resources LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Industrial Products & Services

S+5.50%, 1.00% Floor

9.19

12/18/2024

12/18/2029

11,074,225

10,923,931

11,074,225

1.73

Sweet Oak Parent LLC (fka Ozark Holdings LLC)⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Specialty Retail

S+5.75%, 0.75% Floor

9.50

8/5/2024

8/5/2030

16,373,187

16,090,635

16,225,828

2.54

Telestream 2 LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Software & Services

S+6.25%, 1.00% Floor

10.00

6/7/2025

6/7/2028

9,720,929

9,720,929

9,612,979

1.50

Telestream 2 LLC⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Software & Services

S+8.25%, 1.00% Floor (2.00% on unfunded)

12.00

6/7/2025

6/7/2028

425,843

89,307

63,876

0.01

TETRA Technologies Inc⁽⁷⁾⁽⁸⁾⁽¹⁰⁾

1st Lien Term Loan

Oilfield Services

S+5.85%, 1.00% Floor

9.76

1/12/2024

1/11/2030

15,161,402

14,925,832

14,933,576

2.34

Titan Purchaser, Inc. (Waupaca Foundry)⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Industrial Products & Services

S+6.00%, 1.00% Floor

10.07

3/1/2024

3/1/2030

14,098,706

13,774,489

14,107,258

2.21

Trimlite Mfg US Inc.⁽⁷⁾

1st Lien Term Loan

Building Products

S+5.00%, 1.00% Floor

9.07

9/1/2026

3/11/2031

6,377,104

6,282,987

6,281,447

0.98

USA Debusk LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Commercial Services

S+5.25%, 0.75% Floor

9.01

4/30/2024

4/30/2031

17,373,227

17,206,940

17,069,195

2.67

USA Debusk LLC⁽⁷⁾⁽⁸⁾

1st Lien Delayed Draw Term Loan

Commercial Services

S+5.25%, 0.75% Floor

9.06

4/30/2024

4/30/2031

2,014,540

1,995,890

1,979,286

0.31

USA Debusk LLC⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Commercial Services

S+5.25%, 0.75% Floor (0.50% on unfunded)

9.13

2/2/2026

4/30/2030

1,882,702

1,530,107

1,512,850

0.24

UserZoom Technologies Inc⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Technology

S+7.75%, 1.00% Floor (1.75% PIK)

11.56

1/12/2023

4/5/2029

12,238,953

12,036,668

10,762,116

1.68

Vantage Specialty Chemicals Inc⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Specialty Chemicals

S+6.75%, 1.00% Floor (2.75% PIK)

10.82

8/29/2025

8/29/2029

20,380,387

19,997,014

19,157,564

3.00

Vantage Specialty Chemicals Inc⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Specialty Chemicals

S+6.25%, 1.00% Floor (0.50% on unfunded)

10.04

8/29/2025

2/28/2029

1,731,343

522,051

447,985

0.07

Vensure Employer Services Inc⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Business Services

S+5.00%, 0.50% Floor

9.03

9/27/2024

9/27/2031

5,841,298

5,796,838

5,781,391

0.90

Vensure Employer Services Inc⁽⁶⁾⁽⁷⁾⁽¹²⁾

1st Lien Delayed Draw Term Loan

Business Services

S+5.00%, 0.50% Floor (0.50% on unfunded)

0.50

3/4/2026

9/29/2031

280,134

—

(2,873)

(0.00)

Vital Farms Inc⁽⁷⁾⁽⁸⁾⁽¹⁰⁾

1st Lien Term Loan

Food & Beverage

S+7.50%, 1.00% Floor

11.57

8/4/2026

8/4/2029

11,493,566

11,161,204

11,148,759

1.74

Wrangler Topco, LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Software & Services

S+5.50%, 1.00% Floor

9.26

7/7/2023

9/20/2029

13,575,773

13,360,892

13,233,367

2.07

Wrangler Topco, LLC⁽⁷⁾⁽⁸⁾

1st Lien Delayed Draw Term Loan

Software & Services

S+5.50%, 1.00% Floor

9.23

9/20/2024

9/20/2029

743,925

739,792

725,281

0.11

Wrangler Topco, LLC⁽⁶⁾⁽⁷⁾⁽¹²⁾⁽¹³⁾

1st Lien Revolver

Software & Services

S+5.50%, 1.00% Floor (0.50% on unfunded)

0.50

7/7/2023

9/20/2029

1,502,990

(18,119)

(38,201)

(0.01)

Xactus LLC⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Business Services

S+5.50%, 0.75% Floor

9.57

5/6/2025

5/6/2032

8,753,292

8,639,261

8,692,019

1.36

Xactus LLC⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Business Services

S+5.50%, 0.75% Floor (0.50% on unfunded)

9.57

5/6/2025

5/6/2030

718,711

231,818

230,946

0.04

Total United States of America 1st Lien/Secured Loans

953,894,692

915,764,575

143.21

The accompanying notes are an integral part of these consolidated financial statements.

10


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

September 30, 2026 (Unaudited)

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(17)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

Canada

1261229 BC LTD⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Healthcare Equipment & Supplies

S+6.25%

10.15%

8/28/2025

10/8/2030

$

22,330,519

$22,236,021

$22,233,203

3.48%

Central Wire Acquisition, Co. Inc.⁽⁷⁾⁽⁸⁾⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Industrial Products & Services

S+5.00%, 1.00% Floor

8.74

8/4/2026

8/4/2032

13,842,153

13,704,767

13,703,731

2.14

Central Wire Acquisition, Co. Inc.⁽⁶⁾⁽⁷⁾⁽¹⁰⁾⁽¹²⁾⁽¹³⁾

1st Lien Revolver

Industrial Products & Services

S+5.00%, 1.00% Floor (0.50% on unfunded)

0.50

8/4/2026

8/4/2032

2,030,182

(19,763)

(20,302)

(0.00)

Gateway Casinos & Entertainment Ltd⁽⁸⁾⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Gaming & Entertainment

S+6.25%, 0.75% Floor

10.23

12/18/2024

12/18/2030

20,024,805

19,956,140

19,157,030

3.00

Hootsuite Inc.⁽⁷⁾⁽⁸⁾⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Software & Services

S+5.50%, 0.75% Floor

9.31

5/22/2024

5/22/2030

12,511,246

12,383,337

12,110,886

1.89

Hootsuite Inc.⁽⁶⁾⁽⁷⁾⁽¹⁰⁾

1st Lien Revolver

Software & Services

S+5.50%, 0.75% Floor (0.50% on unfunded)

9.40

5/22/2024

5/22/2030

1,422,136

157,717

125,148

0.02

IE CA Leasing Ltd⁽⁷⁾⁽⁸⁾⁽¹⁰⁾

1st Lien Term Loan

Technology

9.51%

9.51

8/26/2026

8/31/2029

15,822,445

15,822,445

15,822,445

2.47

Otodata Holdings Inc⁽⁷⁾⁽¹⁰⁾

1st Lien Term Loan

Technology Hardware & Equipment

S+4.75%, 0.75% Floor

8.65

8/31/2026

8/31/2033

3,770,140

3,733,024

3,732,438

0.58

Otodata Holdings Inc⁽⁷⁾⁽¹⁰⁾

1st Lien Term Loan

Technology Hardware & Equipment

C+4.75%, 0.75% Floor

7.04

8/31/2026

8/31/2033

C$

212,677

151,400

147,941

0.02

Otodata Holdings Inc⁽⁶⁾⁽⁷⁾⁽¹⁰⁾⁽¹²⁾⁽¹³⁾

1st Lien Delayed Draw Term Loan

Technology Hardware & Equipment

S+4.75%, 0.75% Floor

—

8/31/2026

8/31/2033

1,169,723

(5,777)

(5,849)

(0.00)

Otodata Holdings Inc⁽⁶⁾⁽⁷⁾⁽¹⁰⁾⁽¹²⁾⁽¹³⁾

1st Lien Delayed Draw Term Loan

Technology Hardware & Equipment

C+4.75%, 0.75% Floor

—

8/31/2026

8/31/2033

C$

345,883

(1,229)

(1,215)

(0.00)

Otodata Holdings Inc⁽⁶⁾⁽⁷⁾⁽¹⁰⁾⁽¹²⁾⁽¹³⁾

1st Lien Revolver

Technology Hardware & Equipment

S+4.75%, 0.75% Floor (0.50% on unfunded)

0.50

8/31/2026

8/31/2033

614,400

(6,070)

(6,144)

(0.00)

Source Energy Services Ltd⁽⁷⁾⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Oilfield Services

S+6.25%, 4.25% Floor

10.50

12/20/2024

12/20/2029

1,899,652

1,845,210

1,863,871

0.29

Total Canada 1st Lien/Secured Loans

89,957,222

88,863,183

13.89

Luxembourg

Accelya Lux Finco Sarl⁽¹⁰⁾

1st Lien Term Loan

Software & Services

S+5.25%

9.32

9/29/2025

10/4/2032

7,463,589

7,330,215

6,684,577

1.05

Total Luxembourg 1st Lien/Secured Loans

7,330,215

6,684,577

1.05

Netherlands

OLA Netherlands BV (aka Olacabs / ANI Tech)⁽⁷⁾⁽¹⁰⁾

1st Lien Term Loan

Technology

S+6.25%, 0.75% Floor

10.15

12/3/2021

12/15/2026

3,947,687

3,943,469

3,662,477

0.57

WeTransfer BV⁽¹⁰⁾

1st Lien Term Loan

Technology

E+5.00%

7.59

7/18/2025

3/7/2031

€

7,110,020

8,211,213

8,053,175

1.26

WeTransfer BV⁽¹⁰⁾

1st Lien Term Loan

Technology

E+5.63%

8.22

1/2/2026

3/7/2031

€

984,490

1,114,665

1,117,524

0.17

Total Netherlands 1st Lien/Secured Loans

13,269,347

12,833,176

2.00

United Kingdom

Inspired Entertainment Financing PLC⁽⁷⁾⁽⁸⁾⁽¹⁰⁾

1st Lien Term Loan

Gaming & Entertainment

SONIA+6.00%, 3.00% Floor

9.73

6/11/2025

6/4/2030

£

8,557,880

11,461,072

11,300,461

1.77

Neon Finance Limited (fka TEN Entertainment Group PLC)⁽⁷⁾⁽⁸⁾⁽¹⁰⁾

1st Lien Term Loan

Gaming & Entertainment

SONIA+7.50%, 2.50% Floor

11.23

1/26/2024

2/6/2030

£

3,901,951

4,878,691

5,135,788

0.80

Total United Kingdom 1st Lien/Secured Loans

16,339,763

16,436,249

2.57

Total 1st Lien/Secured Loans

1,080,791,239

1,040,581,760

162.72

The accompanying notes are an integral part of these consolidated financial statements.

11


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

September 30, 2026 (Unaudited)

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(17)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

2nd Lien/Secured Loans

United States of America

Delos Living LLC⁽⁷⁾

2nd Lien Term Loan

Real Estate Development & Management

14.00% (7.00% PIK)

14.00%

10/9/2025

7/11/2027

$

5,579,238

$5,460,272

$4,652,110

0.73%

FourPoint Resources Intermediate Holdings, LLC⁽⁷⁾⁽⁹⁾

2nd Lien Term Loan

Energy

S+7.00%, 2.50% Floor

11.10

1/22/2025

1/22/2030

11,494,239

11,258,606

11,379,297

1.78

Total United States of America 2nd Lien Term Loan

16,718,878

16,031,407

2.51

Total 2nd Lien/Secured Loans

16,718,878

16,031,407

2.51

Equities

United States of America

Alpine Acquisition Corp II⁽⁷⁾⁽¹¹⁾

Preferred Equities

Transportation & Logistics

N/A

N/A

1/14/2026

N/A

35,396

1,504,334

1,534,046

0.24

Alpine Acquisition Corp II⁽⁷⁾⁽¹¹⁾

Common Equities

Transportation & Logistics

N/A

N/A

1/14/2026

N/A

35,396

122,423

—

—

BayMark Health Services Inc⁽⁷⁾⁽¹¹⁾

Common Equities

Healthcare Providers & Services

N/A

N/A

9/30/2026

N/A

10,625

—

—

—

BayMark Health Services Inc⁽⁷⁾⁽¹¹⁾

Preferred Equities

Healthcare Providers & Services

N/A

N/A

9/30/2026

N/A

2,897,051

1,148,681

1,148,681

0.18

Beauty Health Co⁽¹¹⁾

Common Equities

Consumer Services

N/A

N/A

7/7/2023

N/A

913,460

—

575,480

0.09

Circle Graphics Parent, LP⁽⁷⁾⁽¹¹⁾

Preferred Equities

E-Commerce

N/A

N/A

6/30/2025

N/A

3,574,384

—

—

—

Monomoy Capital Partners IV-Titan, L.P. (Waupaca Foundry)⁽⁷⁾⁽¹⁰⁾⁽¹¹⁾

Partnership Interests

Industrial Products & Services

N/A

N/A

2/23/2024

N/A

469,126

217,037

334,721

0.05

RKG Group Partners LP⁽⁷⁾⁽¹¹⁾

Preferred Equities

Consumer Products

N/A

N/A

2/2/2026

N/A

956,421

956,421

1,122,838

0.18

Telestream 2 LLC⁽⁷⁾⁽¹¹⁾

Common Equities

Software & Services

N/A

N/A

6/7/2025

N/A

425,843

4,044,696

2,916,812

0.46

Total United States of America Equities

7,993,592

7,632,578

1.20

Total Equities

7,993,592

7,632,578

1.20

Senior Secured Bonds

United States of America

Amber Energy Inc.⁽⁷⁾

Senior Secured Bonds

Energy

15.00%

15.00

11/26/2025

12/1/2045

49,272

49,272

49,272

0.01

MPT Operating Partnership LP / MPT Finance Corp⁽¹⁰⁾

Senior Secured Bonds

Healthcare Providers & Services

9.25%

9.25

9/22/2026

2/15/2032

3,291,000

3,217,170

3,110,216

0.49

Service Properties Trust⁽¹⁰⁾

Senior Secured Bonds

Real Estate Development & Management

0.00%

0.00

9/15/2025

9/30/2027

8,929,000

8,296,785

8,346,310

1.31

Total United States of America Senior Secured Bonds

11,563,227

11,505,798

1.81

Canada

Bausch Health Cos Inc (Valeant)⁽¹⁰⁾

Senior Secured Bonds

Healthcare Equipment & Supplies

4.88%

4.88

11/5/2025

6/1/2028

1,069,000

996,563

1,012,602

0.16

Total Canada Senior Secured Bonds

996,563

1,012,602

0.16

Italy

LSF12 Rigel US Investments LLC⁽⁷⁾⁽⁸⁾⁽¹⁰⁾

Senior Secured Bonds

Specialty Chemicals

9.50%

9.50

4/30/2026

10/31/2031

€

18,002,000

20,236,443

19,626,307

3.07

Total Italy Senior Secured Bonds

20,236,443

19,626,307

3.07

Total Senior Secured Bonds

32,796,233

32,144,707

5.04

The accompanying notes are an integral part of these consolidated financial statements.

12


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

September 30, 2026 (Unaudited)

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(17)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

Warrants

United States of America

Delos Living LLC⁽⁷⁾⁽¹¹⁾

Warrants

Real Estate Development & Management

N/A

N/A

10/9/2025

N/A

2

$111,308

$—

0.00%

Total Warrants

111,308

—

0.00

Total Non-Controlled/Non-Affiliated Investments

1,138,411,250

1,096,390,452

171.47%

Non-Controlled/Affiliated Investments

1st Lien/Secured Loans

United States of America

Inotiv Inc⁽⁷⁾⁽¹⁶⁾⁽¹⁸⁾

1st Lien Term Loan

Pharmaceuticals & Life Sciences

S+7.61%, 1.00% Floor

11.51

7/20/2026

7/19/2031

9,646,182

9,646,182

9,618,208

1.50

Inotiv Inc⁽⁶⁾⁽⁷⁾⁽¹⁸⁾

1st Lien Delayed Draw Term Loan

Pharmaceuticals & Life Sciences

S+6.00%, 1.00% Floor

10.01

7/20/2026

7/19/2031

1,884,498

879,433

861,844

0.13

Total United States of America 1st Lien/Secured Loans

10,525,615

10,480,052

1.63

Germany

Takko Fashion GmbH⁽⁷⁾⁽¹⁰⁾⁽¹⁸⁾

1st Lien Term Loan

Specialty Retail

9.13%

9.13

11/25/2025

4/15/2030

€

1,189,578

1,370,513

1,347,643

0.21

Total Germany 1st Lien/Secured Loans

1,370,513

1,347,643

0.21

Total 1st Lien/Secured Loans

11,896,128

11,827,695

1.84

Senior Secured Debt

United States of America

Wesco Aircraft Holdings Inc⁽¹⁸⁾

Senior Secured Debt

Industrial Products & Services

S+8.00% (S+8.00% PIK)

11.65

1/31/2025

1/31/2030

6,832,115

6,811,557

6,832,115

1.07

Total United States of America Senior Secured Debt

6,811,557

6,832,115

1.07

Total Senior Secured Debt

6,811,557

6,832,115

1.07

Unsecured Debt

United States of America

Wesco Aircraft Holdings Inc⁽⁷⁾⁽¹⁸⁾

Senior Unsecured Debt

Industrial Products & Services

6.00% (6.00% PIK)

6.00

1/31/2025

1/31/2033

4,588,528

6,799,880

7,470,123

1.17

Total United States of America Unsecured Debt

6,799,880

7,470,123

1.17

Luxembourg

Takko Fashion Sarl⁽⁷⁾⁽¹⁰⁾⁽¹⁸⁾

Subordinated Unsecured Debt

Specialty Retail

15.00% (15.00% PIK)

15.00

8/8/2023

10/15/2030

€

1,987,782

2,133,241

13,139,538

2.05

Total Luxembourg Unsecured Debt

2,133,241

13,139,538

2.05

Total Unsecured Debt

8,933,121

20,609,661

3.22

Equities

United States of America

Inotiv Inc⁽⁷⁾⁽¹¹⁾⁽¹⁸⁾

Common Equities

Pharmaceuticals & Life Sciences

N/A

N/A

7/20/2026

N/A

297,939

4,535,348

3,843,264

0.60

Wesco Aircraft Holdings Inc⁽⁷⁾⁽¹¹⁾⁽¹⁸⁾

Common Equities

Industrial Products & Services

N/A

N/A

1/31/2025

N/A

195,566

7,459,569

8,002,561

1.25

Total Equities

11,994,917

11,845,825

1.85

Total Non-Controlled/Affiliated Investments

39,635,723

51,115,296

7.98%

The accompanying notes are an integral part of these consolidated financial statements.

13


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

September 30, 2026 (Unaudited)

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(17)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

Controlled Investments

1st Lien/Secured Loans

United States of America

SP-CREH 19 Highline LLC⁽⁷⁾⁽¹¹⁾⁽¹⁴⁾⁽¹⁹⁾

1st Lien Term Loan

Multi-Family

S+2.00%, 3.00% Floor

5.74%

6/28/2021

7/1/2027

$

2,628,088

$2,628,088

$1,200,166

0.19%

Total 1st Lien/Secured Loans

2,628,088

1,200,166

0.19

Equities

United States of America

SP-CREH 19 Highline LLC⁽⁷⁾⁽¹¹⁾⁽¹⁹⁾

Common Equities

Multi-Family

N/A

N/A

6/28/2021

N/A

70%

14,608,750

—

—

Total Equities

14,608,750

—

—

Trust Interest

United States of America

TH Liquidating Trust⁽⁷⁾⁽¹¹⁾⁽¹⁹⁾

Trust Interest

Other

N/A

N/A

12/7/2019

12/6/2026

14%

3,153,474

969,500

0.15

TH Liquidating Trust⁽⁶⁾⁽⁷⁾⁽¹¹⁾⁽¹⁹⁾

Trust Interest

Other

N/A

N/A

10/9/2020

12/6/2026

14%

—

—

—

TH Liquidating Trust⁽⁷⁾⁽¹⁹⁾

Trust Interest

Other

P+10.50%, 0.50% Floor (2.00% PIK)

17.50

12/7/2019

12/6/2026

776,522

776,522

618,345

0.10

Total Trust Interest

3,929,996

1,587,845

0.25

Real Estate Properties

United States of America

1035 Mecklenburg Highway, Mooresville, North Carolina⁽⁷⁾⁽¹⁰⁾⁽¹¹⁾⁽¹⁹⁾

Real Estate Properties

Industrial Real Estate

N/A

N/A

8/22/2023

N/A

100%

14,821,662

10,399,220

1.63

Total Real Estate Properties

14,821,662

10,399,220

1.63

Total Controlled Investments

35,988,496

13,187,231

2.07%

Total Investments, September 30, 2026

$1,214,035,469

$1,160,692,979

181.52%

Cash Equivalents

JPMorgan 100% US Treasury Securities Money Market Fund, Capital Class

Money Market Fund

12,434,159

12,434,159

12,434,159

1.94

Total Cash Equivalents

12,434,159

12,434,159

1.94%

Restricted Cash Equivalents

JPMorgan 100% US Treasury Securities Money Market Fund, Capital Class⁽⁸⁾⁽⁹⁾

Money Market Fund

25,549,979

25,549,979

25,549,979

4.00

Total Restricted Cash Equivalents

25,549,979

25,549,979

4.00%

Total Cash Equivalents and Restricted Cash Equivalents, September 30, 2026

$37,984,138

$37,984,138

5.94%

(1)

All of our investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), unless otherwise noted.

(2)

Investments may contain a variable rate structure, subject to an interest rate floor or cap. Variable rate investments bear interest at a rate that may be determined by reference to either Secured Overnight Financing Rate (“SOFR” or “S”), Euro Interbank Offer Rate (“Euribor” or “E”), Canadian Overnight Repo Rate Average (“CORRA” or “C”), Prime Rate (“P”), Sterling Overnight Index Average (“SONIA”) or the Australian Dollar Bank Bill Swap Bid Rate (“BBSY”), which can generally include one-, three- or six-month tenor, at the borrower’s option, which reset periodically based on the terms of the credit agreement. For investments with multiple interest rate contracts, the interest rate shown is the weighted average interest rate in effect on September 30, 2026.

(3)

Par amount includes unfunded commitments, accumulated payment-in-kind (“PIK”) interest and is net of principal repayments. Amounts are in USD unless otherwise noted. Equity investments and investments in money market funds are recorded as number of shares owned or economic ownership percentage.

(4)

Cost represents amortized cost for debt investments, less principal payments, plus capitalized PIK, if any. As of September 30, 2026, the aggregate gross unrealized appreciation for all investments where there was an excess of fair value over tax cost was $25.1 million; the aggregate gross unrealized depreciation for all investments where there was an excess of tax cost over fair value was $85.1 million; the net unrealized depreciation was $60.0 million; the aggregate tax cost of securities for Federal income tax purposes was $1.2 billion.

(5)

Percentage is based on net assets of $639,509,124 as of September 30, 2026.

(6)

The investment has an unfunded commitment as of September 30, 2026 (see Note 8 in the accompanying notes to the consolidated financial statements).

(7)

Fair value was determined using significant unobservable inputs (see Note 5 in the accompanying notes to the consolidated financial statements).

(8)

Some or all of these investments are pledged as collateral to the Revolving Credit Facility (see Note 6 in the accompanying notes to the consolidated financial statements), totaling $480.1 million including restricted cash equivalents.

(9)

Some or all of these investments are pledged as collateral to the 2024 CLO (see Note 6 in the accompanying notes to the consolidated financial statements), totaling $406.7 million including restricted cash equivalents.

The accompanying notes are an integral part of these consolidated financial statements.

14


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

September 30, 2026 (Unaudited)

(10)

These investments are treated as non-qualifying investments under Section 55(a) of the 1940 Act. Under the 1940 Act, the Fund may not acquire any non-qualifying assets unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Fund’s total assets. As of September 30, 2026, qualifying assets totaled 75.2% of the Fund’s total assets.

(11)

Represents a non-income producing investment.

(12)

The negative fair value is the result of an unfunded commitment and the original discount on the loan.

(13)

The negative amortized cost is the result of the original discount being greater than the principal amount outstanding on the loan.

(14)

Investment, representing 3.1% of cost and 1.2% of fair value, respectively, was on non-accrual status as of September 30, 2026, meaning that the Fund has ceased accruing interest income on the investment (see Note 2 in the accompanying notes to the consolidated financial statements for additional information about the Fund’s accounting policies).

(15)

Investment represents a unitranche/last out loan, with characteristics of a traditional first lien senior secured loan which, pursuant to an agreement among lenders, is divided into “first out” and “last out” tranches yielding different interest rates. In exchange for the greater risk of loss, the “last-out” tranche of the Fund’s unitranche loan investment earns a higher interest rate than the “first-out” portions. The “first-out” tranche will have priority as to the “last-out” tranche with respect to payments of principal, interest and any other amounts due thereunder. The Fund’s investment is in the “last out” tranche.

(16)

Investment represents a first lien term loan that, under the terms of the applicable credit agreement, does not have first-out priority, whereby revolving facilities or other term loans referenced therein receive priority with respect to the payment of principal and interest.

(17)

Original acquisition date represents the first or original investment in a portfolio company and there may be subsequent follow-on investments after the original acquisition date.

(18)

Under the 1940 Act, the Fund is generally presumed a non-control “affiliated person” if the Fund owns, either directly or indirectly, between 5% and 25% of a portfolio company’s outstanding voting securities and/or is under common control with the portfolio company. As of September 30, 2026, the Fund’s affiliated/non-controlled investments were as follows:

Portfolio
Company

Type of
Investment

Fair Value at
December 31, 2025

Gross additions*

Gross reductions**

Net change in
unrealized
appreciation
(depreciation)

Net realized
gains
(losses)

Fair Value at
September 30, 2026

Interest
income

Dividend
income

Par Amount ($) / Number Of Shares / Ownership %

Inotiv Inc

Secured Loans

$

—

$

9,646,182

$

—

$

(27,974

)

$

—

$

9,618,208

$

254,520

$

—

9,646,182

Inotiv Inc

Secured Loans

—

879,433

—

(17,589

)

—

861,844

17,488

—

1,884,498

Inotiv Inc

Equities

—

4,535,348

—

(692,084

)

—

3,843,264

—

—

297,939

Takko Fashion GmbH

Secured Loans

1,397,278

—

—

(49,635

)

—

1,347,643

100,102

—

€

1,189,578

Takko Fashion Sarl

Unsecured Debt

†

8,436,923

169,816

—

4,532,799

—

13,139,538

176,550

—

€

1,987,782

Wesco Aircraft Holdings Inc

Secured Debt

6,236,045

600,643

—

(4,573

)

—

6,832,115

603,720

—

6,832,115

Wesco Aircraft Holdings Inc

Unsecured Debt

6,651,946

200,441

—

617,736

—

7,470,123

200,441

—

4,588,528

Wesco Aircraft Holdings Inc

Equities

7,541,025

—

—

461,536

—

8,002,561

—

—

195,566

Total

$

30,263,217

$

16,031,863

$

—

$

4,820,216

$

—

$

51,115,296

$

1,352,821

$

—

* Gross additions include increases in the cost basis of the investments resulting from new and follow-on portfolio investments, accretion of discounts, PIK interest, and the exchange of one or more existing securities for one or more new investments.

** Gross reductions include decreases in the cost basis of investments resulting from principal collections related to investments repayments and sales.

† At September 30, 2026, the unsecured debt contained stapled equities of approximately 9.0 million shares which provided certain voting rights.

(19)

Under the 1940 Act, the Fund is presumed to “control” a portfolio company if the Fund owns more than 25% of a portfolio company’s voting securities and/or holds the power to exercise control over the management or policies of such portfolio company. As of September 30, 2026, the Fund’s controlled investments were as follows:

Portfolio
Company

Type of
Investment

Fair Value at
December 31, 2025

Gross additions*

Gross reductions**

Net change in
unrealized
appreciation
(depreciation)

Net realized
gains
(losses)

Fair Value at
September 30, 2026

Interest
income

Other
income

Par Amount ($) / Number Of Units/ Ownership %

1035 Mecklenburg Highway, Mooresville, North Carolina

Real Estate Properties

$

11,386,450

$

163,658

$

(125,000

)

$

(1,025,888

)

$

—

$

10,399,220

$

—

$

—

100

%

SP-CREH 19 Highline LLC

Secured Loans

1,318,690

—

(1,318,756

)

66

—

—

11,546

—

$

—

SP-CREH 19 Highline LLC

Secured Loans

5,613,869

—

(3,496,912

)

(916,791

)

—

1,200,166

262,904

—

$

2,628,088

SP-CREH 19 Highline LLC

Equities

—

—

—

—

—

—

—

—

70

%

TH Liquidating Trust

Trust Interest

969,500

—

—

—

—

969,500

—

—

14

%

TH Liquidating Trust

Trust Interest

—

—

—

—

—

—

—

—

14

%

TH Liquidating Trust

Trust Interest

543,837

93,567

—

(19,059

)

—

618,345

92,211

—

$

776,522

Total

$

19,832,346

$

257,225

$

(4,940,668

)

$

(1,961,672

)

$

—

$

13,187,231

$

366,661

$

—

* Gross additions include increases in the cost basis of the investments resulting from new and follow-on portfolio investments, accretion of discounts, PIK interest, and the exchange of one or more existing securities for one or more new investments.

** Gross reductions include decreases in the cost basis of investments resulting from principal collections related to investments repayments and sales.

(20)

The Fund sold a participating interest of approximately $1.5 million of the portfolio company’s first lien term loan. As the transaction did not qualify as a “true sale” in accordance with U.S. GAAP, the Fund recorded a corresponding $1.5 million liability, at fair value, and the secured borrowing was included in other liabilities on the consolidated statements of assets and liabilities. The associated expenses are included in other general and administrative expenses on the consolidated statements of operations.

The accompanying notes are an integral part of these consolidated financial statements.

15


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

September 30, 2026 (Unaudited)

Additional Information

Interest Rate Swaps

Pay/Receive Floating Rate

Floating Rate Index

Floating Payment Frequency

Fixed Rate

Fixed Payment Frequency

Maturity Date

Counterparty

Notional Amount

Upfront Premiums Received / (Paid)

Unrealized appreciation/ (depreciation)

Interest Rate Swaps, Non-Hedge Accounting

Euro Interest Rate Swaps

Receive

EuroSTR

Annual

2.150%

Annual

12/1/2030

Goldman Sachs

€

13,300,000

$

(279,807

)

$

631,691

UK Interest Rate Swaps

Receive

SONIA

Annual

4.992%

Annual

9/28/2027

Goldman Sachs

£

2,300,000

—

(13,277

)

UK Interest Rate Swaps

Pay

SONIA

Annual

4.992%

Annual

9/28/2027

Goldman Sachs

£

(2,300,000

)

(133,945

)

13,317

US Interest Rate Swaps

Receive

SOFR

Annual

3.348%

Annual

8/31/2028

Goldman Sachs

$

15,600,000

(9,041

)

178,110

US Interest Rate Swaps

Receive

SOFR

Annual

3.780%

Annual

3/10/2030

Goldman Sachs

$

10,300,000

(91,204

)

322,160

Total

1,132,001

Interest Rate Swaps, Hedge Accounting(1)

US Interest Rate Swaps

Pay

SOFR

Annual

4.000%

Quarterly

11/4/2026

Goldman Sachs

$

(145,000,000

)

(367,503

)

450,144

Total

450,144

Total Interest Rate Swaps

$

1,582,145

(1)

Designated as hedging instruments in a fair value hedge, utilizing hedge accounting. The associated change in fair value is recorded along with the change in fair value of the hedged item within interest expense (see Note 6 and Note 7).

Foreign Currency Forward Contracts

Settlement Date

Amount Purchased

Amount Sold

Fair Value

Derivative Counterparty

Bank of America, N.A.

12/31/2026

$

2,730,348

AU$

3,848,352

$

60,358

Bank of America, N.A.

12/31/2026

$

716,228

C$

1,000,016

10,356

Bank of America, N.A.

12/31/2026

C$

389,983

$

276,022

(748

)

Bank of America, N.A.

12/31/2026

$

856,433

€

752,386

762

Bank of America, N.A.

12/31/2026

€

222,349

$

254,635

(1,763

)

Bank of America, N.A.

12/31/2026

$

58,726,555

€

50,987,694

739,419

Bank of America, N.A.

12/31/2026

$

274,922

€

237,224

5,133

Bank of America, N.A.

12/31/2026

$

271,242

€

232,137

7,237

Bank of America, N.A.

12/31/2026

$

16,998,898

£

12,706,216

138,083

Total

$

958,837

The accompanying notes are an integral part of these consolidated financial statements.

16


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

December 31, 2025

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(34)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

Non-Controlled/Non-Affiliated Investments

1st Lien/Secured Loans

United States of America

175 3rd Street⁽⁷⁾

1st Lien Term Loan

Real Estate Development & Management

S+5.50%, 3.75% Floor

9.37%

4/30/2025

5/1/2026

$

8,969,922

$8,935,184

$8,960,287

1.51%

48Forty Solutions LLC⁽⁷⁾⁽²⁸⁾⁽³¹⁾

1st Lien Term Loan

Transportation & Logistics

S+6.15%, 1.00% Floor

9.94

4/8/2022

11/30/2029

6,649,272

6,568,627

2,865,619

0.48

Accela Inc/US⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Software & Services

S+4.75%, 0.75% Floor

8.47

9/1/2023

9/3/2030

10,516,647

10,372,616

10,422,269

1.76

Accela Inc/US⁽⁷⁾

1st Lien Delayed Draw Term Loan

Software & Services

S+4.75%, 0.75% Floor

8.47

4/11/2025

9/3/2030

1,352,140

1,340,058

1,340,006

0.23

Accela Inc/US⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Software & Services

S+4.75%, 0.75% Floor (0.50% on unfunded)

0.50

9/1/2023

9/3/2030

908,238

(12,105)

(9,220)

(0.00)

Accurate Background LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Business Services

S+6.26%, 1.00% Floor

9.93

10/18/2021

3/26/2029

19,145,481

18,107,848

18,939,476

3.19

Advanced Integration Technology LP⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Aerospace & Defense

S+6.60%, 1.00% Floor

10.32

5/24/2022

5/24/2027

13,103,363

12,975,708

13,071,181

2.20

Allentown LLC⁽⁷⁾⁽⁹⁾⁽¹¹⁾

1st Lien Term Loan

Healthcare Equipment & Supplies

S+7.15%, 1.00% Floor

10.98

4/22/2022

4/22/2027

11,590,340

11,453,301

11,275,731

1.90

Allentown LLC⁽⁷⁾⁽¹¹⁾

1st Lien Delayed Draw Term Loan

Healthcare Equipment & Supplies

S+7.15%, 1.00% Floor

10.97

4/22/2022

4/22/2027

1,728,031

1,720,893

1,681,125

0.28

Allentown LLC⁽⁶⁾⁽⁷⁾⁽¹¹⁾

1st Lien Revolver

Healthcare Equipment & Supplies

P+6.00%, 1.00% Floor (0.50% on unfunded)

13.25

4/22/2022

4/22/2027

1,172,037

105,356

84,405

0.01

Allium Buyer LLC⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Business Services

S+5.00%, 1.00% Floor

8.84

5/2/2023

5/2/2030

5,719,807

5,598,249

5,722,909

0.96

Allium Buyer LLC⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Business Services

S+5.00%, 1.00% Floor (0.50% on unfunded)

0.50

5/2/2023

5/2/2029

573,673

(10,648)

(2,089)

(0.00)

Amerijet Holdings Inc⁽⁷⁾⁽¹⁴⁾

1st Lien Term Loan

Transportation & Logistics

11.50%

11.50

12/19/2023

6/30/2027

6,907,617

6,895,666

12,202,306

2.05

Amerijet Holdings Inc⁽⁷⁾⁽³³⁾

1st Lien Term Loan

Transportation & Logistics

S+7.11%, 1.00% Floor

10.83

12/28/2021

6/30/2027

12,996,392

12,843,329

12,062,413

2.03

Amerijet Holdings Inc⁽⁷⁾⁽³³⁾

1st Lien Revolver

Transportation & Logistics

S+7.11%, 1.00% Floor (0.50% on unfunded)

10.83

12/28/2021

6/30/2027

2,536,322

2,515,691

2,352,266

0.40

Aprimo Inc⁽⁷⁾⁽⁸⁾⁽³²⁾

1st Lien Term Loan

Software & Services

S+6.44%, 0.75% Floor

10.16

5/26/2022

5/26/2028

2,166,369

2,146,434

2,148,405

0.36

Arctic Glacier Group Holdings⁽⁷⁾⁽⁸⁾⁽⁹⁾⁽¹⁵⁾

1st Lien Term Loan

Food & Beverage

S+10.76%, 2.00% Floor

14.43

5/24/2023

5/24/2028

10,676,081

10,560,828

10,659,658

1.80

Arctic Glacier Group Holdings⁽⁶⁾⁽⁷⁾⁽¹⁵⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Food & Beverage

S+10.76%, 2.00% Floor (0.50% on unfunded)

0.50

5/24/2023

11/24/2027

838,563

(8,148)

(6,803)

(0.00)

Artisan Bidco Inc⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Technology

S+7.00%, 1.00% Floor

10.94

11/7/2023

11/7/2029

4,111,713

4,026,318

4,053,062

0.68

Artisan Bidco Inc⁽⁷⁾

1st Lien Term Loan

Technology

E+7.00%, 1.00% Floor

9.03

11/7/2023

11/7/2029

€

7,029,331

7,399,353

8,136,332

1.37

Artisan Bidco Inc⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Technology

S+7.00%, 1.00% Floor (0.50% on unfunded)

10.95

11/7/2023

11/7/2029

1,170,535

855,377

860,254

0.14

Atlas Sand Co LLC⁽⁷⁾⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Oilfield Services

9.51%

9.51

3/5/2025

3/1/2032

5,958,153

5,903,400

5,833,032

0.98

Azurite Intermediate Holdings Inc⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Software & Services

S+6.00%, 0.75% Floor

9.72

3/19/2024

3/19/2031

2,119,510

2,093,020

2,106,242

0.35

Azurite Intermediate Holdings Inc⁽⁷⁾⁽⁹⁾

1st Lien Delayed Draw Term Loan

Software & Services

S+6.00%, 0.75% Floor

9.72

3/19/2024

3/19/2031

4,817,068

4,759,958

4,786,914

0.81

Azurite Intermediate Holdings Inc⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Software & Services

S+6.00%, 0.75% Floor (0.50% on unfunded)

0.50

3/19/2024

3/19/2031

770,731

(8,607)

(7,124)

(0.00)

BayMark Health Services Inc⁽⁷⁾⁽²⁸⁾⁽³¹⁾

1st Lien Term Loan

Healthcare Providers & Services

S+5.26%, 1.00% Floor

8.93

6/10/2021

6/11/2027

4,149,399

4,115,469

3,717,239

0.63

BayMark Health Services Inc⁽⁷⁾⁽²⁸⁾⁽³¹⁾

1st Lien Delayed Draw Term Loan

Healthcare Providers & Services

S+5.26%, 1.00% Floor

8.93

11/19/2021

6/11/2027

2,587,437

2,567,425

2,317,955

0.39

BEL USA LLC⁽⁷⁾⁽²⁸⁾⁽³¹⁾

1st Lien Term Loan

E-Commerce

S+9.15%, 2.50% Floor

12.99

12/13/2018

6/2/2026

8,821,421

8,719,947

2,424,430

0.41

Bending Spoons US Inc⁽⁷⁾⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Technology

S+5.25%, 1.00% Floor

9.03

2/19/2025

3/7/2031

13,774,317

13,557,182

13,388,637

2.25

Circle Graphics Inc⁽⁷⁾⁽¹⁶⁾

1st Lien Term Loan

E-Commerce

S+3.25%, 4.00% Floor

7.30

6/30/2025

3/31/2029

10,569,173

10,103,158

9,527,567

1.60

Circle Graphics Inc⁽⁷⁾⁽¹⁷⁾⁽³³⁾

1st Lien Term Loan

E-Commerce

S+3.76%, 4.00% Floor

7.81

6/30/2025

3/31/2029

10,289,260

7,321,190

5,592,727

0.94

The accompanying notes are an integral part of these consolidated financial statements.

17


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

December 31, 2025

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(34)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

Conservice Midco LLC

1st Lien Term Loan

Utilities

S+2.75%

6.47%

5/6/2025

5/13/2030

$

4,975,000

$4,980,569

$4,980,448

0.84%

Contractual Buyer, LLC (dba Kodiak Solutions)⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Healthcare Technology

S+5.75%, 0.75% Floor

9.59

10/10/2023

10/10/2030

3,451,005

3,386,096

3,417,259

0.58

Contractual Buyer, LLC (dba Kodiak Solutions)⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Healthcare Technology

S+5.75%, 0.75% Floor (0.50% on unfunded)

0.50

10/10/2023

10/10/2029

401,425

(6,841)

(4,893)

(0.00)

Coupa Holdings LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Software & Services

S+5.25%, 0.75% Floor

9.09

2/27/2023

2/27/2030

10,195,886

10,017,882

10,222,443

1.72

Coupa Holdings LLC⁽⁶⁾⁽⁷⁾⁽³⁰⁾

1st Lien Delayed Draw Term Loan

Software & Services

S+5.25%, 0.75% Floor (1.00% on unfunded)

1.00

2/27/2023

2/27/2030

924,210

(9,879)

2,407

0.00

Coupa Holdings LLC⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Software & Services

S+5.25%, 0.75% Floor (0.50% on unfunded)

0.50

2/27/2023

2/27/2029

707,659

(9,306)

(1,474)

(0.00)

CP Atlas Buyer Inc (American Bath)⁽⁸⁾

1st Lien Term Loan

Building Products

S+5.25%

8.97

7/1/2025

7/8/2030

18,453,766

17,634,472

17,807,884

3.00

Crewline Buyer Inc⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Software & Services

S+6.75%, 1.00% Floor

10.59

11/8/2023

11/8/2030

9,501,470

9,321,414

9,403,261

1.58

Crewline Buyer Inc⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Software & Services

S+6.75%, 1.00% Floor (0.50% on unfunded)

0.50

11/8/2023

11/8/2030

989,736

(16,838)

(14,430)

(0.00)

Databricks Inc⁽⁷⁾⁽⁸⁾⁽³³⁾

1st Lien Term Loan

Software & Services

S+4.50%

8.27

12/19/2024

1/3/2031

8,679,743

8,645,400

8,723,142

1.47

Databricks Inc⁽⁶⁾⁽⁷⁾⁽³³⁾

1st Lien Delayed Draw Term Loan

Software & Services

S+4.50%, (1.00% on unfunded)

1.00

12/19/2024

1/3/2031

1,859,945

—

—

—

DMT Solutions Global Corp (dba Bluecrest)⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Technology Hardware & Equipment

S+8.10%, 1.00% Floor

11.94

8/30/2023

8/30/2027

17,482,459

17,233,469

17,074,280

2.88

Elessent Clean Technologies Inc⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Specialty Chemicals

S+6.00%, 1.00% Floor

9.73

11/15/2024

11/15/2029

2,485,946

2,445,716

2,477,693

0.42

Elessent Clean Technologies Inc⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Specialty Chemicals

S+6.00%, 1.00% Floor (0.50% on unfunded)

0.50

11/15/2024

11/15/2029

241,448

(3,739)

(802)

(0.00)

FR Vision Holdings, Inc. (CHA Consulting)⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Professional Services

S+5.00%, 0.75% Floor

8.87

1/19/2024

1/20/2031

2,508,270

2,468,647

2,483,673

0.42

FR Vision Holdings, Inc. (CHA Consulting)⁽⁷⁾

1st Lien Delayed Draw Term Loan

Professional Services

S+5.00%, 0.75% Floor

8.87

1/19/2024

1/20/2031

736,688

724,039

729,464

0.12

FR Vision Holdings, Inc. (CHA Consulting)⁽⁶⁾⁽⁷⁾

1st Lien Delayed Draw Term Loan

Professional Services

S+5.00%, 0.75% Floor (1.00% on unfunded)

8.87

9/26/2025

1/20/2031

557,241

27,648

24,998

(0.00)

FR Vision Holdings, Inc. (CHA Consulting)⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Professional Services

S+5.00%, 0.75% Floor (0.50% on unfunded)

0.50

1/19/2024

1/20/2030

185,747

(2,705)

(1,943)

(0.00)

G-3 Chickadee Purchaser, LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Specialty Chemicals

S+5.75%, 1.00% Floor

9.59

10/31/2025

10/31/2031

5,989,252

5,871,913

5,869,467

0.99

GC Bison Acquisition, LLC (Midland Industries)⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Industrial Products & Services

S+6.00%, 1.00% Floor

9.82

9/1/2023

9/4/2029

7,484,541

7,386,398

7,245,817

1.22

GC Bison Acquisition, LLC (Midland Industries)⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Industrial Products & Services

S+6.00%, 1.00% Floor (0.50% on unfunded)

9.72

9/1/2023

9/4/2029

1,063,447

539,993

518,882

0.09

GI Apple Midco LLC (Atlas Technical)⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Professional Services

S+6.75%, 1.00% Floor

10.47

4/19/2023

4/19/2030

10,801,772

10,610,538

10,772,724

1.81

GI Apple Midco LLC (Atlas Technical)⁽⁷⁾

1st Lien Delayed Draw Term Loan

Professional Services

S+6.75%, 1.00% Floor

10.47

4/19/2023

4/19/2030

207,241

205,130

206,691

0.03

GI Apple Midco LLC (Atlas Technical)⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Professional Services

S+6.75%, 1.00% Floor (0.50% on unfunded)

10.47

4/19/2023

4/19/2029

1,345,718

583,398

603,918

0.10

Gibson Brands Inc⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Consumer Brands

S+5.11%, 0.75% Floor

8.85

2/16/2024

8/11/2028

5,534,715

5,343,239

5,360,510

0.90

GOJO Industries Inc⁽⁷⁾⁽⁸⁾⁽⁹⁾⁽¹⁹⁾⁽³⁷⁾

1st Lien Term Loan

Consumer Products

S+8.75%, 2.50% Floor

12.57

10/26/2023

10/26/2028

18,141,008

17,840,027

18,736,058

3.16

Gopher Resource LLC⁽⁷⁾⁽⁹⁾⁽²⁰⁾

1st Lien Term Loan

Environmental Solutions

S+7.00%, 1.00% Floor

10.67

10/4/2024

10/4/2029

15,135,215

14,773,173

15,011,010

2.53

Gopher Resource LLC⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Environmental Solutions

S+7.00%, 1.00% Floor (0.50% on unfunded)

10.75

10/4/2024

10/4/2029

1,199,019

612,450

625,164

0.11

Guava Buyer LLC (dba AVI-SPL)⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Technology Hardware & Equipment

S+5.50%, 1.00% Floor

9.34

8/12/2025

8/12/2032

17,520,046

17,178,180

17,169,645

2.89

Guava Buyer LLC (dba AVI-SPL)⁽⁶⁾⁽⁷⁾

1st Lien Delayed Draw Term Loan

Technology Hardware & Equipment

S+5.50%, 1.00% Floor (1.00% on unfunded)

9.36

8/12/2025

8/12/2032

2,069,919

879,697

866,810

0.15

Guava Buyer LLC (dba AVI-SPL)⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Technology Hardware & Equipment

S+5.50%, 1.00% Floor (0.50% on unfunded)

9.34

8/12/2025

8/12/2030

2,074,483

680,891

677,664

0.11

Hammer IntermediateCo LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Automobiles & Components

S+5.50%, 1.00% Floor

9.49

10/1/2025

10/1/2031

6,465,389

6,370,515

6,368,409

1.07

Hammer IntermediateCo LLC⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Automobiles & Components

S+5.50%, 1.00% Floor (0.50% on unfunded)

9.34

10/1/2025

10/1/2031

1,062,137

214,867

214,198

0.04

The accompanying notes are an integral part of these consolidated financial statements.

18


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

December 31, 2025

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(34)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

Health Catalyst Inc⁽⁷⁾⁽⁸⁾⁽¹⁰⁾

1st Lien Term Loan

Healthcare Technology

S+6.50%, 1.00% Floor

10.39%

7/16/2024

7/16/2029

$

10,379,856

$10,140,991

$10,172,259

1.71%

Health Catalyst Inc⁽⁷⁾⁽¹⁰⁾

1st Lien Delayed Draw Term Loan

Healthcare Technology

S+6.50%, 1.00% Floor

10.34

7/16/2024

7/16/2029

3,138,490

3,067,886

3,075,720

0.52

Health Catalyst Inc⁽⁶⁾⁽⁷⁾⁽¹⁰⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Delayed Draw Term Loan

Healthcare Technology

S+6.50%, 1.00% Floor (2.50% on unfunded)

2.50

7/16/2024

7/16/2029

5,045,399

(107,663)

(100,908)

(0.02)

Igloo Group Parent Inc⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Technology

S+5.00%, 1.00% Floor

8.73

12/23/2025

12/23/2031

18,483,344

17,374,343

17,374,343

2.93

Inotiv Inc⁽⁷⁾⁽⁸⁾⁽⁹⁾⁽¹⁰⁾⁽²³⁾

1st Lien Term Loan

Pharmaceuticals & Life Sciences

S+6.86%, 1.00% Floor

10.75

11/3/2021

11/5/2026

15,717,919

15,577,563

13,364,582

2.25

Inotiv Inc⁽⁶⁾⁽⁷⁾⁽¹⁰⁾

1st Lien Revolver

Pharmaceuticals & Life Sciences

P+8.50%, 1.00% Floor (0.50% on unfunded)

15.25

11/3/2021

11/5/2026

1,244,402

474,261

584,869

0.10

i.PARK BROADWAY LLC (1050 N Broadway)⁽⁷⁾

1st Lien Term Loan

Real Estate Development & Management

S+5.30%, 4.25% Floor

9.55

7/3/2025

7/6/2027

9,192,144

9,051,115

9,081,654

1.53

IXS Holdings Inc⁽⁸⁾

1st Lien Term Loan

Automobiles & Components

S+5.50%, 1.00% Floor

9.22

8/15/2025

9/21/2029

10,598,266

10,204,357

10,560,732

1.78

Javelin Buyer Inc

1st Lien Term Loan

Software & Services

S+2.75%

6.59

5/6/2025

12/8/2031

7,443,844

7,459,192

7,462,453

1.26

Jennmar Intermediate III LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Industrial Products & Services

S+5.00%

8.73

12/16/2025

12/16/2030

22,926,098

22,239,521

22,582,207

3.80

Kaseya Inc

1st Lien Term Loan

Software & Services

S+3.00%

6.72

5/5/2025

3/22/2032

3,722,497

3,704,609

3,722,757

0.63

KORE Wireless Group Inc⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Telecommunications

S+6.50%, 1.00% Floor

10.38

12/20/2023

11/9/2028

4,544,190

4,487,938

4,534,499

0.76

KORE Wireless Group Inc⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Telecommunications

S+6.50%, 1.00% Floor (0.50% on unfunded)

0.50

12/20/2023

11/9/2028

626,612

(7,319)

(1,336)

(0.00)

LAC Acquisition LLC d/b/a Lighthouse Autism Center⁽⁷⁾⁽⁸⁾⁽²⁴⁾

1st Lien Term Loan

Healthcare Providers & Services

S+11.15%, 3.00% Floor

14.97

7/23/2021

7/23/2027

19,651,661

19,550,482

17,814,386

3.00

LAC Acquisition LLC d/b/a Lighthouse Autism Center⁽⁶⁾⁽⁷⁾⁽²⁹⁾

1st Lien Revolver

Healthcare Providers & Services

S+11.15%, 3.00% Floor (0.50% on unfunded)

0.50

4/3/2024

7/23/2027

500,000

—

(46,746)

(0.01)

Learning Care Group US No 2

1st Lien Term Loan

Education

S+4.00%, 0.50% Floor

7.86

5/12/2025

8/11/2028

7,443,182

7,461,099

6,131,321

1.03

LeVecke Real Estate Holdings, LLC⁽⁶⁾⁽⁷⁾⁽⁸⁾

1st Lien Delayed Draw Term Loan

Real Estate Development & Management

S+7.50%, 3.75% Floor

11.37

12/1/2022

5/29/2026

4,568,481

4,488,500

4,489,564

0.76

Likewize Corp⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Insurance & Insurance Services

S+5.75%, 0.50% Floor

9.66

8/15/2024

8/27/2029

19,106,663

18,684,967

18,342,396

3.09

Lummus Technology Holdings V LLC

1st Lien Term Loan

Industrial Products & Services

S+2.50%

6.22

5/6/2025

12/31/2029

4,962,501

4,973,544

4,964,635

0.84

LVF Holdings Inc⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Food & Beverage

S+5.50%

9.32

2/24/2025

2/24/2032

15,978,435

15,255,930

15,235,502

2.57

LVF Holdings Inc⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Delayed Draw Term Loan

Food & Beverage

S+5.50%, (5.50% on unfunded)

5.50

2/24/2025

2/24/2032

2,408,809

(52,961)

(111,440)

(0.02)

Mad Engine Global, LLC

1st Lien Term Loan

Consumer Apparel

S+7.26%, 1.00% Floor

10.93

6/30/2021

7/15/2027

10,725,000

10,633,803

9,277,125

1.56

Mercury Bidco LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Technology

S+5.75%, 1.00% Floor

9.42

5/31/2023

5/31/2030

17,430,493

17,185,515

17,350,820

2.92

Mercury Bidco LLC⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Technology

S+5.75%, 1.00% Floor (0.50% on unfunded)

0.50

5/31/2023

5/31/2029

1,981,556

(20,408)

(13,263)

(0.00)

Meta Buyer LLC⁽⁷⁾

1st Lien Term Loan

Consumer Products

S+5.25%, 0.75% Floor

8.94

12/22/2025

12/22/2031

3,657,818

3,621,482

3,621,240

0.61

Meta Buyer LLC⁽⁷⁾

1st Lien Term Loan

Consumer Products

E+5.25%, 0.75% Floor

7.29

12/22/2025

12/22/2031

€

5,084,993

5,895,350

5,913,105

1.00

Meta Buyer LLC⁽⁷⁾

1st Lien Term Loan

Consumer Products

BBSY+5.25%, 0.75% Floor

9.02

12/22/2025

12/22/2031

AU$

3,848,352

2,518,079

2,542,325

0.43

Meta Buyer LLC⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Delayed Draw Term Loan

Consumer Products

S+5.25%, 0.75% Floor (1.00% on unfunded)

1.00

12/22/2025

12/22/2031

3,391,761

(14,058)

(14,132)

(0.00)

Meta Buyer LLC⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Consumer Products

S+5.25%, 0.75% Floor (0.50% on unfunded)

0.50

12/22/2025

12/22/2031

1,479,569

(12,179)

(12,235)

(0.00)

Metropolis Technologies Inc

1st Lien Term Loan

Consumer Services

S+5.25%

8.98

10/20/2025

10/20/2032

2,542,173

2,517,165

2,516,751

0.42

Michael Baker International LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Professional Services

S+4.50%, 1.00% Floor

8.19

12/30/2025

12/29/2028

23,376,259

22,558,710

22,558,090

3.80

MMS BidCo LLC⁽⁷⁾⁽⁹⁾⁽³³⁾

1st Lien Term Loan

Healthcare Providers & Services

S+5.375%, 1.00% Floor

9.07

6/30/2022

6/30/2029

9,097,514

9,023,067

9,085,344

1.53

Mounty US Holdings⁽⁷⁾⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Software & Services

S+6.00%, 1.00% Floor

9.88

5/17/2024

5/17/2030

6,865,536

6,761,652

6,673,301

1.12

Mounty US Holdings⁽⁶⁾⁽⁷⁾⁽¹⁰⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Software & Services

S+6.00%, 1.00% Floor (0.25% on unfunded)

0.25

5/17/2024

5/17/2030

995,726

(15,287)

(27,880)

0.00

The accompanying notes are an integral part of these consolidated financial statements.

19


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

December 31, 2025

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(34)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

National Dentex Corp⁽⁷⁾⁽¹¹⁾⁽²⁸⁾⁽³¹⁾⁽³³⁾

1st Lien Term Loan

Healthcare Providers & Services

S+10.15%, 1.00% Floor

14.15%

10/26/2020

4/3/2026

$

12,528,293

$11,554,228

$4,680,062

0.79%

National Dentex Corp⁽⁷⁾⁽¹¹⁾⁽²⁸⁾⁽³¹⁾⁽³³⁾

1st Lien Delayed Draw Term Loan

Healthcare Providers & Services

S+10.15%, 1.00% Floor

14.15

10/26/2020

4/3/2026

6,305,880

5,813,679

2,355,618

0.40

National Dentex Corp⁽⁷⁾⁽¹²⁾⁽²⁸⁾⁽³¹⁾⁽³³⁾

1st Lien Delayed Draw Term Loan

Healthcare Providers & Services

S+12.15%, 1.00% Floor

16.15

10/29/2024

4/3/2026

3,017,963

580,738

1,127,389

0.19

National Dentex Corp⁽⁷⁾⁽¹¹⁾⁽²⁸⁾⁽³¹⁾⁽³³⁾

1st Lien Delayed Draw Term Loan

Healthcare Providers & Services

S+10.15%, 1.00% Floor

14.45

4/4/2024

4/3/2026

1,002,763

898,936

374,591

0.06

National Dentex Corp⁽⁷⁾⁽¹¹⁾⁽²⁸⁾⁽³¹⁾

1st Lien Delayed Draw Term Loan

Healthcare Providers & Services

S+10.15%, 1.00% Floor

13.90

9/24/2025

1/30/2026

1,016,512

1,003,655

1,016,512

0.17

National Dentex Corp⁽⁶⁾⁽⁷⁾⁽¹³⁾⁽²⁸⁾⁽³¹⁾

1st Lien Revolver

Healthcare Providers & Services

S+9.15%, 1.00% Floor (0.50% on unfunded)

12.95

10/26/2020

4/3/2026

1,593,577

1,475,732

580,424

0.10

NetSPI Midco Corporation⁽⁷⁾

1st Lien Term Loan

Professional Services

S+6.25%, 1.00% Floor

10.29

5/31/2024

5/31/2029

6,911,607

6,809,290

6,766,463

1.14

NetSPI Midco Corporation⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Professional Services

S+6.25%, 1.00% Floor (0.50% on unfunded)

0.50

5/31/2024

5/31/2029

767,956

(10,481)

(16,127)

(0.00)

PaperWorks Industries Holding Corp.⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Paper & Packaging

S+6.25%, 1.00% Floor

9.92

6/30/2023

6/30/2029

21,019,134

20,509,662

20,611,773

3.47

Pelican Power Borrower LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾⁽³⁸⁾

1st Lien Term Loan

Power Generation

S+5.50%, 2.00% Floor

9.32

8/30/2024

8/29/2030

27,988,900

26,626,715

28,436,723

4.79

Peloton Interactive Inc⁽⁸⁾⁽¹⁰⁾

1st Lien Term Loan

Fitness & Leisure

S+5.50%

9.22

5/23/2024

5/30/2029

22,013,933

22,176,678

22,115,748

3.72

Pioneer AcquisitionCo LLC

1st Lien Term Loan

Commercial Services

S+3.25%

6.94

10/24/2025

10/27/2032

3,132,000

3,124,219

3,135,915

0.53

Quirch Foods Holdings LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Food & Beverage

S+6.50%, 1.00% Floor

10.34

11/24/2025

11/12/2030

11,689,457

11,546,087

11,543,339

1.94

Quirch Foods Holdings LLC⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Delayed Draw Term Loan

Food & Beverage

S+6.50%, 1.00% Floor (1.00% on unfunded)

1.00

11/24/2025

11/12/2030

1,209,254

(7,465)

(7,558)

(0.00)

Radiate Holdco LLC

1st Lien Term Loan

Telecommunications

S+4.00%, 1.00% Floor

7.72

10/23/2025

6/26/2029

5,000,250

4,926,464

4,962,748

0.84

Radiate Holdco LLC⁽⁶⁾

1st Lien Delayed Draw Term Loan

Telecommunications

S+4.00%, 1.00% Floor (1.50% on unfunded)

7.72

10/23/2025

6/26/2029

15,000,750

4,957,453

4,887,744

0.82

Rayonier AM Products Inc⁽⁷⁾⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Paper & Packaging

S+7.50%, 3.00% Floor

11.17

10/28/2024

10/29/2029

10,749,917

10,534,717

10,292,428

1.73

Recorded Books Inc (RB Media)⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Media: Diversified & Production

S+5.75%, 0.75% Floor

9.57

8/31/2023

9/3/2030

8,696,562

8,572,758

8,613,228

1.45

Recorded Books Inc (RB Media)⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Delayed Draw Term Loan

Media: Diversified & Production

S+5.75%, 0.75% Floor (1.00% on unfunded)

1.00

8/15/2025

9/3/2030

390,213

(7,228)

(3,739)

(0.00)

Recorded Books Inc (RB Media)⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Media: Diversified & Production

S+5.75%, 0.75% Floor (0.50% on unfunded)

0.50

8/31/2023

8/31/2028

987,009

(13,087)

(6,512)

(0.00)

SBP Holdings LP⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Industrial Products & Services

S+5.00%, 1.00% Floor

8.72

3/27/2023

3/27/2028

5,186,456

5,097,645

5,125,564

0.86

SBP Holdings LP⁽⁶⁾⁽⁷⁾

1st Lien Delayed Draw Term Loan

Industrial Products & Services

S+5.00%, 1.00% Floor (1.00% on unfunded)

8.74

11/30/2023

3/27/2028

1,678,837

1,015,964

1,014,183

0.17

SBP Holdings LP⁽⁷⁾⁽⁹⁾

1st Lien Delayed Draw Term Loan

Industrial Products & Services

S+5.00%, 1.00% Floor

8.74

3/27/2023

3/27/2028

746,369

733,970

737,607

0.12

SBP Holdings LP⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Delayed Draw Term Loan

Industrial Products & Services

S+5.00%, 1.00% Floor (1.00% on unfunded)

1.00

8/19/2024

3/27/2028

1,429,513

(4,437)

(16,785)

(0.00)

SBP Holdings LP⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Industrial Products & Services

S+5.00%, 1.00% Floor (0.50% on unfunded)

0.50

3/27/2023

3/27/2028

838,328

(9,352)

(9,948)

(0.00)

Shrieve Chemical Co LLC⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Specialty Chemicals

S+6.00%, 1.00% Floor

9.72

10/30/2024

10/30/2030

6,727,382

6,615,462

6,611,602

1.11

Shrieve Chemical Co LLC⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Specialty Chemicals

S+6.00%, 1.00% Floor (0.50% on unfunded)

9.73

10/30/2024

10/30/2030

539,828

167,356

167,082

0.03

Sintec Media NYC Inc⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Software & Services

S+7.00%, 1.00% Floor

10.69

6/21/2023

6/21/2029

11,974,326

11,736,432

11,581,754

1.95

Sintec Media NYC Inc⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Software & Services

S+7.00%, 1.00% Floor (0.50% on unfunded)

10.70

6/21/2023

6/21/2029

1,164,025

724,798

705,217

0.12

Smarsh Inc⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Software & Services

S+4.75%, 0.75% Floor

8.42

2/18/2022

2/18/2029

4,253,705

4,205,917

4,211,526

0.71

Smarsh Inc⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Delayed Draw Term Loan

Software & Services

S+4.75%, 0.75% Floor (1.00% on unfunded)

1.00

2/18/2022

2/18/2029

472,634

(10,865)

(4,687)

(0.00)

Smarsh Inc⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Software & Services

S+4.75%, 0.75% Floor (0.50% on unfunded)

8.43

2/18/2022

2/18/2029

236,317

88,807

89,033

0.01

SP PF Buyer LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Specialty Retail

S+7.00%, 1.00% Floor

10.86

10/15/2024

10/13/2029

17,916,528

17,480,990

17,479,349

2.94

Spectrum Group Buyer Inc (Pixelle)⁽⁸⁾

1st Lien Term Loan

Paper & Packaging

S+6.50%, 0.75% Floor

10.34

5/11/2022

5/19/2028

6,405,661

6,209,690

5,957,265

1.00

The accompanying notes are an integral part of these consolidated financial statements.

20


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

December 31, 2025

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(34)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

Speedstar Holding LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Automobiles & Components

S+6.00%, 1.00% Floor

9.84%

7/2/2024

7/22/2027

$

14,518,802

$14,373,117

$14,070,897

2.37%

Speedstar Holding LLC⁽⁶⁾⁽⁷⁾

1st Lien Delayed Draw Term Loan

Automobiles & Components

S+6.00%, 1.00% Floor (1.00% on unfunded)

9.79

7/2/2024

7/22/2027

3,187,162

1,559,800

1,487,249

0.25

Storable Inc

1st Lien Term Loan

Software & Services

S+3.25%

6.97

5/6/2025

4/16/2031

7,443,750

7,462,985

7,469,338

1.26

Stryten Energy Resources LLC⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Industrial Products & Services

S+5.50%, 1.00% Floor

9.36

12/18/2024

12/18/2029

13,640,939

13,415,552

13,429,052

2.26

Sweet Oak Parent LLC (fka Ozark Holdings LLC)⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Specialty Retail

S+5.75%, 0.75% Floor

9.69

8/5/2024

8/5/2030

16,504,637

16,171,371

16,125,030

2.72

Telestream 2 LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Software & Services

S+6.25%, 1.00% Floor

10.19

6/7/2025

6/7/2028

9,794,387

9,794,387

9,668,515

1.63

Telestream 2 LLC⁽⁶⁾⁽⁷⁾⁽³⁰⁾

1st Lien Revolver

Software & Services

S+6.25%, 1.00% Floor (2.00% on unfunded)

2.00

6/7/2025

6/7/2028

425,843

(17,251)

—

—

TETRA Technologies Inc⁽⁷⁾⁽⁸⁾⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Oilfield Services

S+5.85%, 1.00% Floor

9.57

1/12/2024

1/11/2030

15,161,402

14,882,001

14,888,136

2.51

TETRA Technologies Inc⁽⁶⁾⁽⁷⁾⁽¹⁰⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Delayed Draw Term Loan

Oilfield Services

S+5.85%, 1.00% Floor (1.50% on unfunded)

1.50

1/12/2024

1/11/2030

5,984,764

(50,339)

(107,868)

(0.02)

Titan Purchaser, Inc. (Waupaca Foundry)⁽⁷⁾⁽⁸⁾⁽⁹⁾

1st Lien Term Loan

Industrial Products & Services

S+6.00%, 1.00% Floor

9.67

3/1/2024

3/1/2030

14,723,709

14,317,105

14,641,008

2.47

TransDigm Inc⁽¹⁰⁾

1st Lien Term Loan

Aerospace & Defense

S+2.25%

5.97

5/5/2025

3/22/2030

7,462,358

7,480,173

7,482,581

1.26

USA Debusk LLC⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Commercial Services

S+5.25%, 0.75% Floor

9.05

4/30/2024

4/30/2031

8,513,032

8,408,015

8,449,184

1.42

USA Debusk LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Commercial Services

S+5.25%, 0.75% Floor

9.05

10/21/2025

4/30/2031

8,992,464

8,903,634

8,925,020

1.50

USA Debusk LLC⁽⁶⁾⁽⁷⁾

1st Lien Delayed Draw Term Loan

Commercial Services

S+5.25%, 0.75% Floor (1.00% on unfunded)

9.12

4/30/2024

4/30/2031

3,165,515

488,319

486,173

0.08

USA Debusk LLC⁽⁶⁾⁽⁷⁾

1st Lien Revolver

Commercial Services

S+5.25%, 0.75% Floor (0.50% on unfunded)

9.06

4/30/2024

4/30/2030

1,783,612

1,152,738

1,146,962

0.19

UserZoom Technologies Inc⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Technology

S+7.50%, 1.00% Floor

11.63

1/12/2023

4/5/2029

11,192,878

10,982,579

10,914,790

1.84

Vensure Employer Services Inc⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Business Services

S+5.00%, 0.50% Floor

8.70

9/27/2024

9/27/2031

5,559,156

5,523,449

5,529,163

0.93

Vensure Employer Services Inc⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Delayed Draw Term Loan

Business Services

S+5.00%, 0.50% Floor (0.50% on unfunded)

0.50

9/27/2024

9/27/2031

89,078

(11,425)

(481)

(0.00)

Southeastern Grocers LLC⁽⁷⁾⁽⁸⁾

1st Lien Term Loan

Staples Retail

S+7.50%, 1.00% Floor

11.17

9/19/2025

9/19/2030

13,106,471

12,727,688

12,843,425

2.16

Wrangler Topco, LLC⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Software & Services

S+5.75%, 1.00% Floor

9.47

7/7/2023

9/20/2029

13,679,669

13,423,100

13,571,679

2.29

Wrangler Topco, LLC⁽⁶⁾⁽⁷⁾

1st Lien Delayed Draw Term Loan

Software & Services

S+5.75%, 1.00% Floor (1.00% on unfunded)

9.62

9/20/2024

9/20/2029

1,113,231

741,745

740,802

0.12

Wrangler Topco, LLC⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Software & Services

S+5.75%, 1.00% Floor (0.50% on unfunded)

0.50

7/7/2023

9/20/2029

1,502,990

(24,167)

(12,961)

(0.00)

Vantage Specialty Chemicals Inc⁽⁷⁾⁽⁸⁾⁽²⁷⁾

1st Lien Term Loan

Specialty Chemicals

S+6.75%, 1.00% Floor

10.42

8/29/2025

8/29/2029

20,109,297

19,639,513

19,616,619

3.30

Vantage Specialty Chemicals Inc⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Specialty Chemicals

S+6.75%, 1.00% Floor (0.50% on unfunded)

0.50

8/29/2025

2/28/2029

1,731,343

(39,053)

(42,418)

(0.01)

Xactus LLC⁽⁷⁾⁽⁹⁾

1st Lien Term Loan

Business Services

S+5.50%, 0.75% Floor

9.17

5/6/2025

5/6/2032

8,819,773

8,692,233

8,784,493

1.48

Xactus LLC⁽⁶⁾⁽⁷⁾⁽²⁹⁾⁽³⁰⁾

1st Lien Revolver

Business Services

S+5.50%, 0.75% Floor (0.50% on unfunded)

0.50

5/6/2025

5/6/2030

718,711

(9,364)

(6,828)

(0.00)

X Corp (as successor to Twitter)

1st Lien Term Loan

Technology

S+6.75%

10.45

9/12/2025

10/29/2029

11,369,963

11,195,301

11,158,823

1.88

Total United States of America 1st Lien/Secured Loans

1,000,438,109

979,155,542

164.89

Australia

Ardonagh Group Finco Pty Ltd⁽¹⁰⁾

1st Lien Term Loan

Insurance & Insurance Services

S+2.75%

6.92

5/5/2025

2/18/2031

2,972,581

2,938,077

2,963,608

0.50

Total Australia 1st Lien/Secured Loans

2,938,077

2,963,608

0.50

Canada

1261229 BC LTD⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Healthcare Equipment & Supplies

S+6.25%

9.97

8/28/2025

10/8/2030

22,500,118

22,388,390

21,927,828

3.69

Arterra Wines Canada Inc⁽⁸⁾⁽¹⁰⁾

1st Lien Term Loan

Food & Beverage

S+3.76%, 0.75% Floor

7.43

10/31/2025

11/26/2027

15,268,647

15,060,563

15,005,568

2.53

Gateway Casinos & Entertainment Ltd⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Gaming & Entertainment

S+6.25%, 0.75% Floor

9.95

12/18/2024

12/18/2030

20,177,278

20,100,979

20,168,904

3.40

Hootsuite Inc.⁽⁷⁾⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Software & Services

S+5.50%, 0.75% Floor

9.23

5/22/2024

5/22/2030

12,607,241

12,455,319

12,317,274

2.07

Hootsuite Inc.⁽⁶⁾⁽⁷⁾⁽¹⁰⁾

1st Lien Revolver

Software & Services

S+5.50%, 0.75% Floor (0.50% on unfunded)

9.22

5/22/2024

5/22/2030

1,422,136

837,684

820,572

0.14

Source Energy Services Ltd⁽⁷⁾⁽⁹⁾⁽¹⁰⁾

1st Lien Term Loan

Oilfield Services

S+5.25%, 4.25% Floor

9.50

12/20/2024

12/20/2029

2,095,378

2,034,245

2,099,256

0.35

Total Canada 1st Lien/Secured Loans

72,877,180

72,339,402

12.18

The accompanying notes are an integral part of these consolidated financial statements.

21


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

December 31, 2025

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(34)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

Luxembourg

Accelya Lux Finco Sarl⁽¹⁰⁾

1st Lien Term Loan

Software & Services

S+5.25%

8.92%

9/29/2025

9/29/2032

$

7,519,989

$7,373,432

$7,458,889

1.26%

Total Luxembourg 1st Lien/Secured Loans

7,373,432

7,458,889

1.26

Netherlands

OLA Netherlands BV (aka Olacabs / ANI Tech)⁽⁷⁾⁽⁸⁾⁽¹⁰⁾

1st Lien Term Loan

Technology

S+6.35%, 0.75% Floor

10.07

12/3/2021

12/15/2026

3,981,759

3,962,794

3,727,725

0.63

WeTransfer BV⁽¹⁰⁾

1st Lien Term Loan

Technology

E+5.25%

7.27

7/18/2025

3/7/2031

€

8,338,465

9,625,464

9,435,216

1.59

Total Netherlands 1st Lien/Secured Loans

13,588,258

13,162,941

2.22

United Kingdom

Inspired Entertainment Financing PLC⁽⁷⁾⁽¹⁰⁾

1st Lien Term Loan

Gaming & Entertainment

SONIA+6.00%, 3.00% Floor

9.97

6/11/2025

6/4/2030

£

9,151,000

12,231,015

12,330,973

2.08

Neon Finance Limited (fka TEN Entertainment Group PLC)⁽⁷⁾⁽¹⁰⁾

1st Lien Term Loan

Gaming & Entertainment

SONIA+7.50%, 2.50% Floor

11.47

1/26/2024

2/6/2030

£

3,991,078

4,972,541

5,344,737

0.90

Total United Kingdom 1st Lien/Secured Loans

17,203,556

17,675,710

2.98

Total 1st Lien/Secured Loans

1,114,418,612

1,092,756,092

184.03

2nd Lien/Secured Loans

United States of America

BayMark Health Services Inc⁽⁷⁾⁽²⁸⁾⁽³¹⁾

2nd Lien Term Loan

Healthcare Providers & Services

S+8.76%, 1.00% Floor

12.43

6/10/2021

6/11/2028

3,333,333

3,307,639

1,069,866

0.18

BayMark Health Services Inc⁽⁷⁾⁽²⁸⁾⁽³¹⁾

2nd Lien Delayed Draw Term Loan

Healthcare Providers & Services

S+8.76%, 1.00% Floor

12.86

11/19/2021

6/11/2028

2,572,287

2,552,151

825,600

0.14

Delos Living LLC⁽⁷⁾⁽¹⁸⁾

2nd Lien Term Loan

Real Estate Development & Management

14.00%

14.00

10/9/2025

7/11/2027

5,319,149

5,077,022

5,041,383

0.85

FourPoint Resources Intermediate Holdings, LLC⁽⁷⁾⁽⁹⁾

2nd Lien Term Loan

Energy

S+7.00%, 2.50% Floor

10.99

1/22/2025

1/22/2030

11,494,239

11,232,718

11,126,423

1.87

Total United States of America 2nd Lien Term Loan

22,169,530

18,063,272

3.04

Total 2nd Lien/Secured Loans

22,169,530

18,063,272

3.04

Equities

United States of America

48Forty Solutions LLC⁽⁷⁾⁽²⁸⁾

Common Equities

Transportation & Logistics

N/A

N/A

11/11/2024

N/A

872

—

—

—

Beauty Health Co⁽²⁸⁾

Common Equities

Consumer Services

N/A

N/A

7/7/2023

N/A

913,460

—

1,269,709

0.21

Circle Graphics Parent, LP⁽⁷⁾⁽²⁸⁾

Preferred Equities

E-Commerce

N/A

N/A

6/30/2025

N/A

3,574,384

—

—

—

Monomoy Capital Partners IV-Titan, L.P. (Waupaca Foundry)⁽⁷⁾⁽¹⁰⁾⁽²⁸⁾

Partnership Interests

Industrial Products & Services

N/A

N/A

2/23/2024

N/A

313,577

217,037

284,885

0.05

Telestream 2 LLC⁽⁷⁾⁽²⁸⁾

Common Equities

Software & Services

N/A

N/A

6/7/2025

N/A

425,843

4,044,696

3,936,280

0.66

Total United States of America Equities

4,261,733

5,490,874

0.92

Total Equities

4,261,733

5,490,874

0.92

Senior Secured Bonds

United States of America

Amber Energy Inc.⁽⁷⁾

Senior Secured Bonds

Energy

15.00%

15.00

11/26/2025

12/1/2045

45,874

45,874

45,874

0.01

Service Properties Trust⁽¹⁰⁾

Senior Secured Bonds

Real Estate Development & Management

0.00%

0.00

9/15/2025

9/30/2027

8,929,000

7,852,574

8,066,633

1.36

Total United States of America Senior Secured Bonds

7,898,448

8,112,507

1.37

The accompanying notes are an integral part of these consolidated financial statements.

22


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

December 31, 2025

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(34)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

Canada

1261229 BC LTD⁽¹⁰⁾

Senior Secured Bonds

Healthcare Equipment & Supplies

10.00%

10.00%

12/26/2025

4/15/2032

$

1,888,000

$1,957,353

$1,962,819

0.33%

Bausch Health Cos Inc (Valeant)⁽¹⁰⁾

Senior Secured Bonds

Healthcare Equipment & Supplies

4.88%

4.88

11/5/2025

6/1/2028

1,069,000

967,371

957,771

0.16

Total Canada Senior Secured Bonds

2,924,724

2,920,590

0.49

Total Senior Secured Bonds

10,823,172

11,033,097

1.86

Unsecured Bonds

United States of America

Stonebriar ABF Issuer LLC⁽¹⁰⁾

Senior Unsecured Bonds

Financial Services

8.13%

8.13

11/14/2025

12/15/2030

6,000,000

6,000,000

6,169,541

1.04

Total United States of America Unsecured Bonds

6,000,000

6,169,541

1.04

Total Unsecured Bonds

6,000,000

6,169,541

1.04

Warrants

United States of America

Delos Living LLC⁽⁷⁾⁽²⁸⁾

Warrants

Real Estate Development & Management

N/A

N/A

10/9/2025

N/A

2

106,385

138,299

0.02

Total Warrants

106,385

138,299

0.02

Total Non-Controlled/Non-Affiliated Investments

1,157,779,432

1,133,651,175

190.91%

Non-Controlled/Affiliated Investments

1st Lien/Secured Loans

Germany

Takko Fashion GmbH⁽⁷⁾⁽¹⁰⁾⁽³⁵⁾

1st Lien Term Loan

Specialty Retail

9.13%

9.13

11/25/2025

4/15/2030

€

1,189,578

1,370,513

1,397,278

0.24

Total Germany 1st Lien/Secured Loans

1,370,513

1,397,278

0.24

Total 1st Lien/Secured Loans

1,370,513

1,397,278

0.24

Senior Secured Debt

United States of America

Wesco Aircraft Holdings Inc⁽²¹⁾⁽³⁵⁾

Senior Secured Debt

Industrial Products & Services

S+8.00%

12.27

1/31/2025

1/31/2030

6,236,045

6,210,914

6,236,045

1.05

Total United States of America Senior Secured Debt

6,210,914

6,236,045

1.05

Total Senior Secured Debt

6,210,914

6,236,045

1.05

Unsecured Debt

United States of America

Wesco Aircraft Holdings Inc⁽⁷⁾⁽²²⁾⁽³⁵⁾

Senior Unsecured Debt

Industrial Products & Services

6.00%

6.00

1/31/2025

1/31/2033

4,388,087

6,599,439

6,651,946

1.12

Total United States of America Unsecured Debt

6,599,439

6,651,946

1.12

Luxembourg

Takko Fashion Sarl⁽¹⁰⁾⁽²⁵⁾⁽³⁵⁾

Subordinated Unsecured Debt

Specialty Retail

15.00%

15.00

8/8/2023

10/15/2030

€

1,847,667

1,963,425

8,436,923

1.42

Total Luxembourg Unsecured Debt

1,963,425

8,436,923

1.42

Total Unsecured Debt

8,562,864

15,088,869

2.54

Equities

United States of America

Wesco Aircraft Holdings Inc⁽⁷⁾⁽²⁸⁾⁽³⁵⁾

Common Equities

Industrial Products & Services

N/A

N/A

1/31/2025

N/A

195,566

7,459,569

7,541,025

1.27

Total Equities

7,459,569

7,541,025

1.27

Total Non-Controlled/Affiliated Investments

23,603,860

30,263,217

5.10%

The accompanying notes are an integral part of these consolidated financial statements.

23


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

December 31, 2025

Portfolio Company(1)

Instrument

Industry

Rate(2)

Interest
Rate

Original
Acquisition
Date
(34)

Maturity
Date

Par Amount(3)

Cost /
Amortized
Cost
(4)

Fair Value

% of
Net Assets
(5)

Controlled Investments

1st Lien/Secured Loans

United States of America

SP-CREH 19 Highline LLC⁽⁷⁾⁽³⁶⁾

1st Lien Term Loan

Multi-Family

S+2.00%, 3.00% Floor , 5.00% Cap

5.84

6/28/2021

7/1/2026

$

1,318,756

$1,318,756

$1,318,690

0.22%

SP-CREH 19 Highline LLC⁽⁷⁾⁽³⁶⁾

1st Lien Revolver

Multi-Family

S+2.00%, 3.00% Floor , 5.00% Cap

5.84

6/28/2021

7/1/2026

6,125,000

6,125,000

5,613,869

0.95

Total 1st Lien/Secured Loans

7,443,756

6,932,559

1.17

Equities

United States of America

SP-CREH 19 Highline LLC⁽⁷⁾⁽²⁸⁾⁽³⁶⁾

Common Equities

Multi-Family

N/A

N/A

6/28/2021

N/A

70%

14,608,750

—

—

Total Equities

14,608,750

—

—

Trust Interest

United States of America

TH Liquidating Trust⁽⁷⁾⁽²⁸⁾⁽³⁶⁾

Trust Interest

Other

N/A

N/A

12/7/2019

12/6/2026

14%

3,153,474

969,500

0.16

TH Liquidating Trust⁽⁶⁾⁽⁷⁾⁽²⁸⁾⁽³⁶⁾

Trust Interest

Other

N/A

N/A

10/9/2020

12/6/2026

14%

—

—

—

TH Liquidating Trust⁽⁷⁾⁽²⁶⁾⁽³⁶⁾

Trust Interest

Other

P+10.50%, 0.50% Floor

17.25

12/7/2019

12/6/2026

682,955

682,955

543,837

0.09

Total Trust Interest

3,836,429

1,513,337

0.25

Real Estate Properties

United States of America

1035 Mecklenburg Highway, Mooresville, North Carolina⁽⁷⁾⁽¹⁰⁾⁽²⁸⁾⁽³⁶⁾

Real Estate Properties

Industrial Real Estate

N/A

N/A

8/22/2023

N/A

100%

14,783,004

11,386,450

1.92

Total Real Estate Properties

14,783,004

11,386,450

1.92

Total Controlled Investments

40,671,939

19,832,346

3.34%

Total Investments, December 31, 2025

$1,222,055,231

$1,183,746,738

199.35%

Cash Equivalents

JPMorgan 100% US Treasury Securities Money Market Fund, Capital Class

Money Market Fund

11,056,883

11,056,883

11,056,883

1.86

Total Cash Equivalents

11,056,883

11,056,883

1.86%

Restricted Cash Equivalents

JPMorgan 100% US Treasury Securities Money Market Fund, Capital Class⁽⁸⁾⁽⁹⁾

Money Market Fund

12,954,969

12,954,969

12,954,969

2.18

Total Restricted Cash Equivalents

12,954,969

12,954,969

2.18%

Total Cash Equivalents and Restricted Cash Equivalents, December 31, 2025

$24,011,852

$24,011,852

4.04%

(1)

All of our investments are issued by eligible portfolio companies, as defined in the 1940 Act, unless otherwise noted.

(2)

Investments may contain a variable rate structure, subject to an interest rate floor or cap. Variable rate investments bear interest at a rate that may be determined by reference to either Secured Overnight Financing Rate (“SOFR” or “S”), Euro Interbank Offer Rate (“Euribor” or “E”), Canadian Dollar Offered Rate (“CDOR” or “C”), Prime Rate (“P”), Sterling Overnight Index Average (“SONIA”) or the Australian Dollar Bank Bill Swap Bid Rate (“BBSY”), which can generally include one-, three- or six-month tenor, at the borrower’s option, which reset periodically based on the terms of the credit agreement. For investments with multiple interest rate contracts, the interest rate shown is the weighted average interest rate in effect on December 31, 2025.

(3)

Par amount includes unfunded commitments, accumulated payment-in-kind (“PIK”) interest and is net of principal repayments. Amounts are in USD unless otherwise noted. Equity investments are recorded as number of shares owned or economic ownership percentage.

(4)

Cost represents amortized cost for debt investments less principal payments, plus capitalized PIK, if any. As of December 31, 2025, the aggregate gross unrealized appreciation for all investments where there was an excess of fair value over tax cost was $21.9 million; the aggregate gross unrealized depreciation for all investments where there was an excess of tax cost over fair value was $71.6 million; the net unrealized depreciation was $49.7 million; the aggregate tax cost of securities for Federal income tax purposes was $1.2 billion.

(5)

Percentage is based on net assets of $593,835,119 as of December 31, 2025.

(6)

The investment has an unfunded commitment as of December 31, 2025 (see Note 8 in the accompanying notes to the consolidated financial statements).

(7)

Fair value was determined using significant unobservable inputs (see Note 5 in the accompanying notes to the consolidated financial statements).

(8)

Some or all of these investments are pledged as collateral to the Revolving Credit Facility (see Note 6 in the accompanying notes to the consolidated financial statements), totaling $341.2 million including restricted cash equivalents.

The accompanying notes are an integral part of these consolidated financial statements.

24


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

December 31, 2025

(9)

Some or all of these investments are pledged as collateral to the 2024 CLO (see Note 6 in the accompanying notes to the consolidated financial statements), totaling $406.7 million including restricted cash equivalents.

(10)

These investments are treated as non-qualifying investments under Section 55(a) of the 1940 Act. Under the 1940 Act, the Fund may not acquire any non-qualifying assets unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Fund’s total assets. As of December 31, 2025, qualifying assets totaled 77.4% of the Fund’s total assets.

(11)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is 1.00%.

(12)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is S+12.15%.

(13)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is S+9.15%.

(14)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is 12.00%.

(15)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is 4.00%.

(16)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is S+3.25%.

(17)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is S+3.76%.

(18)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is 7.00%.

(19)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is 4.50%.

(20)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is 2.50%.

(21)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is S+8.00%.

(22)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is 6.00%.

(23)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is 0.25%.

(24)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is 5.50%.

(25)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is 15.00%.

(26)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is 2.00%.

(27)

The underlying credit agreement or indenture contains a PIK provision, whereby the issuer has either the option or the obligation to make a portion of the interest payments with the issuance of additional investments. The PIK portion of the coupon is 2.75%.

(28)

Represents a non-income producing investment.

(29)

The negative fair value is the result of the original discount on the loan.

(30)

The negative amortized cost is the result of the original discount being greater than the principal amount outstanding on the loan.

(31)

Investment, representing 4.0% of cost and 2.0% of fair value, respectively, was on non-accrual status as of December 31, 2025, meaning that the Fund has ceased accruing interest income on the investment (see Note 2 in the accompanying notes to the consolidated financial statements for additional information about the Fund’s accounting policies).

(32)

Investment represents a unitranche/last out loan, with characteristics of a traditional first lien senior secured loan which, pursuant to an agreement among lenders, is divided into “first out” and “last out” tranches yielding different interest rates. In exchange for the greater risk of loss, the “last-out” tranche of the Fund’s unitranche loan investment earns a higher interest rate than the “first-out” portions. The “first-out” tranche will have priority as to the “last-out” tranche with respect to payments of principal, interest and any other amounts due thereunder. The Fund’s investment is in the “last out” tranche.

(33)

Investment represents a first lien last out loan pursuant to the respective credit agreement, with revolving facilities receiving priority with respect to payment of principal and interest.

(34)

Original acquisition date represents the first or original investment in a portfolio company and there may be subsequent follow-on investments after the original acquisition date.

The accompanying notes are an integral part of these consolidated financial statements.

25


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

December 31, 2025

(35)

Under the 1940 Act, the Fund is generally presumed a non-control “affiliated person” if the Fund owns, either directly or indirectly, between 5% and 25% of a portfolio company’s outstanding voting securities and/or is under common control with the portfolio company. As of December 31, 2025, the Fund’s affiliated/non-controlled investments were as follows:

Portfolio
Company

Type of
Investment

Fair Value at
December 31, 2024

Gross additions*

Gross reductions**

Net change in
unrealized
appreciation
(depreciation)

Net realized
gains
(losses)

Fair Value at
December 31, 2025

Interest
income

Dividend
income

Par Amount ($) / Number Of Shares / Ownership %

Takko Fashion GmbH

Secured Debt

$

4,100,660

$

—

$

(4,336,478

)

$

22,079

$

213,739

$

—

$

79,861

$

—

€

—

Takko Fashion GmbH

Secured Loans

†

—

1,370,513

—

26,765

—

1,397,278

12,000

—

€

1,189,578

Takko Fashion Sarl

Unsecured Debt

†

8,036,760

553,221

(2,460,471

)

2,346,089

(38,676

)

8,436,923

629,814

—

€

1,847,667

Wesco Aircraft Holdings Inc

Secured Debt

—

6,210,913

—

25,132

—

6,236,045

705,215

—

6,236,045

Wesco Aircraft Holdings Inc

Unsecured Debt

—

6,599,439

—

52,507

—

6,651,946

193,063

—

4,388,087

Wesco Aircraft Holdings Inc

Equities

—

7,459,569

—

81,456

—

7,541,025

—

—

195,566

Total

$

12,137,420

$

22,193,655

$

(6,796,949

)

$

2,554,028

$

175,063

$

30,263,217

$

1,619,953

$

—

* Gross additions include increases in the cost basis of the investments resulting from new and follow-on portfolio investments, accretion of discounts, PIK interest, and the exchange of one or more existing securities for one or more new investments.

** Gross reductions include decreases in the cost basis of investments resulting from principal collections related to investments repayments and sales.

† At December 31, 2025, the unsecured debt contained stapled equities of approximately 9.0 million shares which provided certain voting rights.

(36)

Under the 1940 Act, the Fund is presumed to “control” a portfolio company if the Fund owns more than 25% of a portfolio company’s voting securities and/or holds the power to exercise control over the management or policies of such portfolio company. As of December 31, 2025, the Fund’s controlled investments were as follows:

Portfolio
Company

Type of
Investment

Fair Value at
December 31, 2024

Gross additions*

Gross reductions**

Net change in
unrealized
appreciation
(depreciation)

Net realized
gains
(losses)

Fair Value at
December 31, 2025

Interest
income

Other
income

Par Amount ($) / Number Of Units/ Ownership %

1035 Mecklenburg Highway, Mooresville, North Carolina

Real Estate Properties

$

12,808,845

$

372,864

$

—

$

(1,795,259

)

$

—

$

11,386,450

$

—

$

100,000

100

%

30 South Broadway, Irvington, New York***

Real Estate Properties

—

—

(19,934

)

—

19,934

—

—

—

0

%

SP-CREH 19 Highline LLC

Secured Loans

7,639,424

—

(6,321,814

)

1,080

—

1,318,690

169,213

—

$

1,318,756

SP-CREH 19 Highline LLC

Secured Loans

5,970,038

—

—

(356,169

)

—

5,613,869

389,403

—

$

6,125,000

SP-CREH 19 Highline LLC

Equities

1,564,654

—

—

(1,564,654

)

—

—

—

—

70

%

TH Liquidating Trust

Trust Interest

969,500

—

—

—

—

969,500

—

—

14

%

TH Liquidating Trust

Trust Interest

—

—

—

—

—

—

—

—

14

%

TH Liquidating Trust

Trust Interest

455,086

111,454

—

(22,703

)

—

543,837

112,619

—

$

682,955

Total

$

29,407,547

$

484,318

$

(6,341,748

)

$

(3,737,705

)

$

19,934

$

19,832,346

$

671,235

$

100,000

* Gross additions include increases in the cost basis of the investments resulting from new and follow-on portfolio investments, accretion of discounts, PIK interest, and the exchange of one or more existing securities for one or more new investments.

** Gross reductions include decreases in the cost basis of investments resulting from principal collections related to investments repayments and sales.

*** Investment no longer held as of December 31, 2025.

(37)

The Fund sold a participating interest of approximately $3.1 million of the portfolio company’s first lien term loan. As the transaction did not qualify as a “true sale” in accordance with U.S. GAAP, the Fund recorded a corresponding $3.1 million liability, at fair value, and the secured borrowing was included in other liabilities on the consolidated statements of assets and liabilities. The associated expenses are included in other general and administrative expenses on the consolidated statements of operations.

(38)

The Fund sold a participating interest of approximately $1.5 million of the portfolio company’s first lien term loan. As the transaction did not qualify as a “true sale” in accordance with U.S. GAAP, the Fund recorded a corresponding $1.5 million liability, at fair value, and the secured borrowing was included in other liabilities on the consolidated statements of assets and liabilities. The associated expenses are included in other general and administrative expenses on the consolidated statements of operations.

The accompanying notes are an integral part of these consolidated financial statements.

26


Silver Point Specialty Lending Fund

Consolidated Schedule of Investments

December 31, 2025

Additional Information

Interest Rate Swaps

Pay/Receive Floating Rate

Floating Rate Index

Floating Payment Frequency

Fixed Rate

Fixed Payment Frequency

Maturity Date

Counterparty

Notional Amount

Upfront Premiums Received / (Paid)

Unrealized appreciation/ (depreciation)

Interest Rate Swaps, Non-Hedge Accounting

Euro Interest Rate Swaps

Receive

EuroSTR

Annual

2.150%

Annual

12/1/2030

Goldman Sachs

€

600,000

$

60

$

5,143

UK Interest Rate Swaps

Receive

SONIA

Annual

4.992%

Annual

9/28/2027

Goldman Sachs

£

2,300,000

—

(91,397

)

UK Interest Rate Swaps

Pay

SONIA

Annual

4.992%

Annual

9/28/2027

Goldman Sachs

£

(2,300,000

)

(133,945

)

91,397

US Interest Rate Swaps

Receive

SOFR

Annual

3.348%

Annual

9/22/2027

Goldman Sachs

$

9,600,000

(635

)

30,980

US Interest Rate Swaps

Receive

SOFR

Annual

3.780%

Annual

3/10/2030

Goldman Sachs

$

12,500,000

70,509

(134,934

)

Total

(98,811

)

Interest Rate Swaps, Hedge Accounting(1)

US Interest Rate Swaps

Pay

SOFR

Annual

4.000%

Quarterly

11/4/2026

Goldman Sachs

$

(145,000,000

)

(367,503

)

1,017,060

Total

1,017,060

Total Interest Rate Swaps

$

918,249

(1)

Designated as hedging instruments in a fair value hedge, utilizing hedge accounting. The associated change in fair value is recorded along with the change in fair value of the hedged item within interest expense (see Note 6 and Note 7).

Foreign Currency Forward Contracts

Settlement Date

Amount Purchased

Amount Sold

Fair Value

Derivative Counterparty

Bank of America, N.A.

3/31/2026

$

2,544,637

AU$

3,848,352

$

(23,643

)

Bank of America, N.A.

3/31/2026

€

301,133

$

351,733

3,386

Bank of America, N.A.

3/31/2026

€

364,439

$

427,429

2,346

Bank of America, N.A.

3/31/2026

$

1,070,940

€

909,109

(1,153

)

Bank of America, N.A.

3/31/2026

$

12,039,603

€

10,219,999

(12,618

)

Bank of America, N.A.

3/31/2026

$

29,829,778

€

25,245,127

58,752

Bank of America, N.A.

3/31/2026

€

1,242,724

$

1,468,623

(3,105

)

Bank of America, N.A.

3/31/2026

€

5,073,863

$

5,999,639

(16,143

)

Bank of America, N.A.

3/31/2026

$

18,486,350

£

13,811,639

(120,574

)

Bank of America, N.A.

3/31/2026

$

267,030

£

197,794

564

Total

$

(112,188

)

The accompanying notes are an integral part of these consolidated financial statements.

27


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

1.

Organization and Business

Silver Point Specialty Lending Fund (the “Fund”) is an externally managed closed-end management investment company that has elected to be regulated as a business development company (“BDC”) under the 1940 Act and was originally formed on July 31, 2014. Effective November 15, 2021, the Fund changed its name to Silver Point Specialty Lending Fund and converted to a statutory trust organized under the laws of the State of Maryland. The Fund is an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). For so long as the Fund remains an emerging growth company under the JOBS Act, it will be subject to reduced public company reporting requirements.

The Fund’s investment objective is to achieve stable income generation with attractive risk-adjusted returns by investing primarily in U.S. middle market lending opportunities, and specialty asset based financings. The Fund may also, from time to time, invest in larger or smaller companies. In seeking to achieve its investment objective, the Fund may also invest across a broad range of industries. The Fund will invest primarily in first-lien debt, but may also invest in unitranche, second lien, mezzanine and unsecured debt, equity, structured credit, and derivatives depending on the opportunity set and market environment.

Silver Point Specialty Credit Fund Management, LLC (the “Adviser”), a Delaware limited liability company, serves as the Fund’s investment adviser and administrator. Subject to the supervision of the Fund’s Board of Trustees (“Board of Trustees”, the “Board” or the “Trustees”), the Adviser manages the day-to-day operations and provides the Fund with investment advisory and management services. The Adviser is responsible for sourcing, researching and structuring potential investments, monitoring portfolio companies, and providing operating and managerial assistance to the Fund and to its portfolio companies as required.

In 2023, the Fund extended its investment period through June 30, 2025. Following the extension, the Fund was required to provide the holders of common shares of beneficial interests (the “shares”) of the Fund (the “Shareholders” or “Investors”) with the opportunity to sell their shares at a price not less than a net asset value per share prior to June 30, 2025 or the Fund would begin winding up its affairs. In 2025, the Board approved a liquidity event (the “Liquidity Event”), allowing Shareholders to sell some or all of their shares to new investors at the Fund’s net asset value per share as of April 30, 2025, via liquidity election forms. As a result, the Fund is able to continue its operations perpetually.

2.

Summary of Significant Accounting Policies

Basis of Presentation

The accompanying consolidated interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), are presented in U.S. dollars and include the accounts of the Fund and its wholly owned subsidiaries. The Fund is an investment company following accounting and reporting guidance in Accounting Standards Codification (“ASC”) 946, Financial Services – Investment Companies. All material intercompany balances and transactions have been eliminated. All references to the Fund include the accounts of its consolidated subsidiaries.

The consolidated interim financial statements are prepared in accordance with U.S. GAAP and pursuant to the requirements of Article 6 of Regulation S-X of the Securities Act of 1933, as amended (the “1933 Act”). The interim financial data as of September 30, 2026 and for each of the three and nine months ended September 30, 2026 and 2025 is unaudited. In the opinion of management, all adjustments considered necessary for the fair presentation of the consolidated interim financial statements for the periods presented have been included. These consolidated interim financial statements should be read in conjunction with the Fund’s audited consolidated financial statements, and notes related thereto, for the year ended December 31, 2025. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2026.

Basis of Consolidation

The Fund generally consolidates any wholly or substantially owned subsidiary when the design and purpose of the subsidiary is to act as an extension of the Fund’s investment operations and to facilitate the execution of the Fund’s investment strategy. Accordingly, the Fund has consolidated the results of its subsidiaries in its consolidated financial statements, including Silver Point SCF CLO I, Ltd., Silver Point SCF CLO I, LLC, Silver Point SCF CLO IV, Ltd., Silver Point SCF CLO IV, LLC, Specialty Credit Facility, LLC, Specialty Credit Holdings, LLC, Specialty Credit Fund Cayman, Ltd., Silver Point Specialty Credit Depositor, LLC, SCF West, LLC, SCF APEG Holdings, LLC, SCF CAL, L.P., SCF CAL GP, LLC, SCF I SPRE Holdings, LLC, SCF Property Holdings, LLC, Golden Holdings I, LLC and SLMD Holdings, Inc. As provided by ASC 946, the Fund will not consolidate portfolio companies in which it invests, unless the portfolio company is itself an investment company or is a controlled operating company whose business consists of providing services to the Fund. The Fund’s investments in the portfolio

28


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

companies (including its investments held by consolidated subsidiaries) are listed on the Fund’s consolidated statements of assets and liabilities, as investments at fair value.

Use of Estimates

The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the fair value of investments, the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates and such differences could be material.

Investment Classification

The Fund classifies its investments by level of control. Under the 1940 Act, the Fund is presumed to “control” a portfolio company if the Fund owns more than 25% of a portfolio company’s voting securities and/or holds the power to exercise control over the management or policies of such portfolio company; the Fund is generally presumed a non-controlling “affiliated person” if the Fund owns, either directly or indirectly, between 5% and 25% of a portfolio company’s outstanding voting securities and/or is under common control with the portfolio company. Detailed information with respect to the Fund’s investment classification by level of control is disclosed in the accompanying consolidated financial statements, including the consolidated schedules of investments.

Cash, Restricted Cash, Cash Equivalents and Foreign Cash

Cash and restricted cash on deposit at a major financial institution are included in cash and restricted cash, respectively, in the consolidated statements of assets and liabilities. Cash equivalents and restricted cash equivalents consist of highly liquid assets, such as money market funds. At times, cash, restricted cash, and cash equivalents may exceed Federal Deposit Insurance Corporation insured limits. Management believes that the credit risk to these deposits is minimal. Cash equivalents are classified as Level 1 in the U.S. GAAP valuation hierarchy.

Restricted cash and cash equivalents are generally restricted to the purchase of investments, as well as payment of expenses and interest, in connection with the Fund’s credit facilities (Note 6). Certain restricted cash and cash equivalents may be available for monthly withdrawal subject to the terms of the underlying credit facilities.

Additionally, cash denominated in currencies other than U.S. dollars is recorded as foreign cash held at banks. At times, foreign cash held at banks may exceed Federal Deposit Insurance Corporation insured limits.

The table below comprises our cash, restricted cash, cash equivalents and foreign cash as of September 30, 2026 and December 31, 2025:

($ in millions)*

September 30, 2026

December 31, 2025

Cash

$

3.9

$

3.0

Cash equivalents

12.4

11.0

Restricted cash

3.6

4.9

Restricted cash equivalents

25.5

13.0

Foreign cash held at banks

1.3

2.2

Total

$

46.7

$

34.1

(*) Totals may not foot due to rounding.

Interest income generated on cash and cash equivalents is included in interest income on the consolidated statements of operations. The following table presents interest income generated by cash, restricted cash, and cash equivalents for the three and nine months ended September 30, 2026 and 2025:

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

($ in millions)

2026

2025

2026

2025

Interest income on cash, restricted cash, cash equivalents and foreign cash

$

0.4

$

0.7

$

1.0

$

2.4

29


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

Due from and Due to Broker

Due from and due to broker consist of cash and cash collateral related to foreign currency forward contracts and interest rate swaps (Note 7). As of September 30, 2026 and December 31, 2025, due from broker consists of approximately $1.9 million and $1.8 million, respectively, of cash collateral. As of September 30, 2026 and December 31, 2025, due to broker consists of approximately $0.0 million of cash collateral.

Investment Transactions and Related Income and Expense

Investments are carried at fair value, with resulting unrealized appreciation and depreciation reflected in the consolidated statements of operations. Purchases and sales of investments are recorded on a trade date basis. Net gains or losses on investments are included on the consolidated statements of operations. Realized gains and losses on investments are determined on the specific cost identification basis.

Loans including revolving credit agreements are generally recorded on the consolidated statements of assets and liabilities as a component of investments owned at fair value, net of the unfunded portion of the related credit agreement. Real estate properties represent direct ownership of underlying real property assets. The properties are recorded at fair value and generally do not produce rental income.

Interest income and expense are recognized on an accrual basis. Discounts and premiums to par value on investments are accreted and amortized into interest income over the required period of the respective investment using the effective interest method. Loan origination fees received in full at the inception of a loan or bond and fees earned in full upfront and to be paid at the termination of the loan are deferred and accreted into interest income, using the effective yield method as an enhancement to the related loan’s yield over the contractual life of the loan. The amortized cost of investments is adjusted for accretion of fees, if any. For the three months ended September 30, 2026 and 2025, non-cash interest income related to such accretion amounted to $2.8 million and $1.1 million, respectively. For the nine months ended September 30, 2026 and 2025, non-cash interest income related to such accretion amounted to $7.9 million and $5.2 million, respectively. Upon the prepayment of a loan, prepayment premiums and any unamortized fees are recorded as interest income.

The Fund has loans in its portfolio that contain payment-in-kind (“PIK”) provisions. PIK interest, computed at the contractual rate specified in each loan agreement, is generally recorded as interest income on an accrual basis. On the specified capitalization date, PIK interest is added to the principal balance and cost of the loan.

Generally, loans are placed on non-accrual status when there is reasonable doubt that the principal or interest will be collected in full and the accrued interest is reversed against interest income. Interest payments received on debt investments on non-accrual status may be recognized as interest income or treated as a reduction of cost basis of the debt investment based on management’s judgment of ultimate recovery and other considerations.

Distributions from Equity Investments

Distributions received from equity investments in limited liability companies (“LLCs”) and limited partnerships (“LPs”) are evaluated to determine if the distribution should be recorded as dividend income, return of capital or realized gain (loss). Generally, the Fund will not record distributions from equity investments in LLCs and LPs as dividend income unless there are sufficient accumulated tax basis earnings and profits in the LLCs or LPs prior to the distribution. Prior to the ex-dividend date, the value of a dividend may be reflected in the fair value of the equity investment. Distributions from equity investments that are classified as a return of capital are recorded as a reduction in the cost basis of such equity investments.

Other Income

Other income generally includes amendment fees and other similar fees, as well as fees for services provided to portfolio companies by the Adviser. The services provided by the Adviser vary by investment and may include, but are not limited to, syndication, structuring, and diligence services, as well as managerial assistance to our portfolio companies. These fees are recognized when the services are rendered.

Foreign Currency Transactions

Net realized gain (loss) from foreign currency transactions as reported in the consolidated statements of operations arises from sales of foreign currencies; currency gains or losses realized between the trade and settlement dates on investment transactions; and the difference between the amounts of dividends, interest, and foreign withholding taxes recorded in the Fund’s books and records, and U.S. dollars equivalent of the amounts actually received or paid. Net change in unrealized appreciation (depreciation)

30


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

from foreign currency translations as reported in the consolidated statements of operations arises from changes in the fair values of assets and liabilities, other than investments at fiscal period-end, resulting from changes in exchange rates.

Investments and other assets and liabilities denominated in foreign currencies are translated into U.S. dollar amounts at the date of valuation. Purchases and sales of investments and income and expense items denominated in foreign currencies are translated into U.S. dollar amounts on the respective dates of such transactions.

The Fund does not isolate realized and unrealized gains and losses on investments and derivative contracts resulting from changes in foreign currency exchange rates on the consolidated statements of operations. Such fluctuations are reflected on the consolidated statements of operations together with net realized gain (loss) and net change in unrealized gain (loss) on investments and derivative contracts. The Fund generally attempts to hedge its foreign currency exposure through foreign currency forward contracts.

Derivatives and Hedging

In the normal course of business, the Fund has commitments and risks resulting from its investment transactions, which may include those involving derivative instruments. The Fund recognizes all derivative instruments as assets or liabilities at fair value in its consolidated financial statements, pursuant to ASC Topic 815 Derivatives and Hedging.

The Fund enters into interest rate swap transactions from time to time to manage interest rate exposure in certain fixed rate debt investments and such swaps are not designated as hedging instruments in accordance with hedge accounting. The Fund presents changes in the fair value as part of change in unrealized appreciation (depreciation) on the consolidated statements of operations and amounts received or paid related to derivative contracts are recognized on a net basis as realized gain (loss) and determined on the specific cost identification basis.

The Fund also uses certain interest rate swaps to hedge the Fund’s fixed rate debt and designates such interest rate swaps as hedging instruments in a fair value hedge, in accordance with hedge accounting; therefore, both the periodic payment and the change in fair value for the effective hedge, if applicable, are recognized as components of interest expense in the consolidated statements of operations (see Note 6 and Note 7 for more details).

The fair value of interest rate swap agreements are derived using daily swap curves and models that incorporate a number of market data factors, such as discounted cash flows, trades and values of the underlying reference instruments. The fair value of the interest rate swaps does not take into account collateral posted which is recorded separately as due to or due from broker on the Fund’s consolidated statements of assets and liabilities, depending on the nature of the balance at period end. Upfront payments made or received upon entering a derivative contract are treated as a part of the cost basis of the derivative contract.

The Fund may also enter into foreign currency forward contracts, under which the Fund agrees to recover or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. The foreign currency forward contracts are recorded at fair value. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Fund does not utilize hedge accounting for these contracts and as such, realized and unrealized gains and losses on foreign currency forward contracts are presented on the consolidated statements of operations.

Derivative instruments are expressed in terms of the notional contract amount and derive their value based upon one or more underlying instruments. While the notional amount gives some indication of the Fund’s derivative activity, it generally is not exchanged, but is only used as the basis on which interest and other payments are exchanged. Derivative instruments are subject to various risks similar to non-derivative instruments, including market, credit, liquidity, and operational risks. The Fund manages these risks on an aggregate basis as part of its risk management process.

Deferred Financing and Debt Issuance Costs

Deferred financing costs represent fees and other direct costs incurred in connection with the Fund’s revolving credit facilities. These amounts are capitalized as an asset within the consolidated statements of assets and liabilities and are amortized using the straight-line methodology over the expected term of the borrowing which is generally expected to be at the end of the revolving period. The Fund records costs related to the issuance of term debt obligations as debt issuance costs. These costs are deferred and amortized using the effective interest method. These costs are presented as a reduction to the outstanding principal amount of the term debt obligations on the consolidated statements of assets and liabilities.

31


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

Valuation of Investments and Derivative Contracts

Investments at fair value consist primarily of senior secured debt, real estate properties and equities. Derivative contracts consist primarily of foreign currency forward contracts and interest rate swaps.

The Board has designated the Adviser as the Fund’s valuation designee pursuant to Rule 2a-5 under the 1940 Act, which establishes requirements for determining fair value in good faith for purposes of the 1940 Act. Accordingly, the Adviser has appointed its BDC Valuation Committee with the responsibility for fair value determinations pursuant to valuation procedures adopted for the Fund. The Board oversees the Adviser in its role as valuation designee in accordance with the requirements of Rule 2a-5 under the 1940 Act.

Investments and derivative contracts are valued in good faith by the Adviser, as the Fund’s valuation designee, at fair value pursuant to the valuation policy, which considers quotations provided by independent pricing sources, when such quotations are available and deemed reliable. The Fund conducts this valuation process on a quarterly basis.

Investments that are not listed on an exchange but are actively traded over-the-counter are generally valued at the representative “bid” quotation if held long and the representative “ask” quotation if held short or, in the case of equities that trade in over-the-counter marketplaces, at the last deemed reliable sale price provided by independent pricing sources. Derivative contracts not listed on an exchange are generally valued through industry-standard valuation models using inputs obtained from pricing vendors and from the relevant derivative contract.

Investments for which independent pricing sources or recent transaction activity are either not readily available or are not deemed reliable (“Non-Quoted Investments”) are fair valued as determined in good faith by the Adviser, as the Fund’s valuation designee. Non-Quoted Investments are valued in a multi-step process:

1.

The BDC valuation team within the Fund Accounting team of the Adviser (“Fund Accounting”) provides recent portfolio company financial statements and other reporting materials to independent valuation firm(s) approved by the BDC Valuation Committee.

2.

The independent valuation firm(s) evaluates this information along with relevant observable market data to conduct independent valuations each quarter, and their valuation recommendations are documented and discussed with the BDC Valuation Committee, Fund Accounting and the relevant investment professionals, as appropriate.

3.

The valuation recommendations for certain investments may be determined by the BDC Valuation Committee in good faith in accordance with the valuation policy for the Fund without the employment of an independent valuation firm, based on immateriality or other considerations as appropriate.

4.

The BDC Valuation Committee discusses the valuations and approves the fair value of the investments in good faith based on the input and advice provided by the independent valuation firm(s), the BDC valuation team and relevant investment professionals of the Adviser, as necessary.

The estimated fair value of financial instruments is based upon available information and may not be the amount that the Fund would realize in a current transaction or might be ultimately realized, since such amounts depend on future circumstances, and the differences could be material.

In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments according to a hierarchy that prioritizes the inputs used to measure the fair value. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices on a securities exchange in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (level 3 measurements). In accordance with U.S. GAAP, these inputs are summarized in the three broad levels listed below:

Level 1: Inputs that reflect unadjusted quoted prices on a securities exchange in active markets for identical assets or liabilities;

Level 2: Inputs other than quoted prices on a securities exchange that are observable for the asset or liability either directly or indirectly in active markets, or unadjusted prices on a securities exchange in markets that are not considered to be active;

Level 3: Significant inputs that may be unobservable or inputs, including market quotations other than quoted prices on a securities exchange, in markets that are not considered to be active.

Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions including assumptions about risk. Inputs may include price information, volatility statistics, specific and broad credit data, liquidity statistics and other factors. An investment’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes “observable” requires judgment by the Adviser. The Adviser considers observable data to be that market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by multiple independent sources

32


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

that are actively involved in the relevant market. The categorization of an investment within the hierarchy is based upon the pricing transparency of the investment and does not necessarily correspond to the Adviser’s perceived risk of that instrument.

In determining an instrument’s placement within the hierarchy, the Adviser separates the Fund’s investment portfolio into two categories: investments and derivative contracts. Each of these categories can further be divided between assets and liabilities and further by investment type.

Investments whose values are based on the unadjusted quoted prices on a securities exchange in active markets for identical assets or liabilities are classified within Level 1. These include actively traded listed equities and cash equivalents as of September 30, 2026 and December 31, 2025. Cash equivalents primarily consist of money market funds valued at the net asset value per share.

Investments that are valued based on dealer quotations or alternative pricing sources supported by observable inputs are generally classified within level 2. These may include certain bonds or bank loans.

Derivative contracts can be exchange-traded or privately negotiated over-the-counter (“OTC”). OTC derivatives, including foreign currency forward contracts and interest rate swaps are generally valued using observable inputs. In instances where models are used, the value of an OTC derivative depends upon the contractual terms of, and specific risks inherent in the instrument as well as the availability and reliability of observable inputs. OTC derivatives are typically classified within level 2 of the fair value hierarchy depending on their liquidity or the observability of their inputs.

Investments classified within level 3 have significant unobservable inputs. Level 3 instruments may include certain bank loans, trust interests, private equity and real estate properties. When observable prices are not available for these investments, one or more valuation techniques (e.g., market approach or income approach) for which sufficient and reliable data is available may be used. Within level 3, the use of the market approach technique generally consists of using comparable market data, while the use of the income approach technique generally consists of the net present value of estimated future cash flows, adjusted as appropriate for liquidity, credit, market and/or other factors. Quotations provided by independent pricing sources may also be considered, if available and deemed reliable, in determining the value of level 3 investments.

The inputs used in estimating the value of level 3 investments that are not valued using quotations provided by independent pricing sources may include but are not limited to the original transaction price, recent transactions in the same or similar instruments, completed or pending third party transactions in the underlying investment or comparable issuers, subsequent rounds of financing, recapitalizations and other transactions across the capital structure, offerings in the equity or debt capital markets, discount rates, durations and changes in financial ratios or cash flows. Comparable public companies may also be identified based on industry, size, strategy, etc. and a trading multiple or yield is determined for each comparable company. Additionally, level 3 investments may also be adjusted to reflect illiquidity and/or non-transferability, with the amount of such discount estimated in the absence of market information. Assumptions used due to the lack of observable inputs may significantly impact the resulting fair value and therefore the Fund’s consolidated results of operations.

Income Taxes

Effective May 1, 2025, the Fund has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) as defined under Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code"). As a RIC, the Fund generally does not pay corporate-level U.S. federal income taxes on any ordinary income or capital gains that it distributes at least annually to its shareholders. Any tax liability related to income earned and distributed by the Fund represents obligations of the shareholders.

To qualify for and maintain qualification as a RIC, the Fund must, among other things, meet certain source-of-income and asset diversification requirements. In addition, to qualify for RIC tax treatment, the Fund must distribute to its shareholders, for each taxable year, at least 90% of its investment company taxable income, which is generally its ordinary income plus the excess, if any, of its realized net short-term capital gains over its realized net long-term capital losses. As a RIC, the Fund is also subject to a 4% nondeductible federal excise tax on undistributed income unless the Fund distributes in a timely manner, for each taxable year, an amount at least equal to the sum of (1) 98% of its ordinary net income for the calendar year, (2) 98.2% of capital gains (both long-term and short-term) for the one-year period ending October 31 in that calendar year and (3) any income realized, but not distributed, in prior years. To maintain its tax treatment as a RIC, the Fund intends, among other things, to make the requisite distributions to its shareholders, which generally relieves the Fund from corporate-level U.S. federal income taxes.

Depending on the level of taxable income earned in a tax year, the Fund may carry forward taxable income (including net capital gains, if any) in excess of current year dividend distributions from the current tax year into the next tax year. To the extent that the Fund determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions from such income, the Fund will be subject to a nondeductible 4% U.S. federal excise tax on estimated excess taxable income.

33


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

For the three and nine months ended September 30, 2026 and 2025, there was no accrued U.S. federal excise tax.

Prior to May 1, 2025, the Fund was treated as a partnership for U.S. federal income tax purposes. As a partnership, the Fund was generally not subject to U.S. federal income taxes at the entity level. Instead each investor was individually responsible for income taxes, if any, on its share of the Fund’s net taxable income. During this period, the Fund may have incurred entity-level state taxes or withholding taxes based on specific investors or income sources. Such taxes, were either recorded as entity-level expenses or charged directly to respective investors. Non-U.S. sourced income, such as interest, dividends, or capital gains, could have been subject to withholding and other taxes levied by the jurisdiction where the income was sourced. Such withholding taxes are accrued when incurred as withholding taxes against the relevant income stream. For the three and nine months ended September 30, 2026 and 2025, the Fund did not incur any non-U.S. tax expenses.

During the period when the Fund was treated as a partnership for U.S. federal income tax purposes, IRS audits and adjustments were conducted at the Fund level, with the Fund potentially responsible for taxes (and associated interest and penalties) resulting from such adjustments. In certain cases, the Fund could elect to have the tax assessed or collected at the investor level. In the event of an audit, partnership audit rules and elections could significantly affect the amount and timing of tax (and associated interest and penalties) that is required to be borne by the Fund and its investors (including former investors).

The Fund follows the authoritative guidance on accounting for and disclosure of uncertainty in tax positions, and is required to determine whether a tax position of the Fund is more likely than not to be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For tax positions meeting the more likely than not threshold, the tax amount recognized in the consolidated financial statements is reduced by the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant taxing authority. For the three and nine months ended September 30, 2026 and 2025, there were no liabilities related to accounting for uncertain tax positions.

The Fund files tax returns as required in the jurisdictions where it operates or invests and may be subject to examination for all open tax years, the earliest of which is 2023. The Fund recognizes interest and penalties, when known on the consolidated statements of operations. For the three and nine months ended September 30, 2026 and 2025, there were no material interest and penalties.

Retroactive Adjustments for Reverse Share Split

The Fund’s Board approved a one for two reverse share split of the Fund’s common shares on December 15, 2025 which was effective as of close of business December 26, 2025 (the “Reverse Share Split”). All common share and per common share amounts in the financial statements and notes thereto have been retroactively adjusted for all periods presented to give effect to the reverse share split.

Segment Reporting

In accordance with ASC Topic 280 - Segment Reporting, the Fund has determined that it has a single operating and reporting segment. Operating and reporting segments are components of an enterprise for which separate financial information is available and are evaluated regularly by the Fund’s chief operating decision maker ( the “CODM”) in deciding how to allocate resources and assess performance. The Fund’s CODM is its Chief Executive Officer and Chief Financial Officer. The key metrics, along with other various factors, the CODM utilizes to determine performance and make operating decisions are net investment income and net increase (decrease) in net assets resulting from operations, as reported on the consolidated statements of operations. The Fund’s CODM views the Fund’s operations and manages its business in one operating segment, which is to primarily invest in U.S. middle market lending opportunities to achieve the Fund’s investment objective.

Recent Accounting Pronouncements

In November 2024, the FASB issued ASU 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40),” which requires disaggregated disclosure of certain costs and expenses, including purchases of inventory, employee compensation, depreciation, amortization and depletion, in each relevant expense caption. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption and retrospective application is permitted. The Fund is currently assessing the impact of this guidance, however, the Fund does not expect a material impact to its consolidated financial statements.

3.

Significant Agreements and Related Party Transactions

The Fund is party to a fourth amended and restated advisory agreement, entered into on April 30, 2025 (the “Advisory Agreement”) pursuant to which the Fund has agreed to pay the Adviser a fee for its investment advisory and management services consisting of a management fee (the “Management Fee”) and an incentive fee (the “Incentive Fee”), which are ultimately borne by the Shareholders.

34


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

Management Fee

The Management Fee is calculated at an annual rate of 1.25% (0.3125% per quarter) of the Fund’s net assets on the last day of each calendar quarter, payable quarterly in arrears. The Adviser has agreed to waive 0.25% of the management fee rate from May 1, 2025 to May 1, 2027.

For the period from October 31, 2021 to April 30, 2025, the Management Fee was calculated at an annual rate of 0.75% (0.1875% per quarter) of the Shareholders’ aggregate net capital contributions on the last day of each calendar quarter.

At September 30, 2026 and December 31, 2025, management fees payable were $1.6 million and $1.5 million, respectively. For the three months ended September 30, 2026 and 2025, the Management Fees incurred were $2.0 million and $1.7 million, respectively. For the nine months ended September 30, 2026 and 2025, the Management Fees incurred were $6.0 million and $4.2 million, respectively. For the three months ended September 30, 2026 and 2025, the Management Fees waived were $0.4 million and $0.3 million, respectively. For the nine months ended September 30, 2026 and 2025, the Management Fees waived were $1.2 million and $0.6 million, respectively.

Incentive Fee

The Incentive Fee consists of two components that are determined independent of each other, with the result that one component may be payable even if the other is not. A portion of the Incentive Fee is based on income (“Income Incentive Fee”), and a portion is based on capital gains (“Incentive Fee on Capital Gains”).

Income Incentive Fee

(i) Income Incentive Fee - Effective May 1, 2025

The Income Incentive Fee is calculated and payable to the Adviser quarterly in arrears based on the Pre-Incentive Fee Net Investment Income generated by the Fund. For this purpose, “Pre-Incentive Fee Net Investment Income” means dividends (including reinvested dividends), interest and fee income accrued by the Fund during the calendar quarter, minus the Fund’s accrued operating expenses for the quarter (including the Management Fee, expenses payable under any Administration Agreement, and any interest expense and dividends paid on any issued and outstanding preferred shares, but excluding the Incentive Fee). Pre-Incentive Fee Net Investment Income includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with pay-in-kind interest and zero coupon securities), accrued income that the Fund may not have received in cash. Pre-Incentive Fee Net Investment Income also includes net interest income, if any, from derivative financial instruments or swaps on a look-through basis as if the Fund owned the reference assets directly (where such net interest income is defined as the difference between (A) the interest income and fees received in respect of the reference assets of the derivative financial instrument or swap and (B) the interest expense or financing charges and other expenses paid by the Fund to the derivative or swap counterparty). Pre-Incentive Fee Net Investment Income does not include any realized capital gains, realized capital losses and unrealized capital appreciation or depreciation.

The Income Incentive Fee, if any, is calculated and paid quarterly in arrears based on a percentage of the amount by which Pre-Incentive Fee Net Investment Income in respect of the current calendar quarter and the eleven preceding calendar quarters (the “Trailing Twelve Quarters”) exceeds the Hurdle Rate Amount (as defined below) in respect of the Trailing Twelve Quarters. The “Hurdle Rate Amount” is determined on a quarterly basis, and is calculated by multiplying 1.50% (6.00% annualized) by the value of the Fund’s net assets (total assets less indebtedness) at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters. The amount of Income Incentive Fee paid to the Adviser for a particular calendar quarter will equal the excess, if any, of the Income Incentive Fee so calculated less the aggregate Income Incentive Fee that was paid to the Adviser in the preceding eleven calendar quarters comprising the relevant Trailing Twelve Quarters. Income Incentive Fee for each calendar quarter is calculated as follows:

•

No amount in any calendar quarter in which the Fund’s Pre-Incentive Fee Net Investment Income for the Trailing Twelve Quarters does not exceed the Hurdle Rate Amount;

•

100% of the Fund’s Pre-Incentive Fee Net Investment Income for the Trailing Twelve Quarters, if any, that exceeds the Hurdle Rate Amount but is less than or equal to an amount (the “Catch-Up Amount”) determined on a quarterly basis by multiplying 1.7143% (6.8571% annualized) and the value of the Fund’s net assets (total assets less indebtedness) at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters; and

•

For any calendar quarter in which the Fund’s Pre-Incentive Fee Net Investment Income for the Trailing Twelve Quarters exceeds the Catch-Up Amount, 12.5% of the amount of the Fund’s Pre-Incentive Fee Net Investment Income, if any, that exceeds the Catch-Up Amount for such Trailing Twelve Quarters.

35


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

These calculations shall be appropriately adjusted for any share issuances or repurchases during the quarter (based on the actual number of days elapsed relative to the total number of days in such calendar quarter) and shall be appropriately prorated for any period of less than three months.

(ii) Income Incentive Compensation - October 31, 2021 to April 30, 2025

For the period from October 31, 2021 to April 30, 2025, the income Incentive Compensation was calculated and payable to the Adviser quarterly in arrears based on the amount by which Pre-Incentive Compensation Net Investment Income (as defined below) in respect of the current calendar quarter and the eleven preceding calendar quarters (the “Trailing Twelve Quarters”) exceeds the Hurdle Rate Amount (as defined below). The amount of Income Incentive Compensation paid to the Adviser for a particular calendar quarter equals the excess, if any, of the Income Incentive Compensation so calculated less the aggregate Income Incentive Compensation that was paid to the Adviser in the preceding eleven calendar quarters (or portion thereof) comprising the relevant Trailing Twelve Quarters. Income Incentive Compensation is calculated and paid as follows:

•

No amount in any calendar quarter in which the Fund’s Pre-Incentive Compensation Net Investment Income for the Trailing Twelve Quarters does not exceed the Hurdle Rate Amount.

•

100% of the Fund’s Pre-Incentive Compensation Net Investment Income for the Trailing Twelve Quarters, if any, that exceeds the Hurdle Rate Amount but is less than or equal to the Catch-up Amount (as defined below).

•

For any calendar quarter in which the Fund’s Pre-Incentive Compensation Net Investment Income for the Trailing Twelve Quarters exceeds the Catch-up Amount, 15% of the excess will be paid.

The “Hurdle Rate Amount” was calculated on a quarterly basis by multiplying 1.75% (7.00% annualized) and the Fund’s net asset value (total assets less indebtedness) at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters. The “Catch-up Amount” was calculated on a quarterly basis by multiplying 2.0588% (8.2353% annualized) and the Fund’s net asset value at the beginning of each applicable calendar quarter comprising the relevant Trailing Twelve Quarters. The above calculations were appropriately adjusted for distributions during the quarter. “Pre-Incentive Compensation Net Investment Income” means, with respect to any period, (a) interest income, dividend income and any other income accrued or earned by the Fund during such period minus (b) operating expenses for that period (including Management Fee, expenses payable under any advisory agreement or sub-administrative agreement, and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding Incentive Compensation); provided that Pre-Incentive Compensation Net Investment Income also includes in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with pay in kind interest and zero-coupon securities) accrued income that the Fund has not yet received in cash and net interest income, if any, from derivative financial instruments or swaps on a look-through basis as if the Fund owned the reference assets directly (where such net interest income is defined as the difference between (A) the interest income and fees received in respect of the reference assets of the derivative financial instrument or swap and (B) the interest expense or financing charges paid by the Fund to the derivative or swap counterparty); provided further that Pre-Incentive Compensation Net Investment Income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation.

At September 30, 2026 and December 31, 2025, Income Incentive Fee payable was $2.6 million and $2.5 million, respectively. For the three months ended September 30, 2026 and 2025, the Income Incentive Fee was $2.6 million and $2.0 million, respectively. For the nine months ended September 30, 2026 and 2025, the Income Incentive Fee was $7.5 million and $6.8 million, respectively.

Incentive Fee on Capital Gains

(i) Incentive Fee on Capital Gains - Effective May 1, 2025

The Incentive Fee on Capital Gains is determined in arrears at the end of each fiscal year and is equal to 12.5% of the Fund’s cumulative net capital gains (without giving consideration to any unrealized gains) subsequent to the Liquidity Event through the end of such fiscal year, less amounts previously paid subsequent to the Liquidity Event.

(ii) Capital Gains Incentive Compensation - October 31, 2021 to April 30, 2025

For the period from October 31, 2021 to April 30, 2025, Capital Gains Incentive Compensation was determined in arrears at the end of each fiscal year and was equal to 15% of the Fund’s cumulative net capital gains (without giving consideration to any unrealized gains) since inception through the Liquidity Event, less the amount of any Capital Gains Incentive Compensation previously paid.

36


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

Under U.S. GAAP, the Fund is required to accrue any Incentive Fee on Capital Gains that includes net realized capital gains and losses and net unrealized capital appreciation and depreciation on investments held at the end of each reporting period. In calculating the accrual for the Incentive Fee on Capital Gains, the Fund considers the cumulative aggregate unrealized capital appreciation in the calculation, because the Incentive Fee on Capital Gains would be payable if such unrealized capital appreciation were realized, even though such unrealized capital appreciation is not permitted to be considered in calculating the fee actually payable under the Advisory Agreement. There can be no assurance that such unrealized capital appreciation will be realized in the future and therefore the corresponding accrued Incentive Fee on Capital Gains for U.S. GAAP purposes may be reversed accordingly.

At September 30, 2026 and December 31, 2025, there was no Incentive Fee on Capital Gains payable. For the three and nine months ended September 30, 2026 and 2025, there was no Incentive Fee on Capital Gains.

Incentive Compensation Clawback - Through April 30, 2025

In accordance with U.S. GAAP, the Fund accrues an incentive fee based upon the cumulative net realized capital gains and losses and the cumulative net unrealized capital appreciation and depreciation on investments held at the end of each period. Actual amounts paid to the Adviser are consistent with the Advisory Agreement and are based only on realized capital gains computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis from inception through the end of each calendar year as if the entire portfolio was sold at fair value. Prior to the Liquidity Event, if the Fund was to wind down its affairs and complete final distributions to Shareholders or in connection with the Liquidity Event, the Adviser was obligated to pay the Fund an amount equal to (i) the cumulative Incentive Compensation received by the Adviser minus (ii) the product of 15% (adjusted for any waiver or reduction of Incentive Compensation paid) and the sum of the aggregate amount of cumulative net capital gains or losses and Pre-Incentive Compensation Net Investment Income generated since inception through the date of determination (the “Clawback Amount”). In connection with the Liquidity Event, the Adviser paid $8.5 million to the Fund to satisfy the Clawback Amount accrued as of the Liquidity Event, and will not be obligated to pay a Clawback Amount for any period after the Liquidity Event. For the three months ended September 30, 2026 and 2025, the change in Clawback Amount was $0.0 million and $0.0 million, respectively. For the nine months ended September 30, 2026 and 2025, the change in Clawback Amount was $0.0 million and $(1.5) million, respectively.

Other Related Party Transactions

Pursuant to the Advisory Agreement, the Adviser is responsible for providing various accounting and administrative services to the Fund and the Fund will reimburse the Adviser for all costs and expenses incurred in performing its administrative obligations, including the allocable portion of overhead (such as rent, office equipment and utilities) and the allocable portion of the compensation paid to the Fund’s General Counsel, Chief Compliance Officer and Chief Financial Officer and their respective staffs. At September 30, 2026 and December 31, 2025, the related party administration fee payables were $0.7 million and $0.7 million, respectively, and were included in accrued expenses in the consolidated statements of assets and liabilities. For the three months ended September 30, 2026 and 2025, the Fund incurred approximately $0.5 million and $0.4 million, respectively in related party administration fees. For the nine months ended September 30, 2026 and 2025, the Fund incurred approximately $1.5 million and $1.1 million, respectively in related party administration fees.

The Adviser, or its affiliates, is authorized to pay expenses in the name of and on behalf of the Fund. To the extent that expenses borne by or reimbursements due to the Fund are paid by the Adviser, or an affiliate, the Fund will reimburse or seek reimbursement from such party. At September 30, 2026 and December 31, 2025, the Fund owed less than $0.1 million to an affiliate.

37


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

4.

Investments

Investments consisted of the following at September 30, 2026 and December 31, 2025:

September 30, 2026

December 31, 2025

Amortized Cost

Fair Value

% of Fair
Value

Amortized Cost

Fair Value

% of Fair
Value

First lien debt

$

1,134,923,245

$

1,092,586,443

94.13

%

$

1,140,266,967

$

1,118,355,071

94.48

%

Second lien debt

16,718,878

16,031,407

1.38

22,169,530

18,063,272

1.53

Unsecured debt

8,933,121

20,609,661

1.78

14,562,864

21,258,410

1.80

Equities and warrants

34,708,567

19,478,403

1.68

26,436,437

13,170,198

1.11

Real estate properties

14,821,662

10,399,220

0.90

14,783,004

11,386,450

0.96

Trust interest

3,929,996

1,587,845

0.13

3,836,429

1,513,337

0.12

Total

$

1,214,035,469

$

1,160,692,979

100.00

%

$

1,222,055,231

$

1,183,746,738

100.00

%

The Fund invests primarily in first-lien debt which may include stand-alone first-lien loans, unitranche/last-out loans and first lien/last-out loans which generally bear greater risk in exchange for a higher interest rate, and senior secured corporate bonds with similar features to these categories of first-lien loans. At September 30, 2026, the unitranche/last-out loans and first lien/last-out loans, at fair value, were 0.2% and 4.7% of the investment portfolio, respectively. At December 31, 2025, the unitranche/last-out loans and first lien/last-out loans, at fair value, were 0.2% and 3.9% of the investment portfolio, respectively.

38


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

The following table presents the composition of the investment portfolio by industry classifications at amortized cost and fair value as of September 30, 2026 and December 31, 2025 with corresponding percentages of total fair value:

September 30, 2026

December 31, 2025

Industry Classification

Amortized Cost

Fair Value

% of Fair
Value

Amortized Cost

Fair Value

% of Fair
Value

Aerospace & Defense

$

—

$

—

—

%

$

20,455,881

$

20,553,762

1.74

%

Automobiles & Components

21,496,009

18,333,507

1.58

32,722,656

32,701,485

2.76

Building Products

23,895,754

21,257,983

1.83

17,634,472

17,807,884

1.50

Business Services

32,847,602

33,432,008

2.88

37,890,342

38,966,643

3.29

Commercial Services

20,732,937

20,561,331

1.77

22,076,925

22,143,254

1.87

Consumer Apparel

—

—

—

10,633,803

9,277,125

0.78

Consumer Brands

9,017,441

8,982,480

0.77

5,343,239

5,360,510

0.45

Consumer Products

33,198,413

33,295,916

2.87

29,848,701

30,786,361

2.60

Consumer Services

—

575,480

0.05

2,517,165

3,786,460

0.32

E-Commerce

27,524,927

16,480,854

1.42

26,144,295

17,544,724

1.48

Education

11,300,213

9,046,206

0.78

7,461,099

6,131,321

0.52

Energy

16,968,971

17,102,529

1.47

11,278,592

11,172,297

0.94

Environmental Solutions

17,499,980

17,703,114

1.53

15,385,623

15,636,174

1.32

Financial Services

19,556,457

19,731,023

1.70

6,000,000

6,169,541

0.52

Fitness & Leisure

21,973,502

21,832,715

1.88

22,176,678

22,115,748

1.87

Food & Beverage

44,740,515

44,344,365

3.82

52,354,834

52,318,266

4.42

Gaming & Entertainment

50,242,414

49,543,215

4.27

37,304,535

37,844,614

3.20

Healthcare Equipment & Supplies

36,965,041

36,529,720

3.15

38,592,664

37,889,679

3.20

Healthcare Providers & Services

72,388,207

55,940,351

4.82

62,443,201

44,918,240

3.79

Healthcare Technology

3,380,263

3,390,368

0.29

16,480,469

16,559,437

1.40

Industrial Products & Services

108,700,123

110,807,019

9.55

90,192,862

90,946,123

7.68

Industrial Real Estate

14,821,662

10,399,220

0.90

14,783,004

11,386,450

0.96

Insurance & Insurance Services

18,044,401

16,721,121

1.44

21,623,044

21,306,004

1.80

Media: Diversified & Production

9,593,885

9,516,371

0.82

8,552,443

8,602,977

0.73

Multi-Family

17,236,838

1,200,166

0.10

22,052,506

6,932,559

0.59

Oilfield Services

22,510,070

22,524,387

1.94

22,769,307

22,712,556

1.92

Paper & Packaging

35,193,955

34,522,464

2.97

37,254,069

36,861,466

3.11

Pharmaceuticals & Life Sciences

29,196,421

28,550,351

2.46

16,051,824

13,949,451

1.18

Power Generation

26,805,254

28,380,740

2.45

26,626,715

28,436,723

2.40

Professional Services

39,809,028

39,648,778

3.42

43,974,214

44,127,951

3.73

Real Estate Development & Management

18,391,465

16,779,958

1.45

35,510,780

35,777,820

3.02

Software & Services

115,552,151

112,339,028

9.68

139,387,232

139,506,703

11.79

Specialty Chemicals

71,551,130

69,467,752

5.99

34,697,168

34,699,243

2.93

Specialty Retail

37,938,328

49,037,477

4.22

36,986,299

43,438,580

3.67

Staples Retail

9,587,513

11,776,076

1.01

12,727,688

12,843,425

1.08

Technology

113,755,565

111,639,413

9.62

96,143,818

96,386,739

8.14

Technology Hardware & Equipment

22,352,753

22,688,910

1.95

35,972,237

35,788,399

3.02

Telecommunications

9,929,450

9,981,800

0.86

14,364,536

14,383,655

1.22

Transportation & Logistics

25,406,835

25,040,938

2.16

28,823,313

29,482,604

2.49

Utilities

—

—

—

4,980,569

4,980,448

0.42

Other

3,929,996

1,587,845

0.13

3,836,429

1,513,337

0.15

Total

$

1,214,035,469

$

1,160,692,979

100.00

%

$

1,222,055,231

$

1,183,746,738

100.00

%

39


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

The following table presents the composition of the investment portfolio by geographic dispersion at amortized cost and fair value as of September 30, 2026 and December 31, 2025 with corresponding percentages of total fair value:

September 30, 2026

December 31, 2025

Geographic Dispersion(1)

Amortized Cost

Fair Value

% of Fair
Value

Amortized Cost

Fair Value

% of Fair
Value

Australia

$

—

$

—

—

%

$

2,938,077

$

2,963,608

0.25

%

Canada

90,953,785

89,875,785

7.74

75,801,904

75,259,992

6.36

Germany

1,370,513

1,347,643

0.12

1,370,513

1,397,278

0.12

Italy

20,236,443

19,626,307

1.69

—

—

—

Luxembourg

9,463,456

19,824,115

1.71

9,336,857

15,895,812

1.34

Netherlands

13,269,347

12,833,176

1.11

13,588,258

13,162,941

1.11

United Kingdom

16,339,763

16,436,249

1.42

17,203,556

17,675,710

1.49

United States of America

1,062,402,162

1,000,749,704

86.21

1,101,816,066

1,057,391,397

89.33

Total

$

1,214,035,469

$

1,160,692,979

100.00

%

$

1,222,055,231

$

1,183,746,738

100.00

%

(1)

Geographic dispersion represents the country of the issuer and may not represent the operating domicile.

5.

Fair Value Measurements

The following table presents the investments carried on the consolidated statements of assets and liabilities by level within the fair value hierarchy as of September 30, 2026:

September 30, 2026

Level 1

Level 2

Level 3

Total

Investments:

Secured loans

$

—

$

202,241,893

$

867,399,135

$

1,069,641,028

Secured debt

—

19,301,243

19,675,579

38,976,822

Unsecured debt

—

—

20,609,661

20,609,661

Equities and warrants

575,480

—

18,902,923

19,478,403

Trust interest

—

—

1,587,845

1,587,845

Real estate properties

—

—

10,399,220

10,399,220

Total investments

$

575,480

$

221,543,136

$

938,574,363

$

1,160,692,979

Cash-related Assets:

Cash equivalents and restricted cash equivalents

$

37,984,138

$

—

$

—

$

37,984,138

Total

$

37,984,138

$

—

$

—

$

37,984,138

Derivative Assets

Interest rate swaps

$

—

$

1,595,422

$

—

$

1,595,422

Foreign currency forward contracts

—

961,348

—

961,348

Total

$

—

$

2,556,770

$

—

$

2,556,770

Derivative Liabilities

Interest rate swaps

$

—

$

(13,277

)

$

—

$

(13,277

)

Foreign currency forward contracts

—

(2,511

)

—

(2,511

)

Total

$

—

$

(15,788

)

$

—

$

(15,788

)

40


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

The following table presents the investments carried on the consolidated statements of assets and liabilities by level within the fair value hierarchy as of December 31, 2025:

December 31, 2025

Level 1

Level 2

Level 3

Total

Investments:

Secured loans

$

—

$

229,896,677

$

889,252,524

$

1,119,149,201

Secured debt

—

17,223,268

45,874

17,269,142

Unsecured debt

—

14,606,464

6,651,946

21,258,410

Equities and warrants

1,269,709

—

11,900,489

13,170,198

Trust interest

—

—

1,513,337

1,513,337

Real estate properties

—

—

11,386,450

11,386,450

Total investments

$

1,269,709

$

261,726,409

$

920,750,620

$

1,183,746,738

Cash-related Assets:

Cash equivalents and restricted cash equivalents

$

24,011,852

$

—

$

—

$

24,011,852

Total

$

24,011,852

$

—

$

—

$

24,011,852

Derivative Assets

Interest rate swaps

$

—

$

1,144,580

$

—

$

1,144,580

Foreign currency forward contracts

—

65,048

—

65,048

Total

$

—

$

1,209,628

$

—

$

1,209,628

Derivative Liabilities

Interest rate swaps

$

—

$

(226,331

)

$

—

$

(226,331

)

Foreign currency forward contracts

—

(177,236

)

—

(177,236

)

Total

$

—

$

(403,567

)

$

—

$

(403,567

)

The following table includes a roll forward of the amounts for the three months ended September 30, 2026 for investments classified within level 3. The classification of an investment within level 3 is based upon the significance of the unobservable inputs to the overall fair value measurement.

Fair Value Measurements of Level 3 Investments

Secured Loans and Debt

Unsecured Debt

Equities and Warrants

Trust Interest

Real Estate Properties

Total

Balance at July 1, 2026

$

889,385,391

$

19,722,672

$

14,774,231

$

1,561,627

$

10,399,219

$

935,843,140

Transfer in(1)

—

—

—

—

—

—

Transfer out(1)

—

—

—

—

—

—

Accretion/amortization of discounts/premiums

2,159,577

4,777

—

—

—

2,164,354

Interest paid-in-kind

1,233,069

67,811

—

32,924

—

1,333,804

Purchases(2)

55,811,765

—

5,684,089

—

48,087

61,543,941

Sales, paydowns and resolutions(2)

(54,910,341

)

—

—

—

—

(54,910,341

)

Net realized gain/(loss)

(12,514,706

)

—

—

—

—

(12,514,706

)

Net change in unrealized appreciation/(depreciation)

5,909,959

814,401

(1,555,397

)

(6,706

)

(48,086

)

5,114,171

Balance at September 30, 2026

$

887,074,714

$

20,609,661

$

18,902,923

$

1,587,845

$

10,399,220

$

938,574,363

Change in net unrealized appreciation / (depreciation) on investments held as of September 30, 2026

$

(5,638,475

)

$

814,401

$

(1,555,397

)

$

(6,706

)

$

(48,086

)

$

(6,434,263

)

(1)

There was no investment transferred in to or out from level 3.

(2)

Includes the effects of reorganizations, if any.

41


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

The following table includes a roll forward of the amounts for the nine months ended September 30, 2026 for investments classified within level 3:

Fair Value Measurements of Level 3 Investments

Secured Loans and Debt

Unsecured Debt

Equities and Warrants

Trust Interest

Real Estate Properties

Total

Balance at January 1, 2026

$

889,298,398

$

6,651,946

$

11,900,489

$

1,513,337

$

11,386,450

$

920,750,620

Transfer in(1)

—

8,436,923

—

—

—

8,436,923

Transfer out(2)

(18,749,147

)

—

—

—

—

(18,749,147

)

Accretion/amortization of discounts/premiums

6,087,838

13,668

—

—

—

6,101,506

Interest paid-in-kind

2,944,748

356,589

—

93,567

—

3,394,904

Purchases(3)

197,946,548

—

8,272,129

—

163,658

206,382,335

Sales, paydowns and resolutions(3)

(163,072,100

)

—

—

—

(125,000

)

(163,197,100

)

Net realized gain/(loss)

(16,014,395

)

—

—

—

—

(16,014,395

)

Net change in unrealized appreciation/(depreciation)

(11,367,176

)

5,150,535

(1,269,695

)

(19,059

)

(1,025,888

)

(8,531,283

)

Balance at September 30, 2026

$

887,074,714

$

20,609,661

$

18,902,923

$

1,587,845

$

10,399,220

$

938,574,363

Change in net unrealized appreciation / (depreciation) on investments held as of September 30, 2026

$

(20,683,639

)

$

5,150,535

$

(1,269,695

)

$

(19,059

)

$

(1,025,888

)

$

(17,847,746

)

(1)

Investment was transferred in from level 2 to level 3 due to a lack of observable market data.

(2)

Investment was transferred out from level 3 due to changes in observability of valuation inputs.

(3)

Includes the effects of reorganizations, if any.

The following table includes a roll forward of the amounts for the three months ended September 30, 2025 for investments classified within level 3:

Fair Value Measurements of Level 3 Investments

Secured Loans and Debt

Unsecured Debt

Equities

Trust Interest

Real Estate Properties

Total

Balance at July 1, 2025

$

739,538,278

$

6,334,487

$

12,423,446

$

1,467,056

$

10,116,813

$

769,880,080

Transfer in(1)

—

—

—

—

—

—

Transfer out(1)

—

—

—

—

—

—

Accretion/amortization of discounts/premiums

941,373

—

—

—

—

941,373

Interest paid-in-kind

940,954

128,490

—

27,628

—

1,097,072

Purchases(2)

84,785,811

—

—

—

37,479

84,823,290

Sales, paydowns and resolutions(2)

(6,907,616

)

—

(96,540

)

—

—

(7,004,156

)

Net realized gain/(loss)

3,920

—

—

—

—

3,920

Net change in unrealized appreciation/(depreciation)

(2,408,202

)

254,005

(484,608

)

(5,628

)

1,388,988

(1,255,445

)

Balance at September 30, 2025

$

816,894,518

$

6,716,982

$

11,842,298

$

1,489,056

$

11,543,280

$

848,486,134

Change in net unrealized appreciation / (depreciation) on investments held as of September 30, 2025

$

(2,462,733

)

$

254,005

$

(484,608

)

$

(5,628

)

$

1,388,988

$

(1,309,976

)

(1)

There was no investment transferred in to or out from level 3.

(2)

Includes the effects of reorganizations, if any.

The following table includes a roll forward of the amounts for the nine months ended September 30, 2025 for investments classified within level 3:

Fair Value Measurements of Level 3 Investments

Secured Loans and Debt

Unsecured Debt

Equities

Trust Interest

Real Estate Properties

Total

Balance at January 1, 2025

$

780,905,839

$

—

$

1,975,126

$

1,424,586

$

12,808,845

$

797,114,396

Transfer in(1)

—

—

—

—

—

—

Transfer out(1)

—

—

—

—

—

—

Accretion/amortization of discounts/premiums

4,641,141

—

—

—

—

4,641,141

Interest paid-in-kind

3,306,320

128,490

—

80,962

—

3,515,772

Purchases(2)

166,411,164

6,406,376

11,504,264

—

221,881

184,543,685

Sales, paydowns and resolutions(2)

(124,332,492

)

—

(96,540

)

—

—

(124,429,032

)

Net realized gain/(loss)

(9,565,726

)

—

—

—

—

(9,565,726

)

Net change in unrealized appreciation/(depreciation)

(4,471,728

)

182,116

(1,540,552

)

(16,492

)

(1,487,446

)

(7,334,102

)

Balance at September 30, 2025

$

816,894,518

$

6,716,982

$

11,842,298

$

1,489,056

$

11,543,280

$

848,486,134

Change in net unrealized appreciation / (depreciation) on investments held as of September 30, 2025

$

(8,306,218

)

$

182,116

$

(1,540,552

)

$

(16,492

)

$

(1,487,446

)

$

(11,168,592

)

(1)

There was no investment transferred in to or out from level 3.

(2)

Includes the effects of reorganizations, if any.

All realized gains (losses) and change in unrealized appreciation (depreciation) in the tables above are reflected in the accompanying consolidated statements of operations. Transfers between levels, if any, are recognized at the beginning of each reporting period.

42


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

The following tables provide quantitative information about the Fund’s level 3 fair value measurements for the Fund’s investments as of September 30, 2026 and December 31, 2025. In addition to the techniques and inputs noted in the tables below, the Fund may also use, in accordance with the valuation policy, other valuation techniques and methodologies when determining the Fund’s fair value measurements. The below tables are not intended to be inclusive of all unobservable inputs, but rather provide information on the significant level 3 inputs as they relate to the Fund’s fair value measurements.

Quantitative Information about Level 3 Value Investments

Investment Type

Fair Value at September 30, 2026

Valuation
Technique(s)

Unobservable
Input(s)

Range (Weighted
Average)

Impact to
Valuation
from an
Increase
in Input
(1)

Secured Loans and Debt

$

773,359,355

Income Approach

Yield

8.9% - 35.3% (12.0%)

Decrease

Expected Term(2)

0.3 yrs. - 3.1 yrs. (1.7 yrs.)

Decrease

63,126,915

Recent Transaction

N/A

N/A

Increase

50,588,444

Market Comparables

Market Multiple

0.2x - 8.2x (5.8x)

Increase

Unsecured Debt

14,039,892

Market Comparables

Market Multiple

3.5x - 11.0x (6.2x)

Increase

6,569,769

Income Approach

Yield

15.8%

Decrease

Equities and Warrants

18,902,923

Market Comparables

Market Multiple

3.3x - 11.6x (8.9x)

Increase

Real Estate Property

10,399,220

Income Approach

Discount Rate

13.0%

Decrease

Expected Term(2)

1.4 yrs.

Decrease

Trust Interest

1,587,845

Asset Approach

Recovery Rate

0.8%

Increase

Total Level 3 Investments

$

938,574,363

(1)

This column represents the directional change in the fair value of the Level 3 investments that would result from an increase to the corresponding unobservable input. A decrease to the unobservable input would have the opposite effect. Significant changes in these inputs in isolation could result in significantly higher or lower fair value measurements.

(2)

Expected term is an unobservable input for debt or non-debt investments where the valuation methodology contemplates exits other than contractual maturities, if any. Weighted average expected term for Level 3 debt investments, including those valued to contractual maturity, was approximately 3.2 years as of September 30, 2026.

Quantitative Information about Level 3 Value Investments

Investment Type

Fair Value at December 31, 2025

Valuation
Technique(s)

Unobservable
Input(s)

Range (Weighted
Average)

Impact to
Valuation
from an
Increase
in Input
(1)

Secured Loans and Debt

$

725,148,461

Income Approach

Yield

5.6% - 30.1% (11.4%)

Decrease

Expected Term(2)

0.1 yrs. - 1.8 yrs. (0.8 yrs.)

Decrease

105,037,332

Recent Transaction

N/A

N/A

N/A

46,781,632

Market Comparables

Market Multiple

0.2x - 11.0x (4.9.x)

Increase

12,330,973

Market Quotation

Market Quotation

N/A

N/A

Unsecured Debt

6,651,946

Market Comparables

Market Multiple

10.9x

Increase

Equities

11,762,190

Market Comparables

Market Multiple

3.8x - 10.9x (9.4x)

Increase

Warrants

138,299

Recent Transaction

N/A

N/A

N/A

Real Estate Property

11,386,450

Income Approach

Discount Rate

13.0%

Decrease

Expected Term(2)

0.5 yrs.

Decrease

Trust Interest

1,513,337

Asset Approach

Recovery Rate

0.8%

Increase

Total Level 3 Investments

$

920,750,620

(1)

This column represents the directional change in the fair value of the Level 3 investments that would result from an increase to the corresponding unobservable input. A decrease to the unobservable input would have the opposite effect. Significant changes in these inputs in isolation could result in significantly higher or lower fair value measurements.

(2)

Expected term is an unobservable input for debt or non-debt investments where the valuation methodology contemplates exits other than contractual maturities, if any. Weighted average expected term for Level 3 debt investments, including those valued to contractual maturity, was approximately 3.4 years as of December 31, 2025.

43


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

6.

Debt

In February 2025, the Board approved reducing the Fund’s asset coverage requirements from 200% to 150% and in April 2025, the Fund’s Shareholders approved the reduction at a special meeting of Shareholders. As a result, the reduction of the asset coverage requirements became effective for the Fund on May 1, 2025. Asset coverage ratio is equal to (i) total assets at the end of the period, less all liabilities and indebtedness not represented by senior securities, divided by (ii) total debt represented by senior securities at the end of the period. As of September 30, 2026 and December 31, 2025, the asset coverage ratio based on the aggregate amount outstanding of the Fund’s senior securities was 214% and 199%, respectively.

Revolving Credit Facility

The Fund is party to a secured revolving credit facility with Deutsche Bank AG (the “Revolving Credit Facility”) that allows the Fund to borrow an amount up to $250 million. The interest rate is 3-Month SOFR plus a margin of 170 basis points per annum on the drawn portion, as well as a commitment fee of 40 basis points per annum on any unused portion. The revolving period ends April 17, 2028 and the stated maturity is April 17, 2031. In connection with the Revolving Credit Facility, the Fund has pledged certain investments and cash as collateral and such pledged investments may accordingly be restricted as to resale. Certain specified revaluation events related to pledged assets may result in a decrease in the borrowing base, and could incent or require the Fund to pledge additional collateral.

As of September 30, 2026 and December 31, 2025, $109.4 million and approximately $151.1 million, respectively, of the Revolving Credit Facility was outstanding.

2021 Debt Securitization

On September 9, 2021, the Fund completed a $400 million term debt securitization (the “2021 Debt Securitization”), also known as a collateralized loan obligation transaction, which is a form of secured financing incurred by the Fund. The debt offered in the 2021 Debt Securitization (the “2021 CLO”) was issued by Silver Point SCF CLO I, Ltd., a wholly owned subsidiary of the Fund, and was backed by a diversified portfolio of senior secured bonds and loans and second lien loans. The Fund owned $112 million of Class D and Subordinated Notes. All transactions and balances associated with these two classes of notes were eliminated in consolidation. The Class A-1 Loans and Class A-1a through Class D Notes were secured obligations; the Subordinated Notes were the unsecured obligations of the 2021 CLO. The indenture governing the 2021 CLO included customary covenants.

2024 Debt Securitization

On September 26, 2024, the Fund completed a $428 million term debt securitization (the “2024 Debt Securitization”), also known as a collateralized loan obligation transaction, which is a form of secured financing incurred by the Fund. The 2024 Debt Securitization is commonly referred to as a “CLO Reset”, in which the 2021 CLO was reset with a new capital structure and reinvestment period. The debt offered in the 2024 Debt Securitization (the “2024 CLO”) was issued by Silver Point SCF CLO IV, Ltd., a wholly owned subsidiary of the Fund, and is backed by a diversified portfolio of senior secured bonds and loans and second lien loans. The Fund owns $124 million of Class D and Subordinated Notes. All transactions and balances associated with these two classes of notes have been eliminated in consolidation. The Class A-1 Loans and Class A-1a through Class D Notes are secured obligations; the Subordinated Notes are the unsecured obligations of the 2024 CLO. The indenture governing the 2024 CLO includes customary covenants. The stated maturity for the 2024 CLO is October 15, 2036.

44


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

The 2024 CLO consists of the following:

September 30, 2026

2024 CLO

Total Principal
Amount
Committed

Principal
Amount
Outstanding

Carrying Value(1)

Fair Value

Coupon

Interest Rate

Class A-1 Loans

$

100,000,000

$

100,000,000

$

99,577,314

$

100,180,000

S+1.72%

5.47

%

Class A-1a Notes

115,500,000

115,500,000

115,011,798

115,707,900

S+1.72%

5.47

%

Class A-1b Notes

16,500,000

16,500,000

16,430,257

16,254,150

5.10%

5.10

%

Class A-2 Notes

16,000,000

16,000,000

15,932,370

16,024,000

S+1.95%

5.70

%

Class B Notes

24,000,000

24,000,000

23,898,555

24,050,400

S+2.10%

5.85

%

Class C Notes

32,000,000

32,000,000

31,864,741

32,060,800

S+2.70%

6.45

%

Total 2024 CLO

$

304,000,000

$

304,000,000

$

302,715,035

$

304,277,250

5.60

%

December 31, 2025

2024 CLO

Total Principal
Amount
Committed

Principal
Amount
Outstanding

Carrying Value(1)

Fair Value

Coupon

Interest Rate

Class A-1 Loans

$

100,000,000

$

100,000,000

$

99,436,635

$

100,020,000

S+1.72%

5.62

%

Class A-1a Notes

115,500,000

115,500,000

114,849,313

115,523,100

S+1.72%

5.62

%

Class A-1b Notes

16,500,000

16,500,000

16,407,045

16,531,350

5.10%

5.10

%

Class A-2 Notes

16,000,000

16,000,000

15,909,862

16,046,400

S+1.95%

5.85

%

Class B Notes

24,000,000

24,000,000

23,864,792

24,072,000

S+2.10%

6.00

%

Class C Notes

32,000,000

32,000,000

31,819,723

32,112,000

S+2.70%

6.60

%

Total 2024 CLO

$

304,000,000

$

304,000,000

$

302,287,370

$

304,304,850

5.74

%

(1)

Carrying value represents aggregate principal amount outstanding less unamortized debt issuance costs.

2026 Notes

On November 4, 2021, the Fund placed $145 million in aggregate principal of unsecured notes that mature on November 4, 2026 (the “2026 Notes”). The 2026 Notes were issued in two tranches, with $100 million of tranche A notes funded on November 4, 2021 and $45 million of tranche B notes funded on January 21, 2022. The 2026 Notes bear contractual interest at a rate of 4.00% per year, payable semi-annually on November 4 and May 4, of each year, commencing on May 4, 2022. The 2026 Notes are subject to various repayment and redemption provisions. Additionally, in connection with the 2026 Notes, the Fund is required to maintain certain asset ratios.

In connection with the 2026 Notes, the Fund entered into two interest rate swaps in April and May 2023, respectively, to align the interest rates of its liabilities with the Fund’s investment portfolio which consists of predominately floating rate loans. The notional amount of the interest rate swaps were each $72.5 million, or $145 million in aggregate, with a maturity date of June 30, 2025. In October 2024, the Fund simultaneously closed out these swaps and entered into a succeeding $145 million interest rate swap with a maturity date of November 4, 2026. For all swaps entered into in connection with the 2026 Notes, the Fund received a fixed rate of interest at 4.00% and paid a variable rate of interest based on SOFR (see additional information to the consolidated schedules of investments and Note 7 for more details on these interest rate swaps).

These interest rate swaps were designated as hedging instruments for the 2026 Notes in a fair value hedge, in accordance with hedge accounting. The April and May 2023 interest rate swaps were discontinued as fair value hedges upon their closure. As a result, the Fund’s effective interest rate on the 2026 Notes is SOFR plus 13 basis points during the swaps’ outstanding period. The interest expense related to the 2026 Notes is equally offset by the proceeds received from the interest rate swaps. Income and expenses generated by the hedging swaps are included as a component of total interest expense on the Fund’s consolidated statements of operations. The change in fair value of the interest rate swaps is offset by the change in the interest rate component of the fair value of the 2026 Notes, with the remaining difference as a component of total interest expense on the consolidated statements of operations.

45


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

2055 Promissory Notes

On April 30, 2025, the Fund issued $1.5 million in aggregate principal of promissory notes (the “2055 Promissory Notes”). The Fund pays interest on the principal amount of the 2055 Promissory Notes at a rate of 12% per annum, payable annually in arrears. The 2055 Promissory Notes mature on April 30, 2055 and may be prepaid by the Fund at any time, in whole or in part, provided that (i) the Fund will pay on the date of such prepayment all accrued and unpaid interest due on such prepaid principal amount to and including the date of prepayment and (ii) if the prepayment occurs within twenty-four months after the issue date of the 2055 Promissory Notes, the Fund will pay a one-time premium.

The following tables present the details of the Fund’s borrowings as of September 30, 2026 and December 31, 2025:

September 30, 2026

Facility

Total Principal
Amount
Committed

Principal
Amount
Outstanding

Carrying Value

Fair Value

Coupon

Interest
Rate

Maturity
Date

Revolving Credit Facility(1)

$

250,000,000

$

109,400,000

$

109,400,000

$

109,400,000

S+1.70%

5.78%

4/17/2031

2024 CLO(2)(3)

304,000,000

304,000,000

302,715,035

304,277,250

Various

5.60%

10/15/2036

2026 Notes(3)(4)

145,000,000

145,000,000

144,911,662

144,710,000

4.00%

4.00%

11/4/2026

2055 Promissory Notes(3)

1,500,000

1,500,000

1,367,361

1,489,500

12.00%

12.00%

4/30/2055

Total

$

700,500,000

$

559,900,000

$

558,394,058

$

559,876,750

December 31, 2025

Facility

Total Principal
Amount
Committed

Principal
Amount
Outstanding

Carrying Value

Fair Value

Coupon

Interest
Rate

Maturity
Date

Revolving Credit Facility(1)

$

250,000,000

$

151,100,000

$

151,100,000

$

151,100,000

S+1.70%

5.37%

4/17/2031

2024 CLO(2)(3)

304,000,000

304,000,000

302,287,370

304,304,850

Various

5.74%

10/15/2036

2026 Notes(3)(4)

145,000,000

145,000,000

144,988,805

142,825,000

4.00%

4.00%

11/4/2026

2055 Promissory Notes(3)

1,500,000

1,500,000

1,367,047

1,492,625

12.00%

12.00%

4/30/2055

Total

$

700,500,000

$

601,600,000

$

599,743,222

$

599,722,475

(1)

Interest rate as of September 30, 2026 and December 31, 2025 was 3-Month SOFR+1.70%, respectively. The base interest rate is subject to monthly changes. Interest rate does not include the amortization of upfront fees, facility agent fee, unfunded fees and expenses that were incurred in connection with the Revolving Credit Facility.

(2)

Interest rates as of September 30, 2026 and December 31, 2025 were calculated using the weighted average interest rate based on the 2024 CLO. Interest rate does not include the amortization of upfront fees. Refer to 2024 CLO table above for the respective coupon rates.

(3)

Carrying value represents aggregate principal amount outstanding less unamortized debt issuance costs.

(4)

Carrying value includes the change in fair value of effective hedges. As of September 30, 2026 and December 31, 2025, carrying value of the 2026 Notes includes the change in fair value of effective hedges of less than $0.1 million and $0.6 million, respectively.

The fair value of the Fund’s borrowings are categorized as Level 3 within the fair value hierarchy as of September 30, 2026 and December 31, 2025.

The components of the Fund’s interest and financing expenses for the three and nine months ended September 30, 2026 and September 30, 2025 were as follows:

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2026

2025

2026

2025

Stated interest expense

$

7,197,120

$

7,133,831

$

22,485,486

$

20,292,880

Unfunded fees

274,863

168,949

646,670

507,007

Amortization of deferred financing costs and debt issuance costs

501,434

414,220

1,474,685

1,242,291

Net change in unrealized appreciation/(depreciation) on effectively hedged interest rate swaps and debt(1)

10,112

9,432

(5,744

)

(40,928

)

Total interest expense(2)

$

7,983,529

$

7,726,432

$

24,601,097

$

22,001,250

Weighted average interest rate(3)

5.78

%

6.17

%

5.66

%

6.24

%

Average borrowings

$

553,750,000

$

496,700,000

$

581,200,000

$

471,117,494

(1)

Refer to “2026 Notes” for details on designated hedge relationship with the interest rate swaps.

(2)

Interest expense includes the portion of the facility agent fee applicable to the drawn portion of the Revolving Credit Facility and the unfunded fee includes the portion of the facility agent fee applicable to the undrawn portion of the Revolving Credit Facility (see table above for details of the Fund’s borrowings).

(3)

Annualized.

46


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

7.

Derivatives

The Fund may enter into derivative financial instruments in the normal course of business to achieve certain risk management objectives, including managing its interest rate, credit risk and foreign currency risk exposures. The Fund is a party to International Swap and Derivatives Association, Inc. Master Agreements (“ISDA Master Agreements”) with certain counterparties that govern over-the-counter derivative contracts entered into from time to time. The Fund is also a party to agreements that govern derivatives cleared by a Central Counterparty Clearing House (“Cleared Derivative Agreements” and together with ISDA Master Agreements, “Derivative Agreements”). The Derivative Agreements may contain provisions regarding, among other things, the parties’ general obligations, representations, agreements, collateral requirements, events of default and early termination. Collateral requirements under Derivative Agreements are determined based on the Fund’s net position with each counterparty. Collateral can be in the form of cash and U.S. government securities as agreed to by the Fund and the applicable counterparty. Collateral pledged by the Fund is segregated by the Fund’s custodians and may be restricted as to resale. Collateral posted to the Fund is held by the Fund’s custodians or the central counterparty clearing house and with respect to those amounts that can be sold or repledged, are presented in the Fund’s portfolio. As of September 30, 2026 and December 31, 2025, only cash was pledged and received by the Fund as collateral under the Derivative Agreements and was included in due from broker and due to broker on the consolidated statements of assets and liabilities.

The following table presents the details of the Fund’s average U.S. dollar notional exposure for the three and nine months ended September 30, 2026 and September 30, 2025:

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

Average notional value(1)

2026

2025

2026

2025

Interest Rate Swaps(2), hedge accounting

$

145,000,000

$

145,000,000

$

145,000,000

$

145,000,000

Interest Rate Swaps(2), non-hedge accounting

37,058,250

7,553,587

27,309,779

5,452,447

Foreign Currency Forward Contracts(3)

78,478,114

47,871,711

68,912,566

33,647,623

(1)

For each contract type, calculated based on month end amounts during which the contract was held (see consolidated statements of operations for net realized and unrealized gain (loss) on each non-hedging contract type, consolidated schedule of investments for detailed terms of the contracts, Note 2 on the purpose of the derivative activities and Note 6 for a description of the hedge accounting relationship between certain interest rate swaps and the 2026 Notes).

(2)

Risk exposure is interest rate. Certain interest rate swaps were designated as hedging instruments in accordance with hedge accounting (see Note 6).

(3)

Risk exposure is foreign currency. No foreign currency forward contract was designated as a hedging instrument in accordance with hedge accounting.

The Fund’s net exposure to foreign currency forward contracts and interest rate swaps presented on the consolidated statements of assets and liabilities was as follows:

Amounts Not Offset in Consolidated Statements of Assets and Liabilities

Gross Amount of Assets

Gross Amount of Liabilities

Net Amount of Assets (Liabilities)

Collateral (Received) Pledged

Net Amounts

September 30, 2026

Interest Rate Swaps, hedge accounting(1)

$

450,144

$

—

$

450,144

$

—

$

450,144

Interest Rate Swaps, non-hedge accounting

1,145,278

13,277

1,132,001

(1,052,673

)

79,328

Foreign Currency Forward Contracts(2)

961,348

2,511

958,837

—

958,837

December 31, 2025

Interest Rate Swaps, hedge accounting(3)

$

1,017,060

$

—

$

1,017,060

$

—

$

1,017,060

Interest Rate Swaps, non-hedge accounting(4)

127,520

226,331

(98,811

)

—

(98,811

)

Foreign Currency Forward Contracts(5)

65,048

177,236

(112,188

)

112,188

—

(1)

Over collateralization of $1.1 million is excluded from Collateral (Received)/Pledged at September 30, 2026.

(2)

Over collateralization of $1.9 million is excluded from Collateral (Received)/Pledged at September 30, 2026.

(3)

Over collateralization of $1.7 million is excluded from Collateral (Received)/Pledged at December 31, 2025.

(4)

Over collateralization of $(1.2) million is excluded from Collateral (Received)/Pledged at December 31, 2025.

(5)

Over collateralization of $1.2 million is excluded from Collateral (Received)/Pledged at December 31, 2025.

47


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

The effect of transactions in derivative instruments not utilizing hedge accounting is presented in net gain (loss) on interest rate swaps and foreign currency forward contracts in the consolidated statements of operations as follows:

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

2026

2025

2026

2025

Net realized gain (loss) on derivative contracts:

Foreign currency forward contracts

$

(500,058

)

$

(163,707

)

$

1,862,999

$

(2,347,438

)

Interest rate swaps

(84,444

)

4,941

(278,395

)

15,217

Total net realized gain (loss) on derivative contracts

$

(584,502

)

$

(158,766

)

$

1,584,604

$

(2,332,221

)

Net change in unrealized appreciation / (depreciation) on derivative contracts:

Foreign currency forward contracts

$

1,213,457

$

837,661

$

1,071,025

$

(94,397

)

Interest rate swaps

835,994

17,897

1,230,358

(236,759

)

Total net change in unrealized appreciation / (depreciation) on derivative contracts

$

2,049,451

$

855,558

$

2,301,383

$

(331,156

)

Refer to Note 6 for interest rate swaps designated as hedging instruments associated with the 2026 Notes.

8.

Commitments and Contingencies

From time to time, the Fund may enter into commitments to fund investments. Such commitments are incorporated into the Fund’s assessment of its liquidity position. The Fund’s senior secured revolver commitments are generally available on a borrower’s demand. The Fund’s senior secured delayed draw term loan commitments are generally available on a borrower’s demand and, once drawn, generally have the same remaining term as the associated loan agreement. Undrawn senior secured delayed draw term loan commitments generally have a shorter availability period than the term of the associated loan agreement.

48


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

A summary of the composition of the Fund’s unfunded commitments as of September 30, 2026 and December 31, 2025 is shown in the table below:

Portfolio Company

Investment Type

September 30, 2026

December 31, 2025

Accela Inc/US

1st Lien Revolver

$

2,242,023

$

908,238

Allentown LLC

1st Lien Revolver

706,661

1,054,199

Allium Buyer LLC

1st Lien Revolver

—

573,673

Alpine Acquisition Corp II

1st Lien Delayed Draw Term Loan

53,094

—

Alpine Acquisition Corp II

1st Lien Revolver

212,377

—

Arctic Glacier Group Holdings

1st Lien Revolver

—

838,563

Artisan Bidco Inc

1st Lien Revolver

117,053

292,634

Azurite Intermediate Holdings Inc

1st Lien Revolver

770,731

770,731

Central Wire Acquisition, Co. Inc.

1st Lien Revolver

2,030,182

—

Contractual Buyer, LLC (dba Kodiak Solutions)

1st Lien Revolver

401,425

401,425

Coupa Holdings LLC

1st Lien Delayed Draw Term Loan

—

924,210

Coupa Holdings LLC

1st Lien Revolver

235,886

707,659

Crewline Buyer Inc

1st Lien Revolver

989,736

989,736

Databricks Inc

1st Lien Delayed Draw Term Loan

13,716,358

1,859,945

Elessent Clean Technologies Inc

1st Lien Revolver

241,448

241,448

FR Vision Holdings, Inc. (CHA Consulting)

1st Lien Delayed Draw Term Loan

487,400

526,779

FR Vision Holdings, Inc. (CHA Consulting)

1st Lien Revolver

133,738

185,747

GC Bison Acquisition, LLC (Midland Industries)

1st Lien Revolver

1,063,447

510,455

GI Apple Midco LLC (Atlas Technical)

1st Lien Revolver

259,531

740,145

Gopher Resource LLC

1st Lien Revolver

357,803

559,542

Guava Buyer LLC (dba AVI-SPL)

1st Lien Delayed Draw Term Loan

1,161,710

1,161,710

Guava Buyer LLC (dba AVI-SPL)

1st Lien Revolver

1,521,288

1,355,329

Hammer IntermediateCo LLC

1st Lien Revolver

—

832,008

Health Catalyst Inc

1st Lien Delayed Draw Term Loan

—

5,045,399

Hootsuite Inc.

1st Lien Revolver

1,251,480

568,854

Industrial Service Solutions WC, Inc.

1st Lien Revolver

1,278,752

—

Inotiv Inc

1st Lien Delayed Draw Term Loan

1,005,066

—

Inotiv Inc

1st Lien Revolver

—

746,641

KORE Wireless Group Inc

1st Lien Revolver

—

626,612

LA Specialty Produce Co LLC(dba Vesta Foodservice)

1st Lien Delayed Draw Term Loan

1,737,432

—

LA Specialty Produce Co LLC(dba Vesta Foodservice)

1st Lien Revolver

1,003,850

—

LAC Acquisition LLC d/b/a Lighthouse Autism Center

1st Lien Revolver

500,000

500,000

LeVecke Real Estate Holdings, LLC

1st Lien Delayed Draw Term Loan

—

70,645

LVF Holdings Inc

1st Lien Delayed Draw Term Loan

—

2,408,809

Mercury Bidco LLC

1st Lien Revolver

1,981,556

1,981,556

Meta Buyer LLC

1st Lien Delayed Draw Term Loan

1,774,740

3,391,761

Meta Buyer LLC

1st Lien Revolver

1,037,975

1,479,569

Mounty US Holdings

1st Lien Revolver

995,726

995,726

National Dentex Corp

1st Lien Revolver

14,869

14,872

NetSPI Midco Corporation

1st Lien Revolver

460,774

767,956

NP Gaming Acquisition LLC

1st Lien Revolver

742,723

—

Otodata Holdings Inc

1st Lien Delayed Draw Term Loan

1,418,399

—

Otodata Holdings Inc

1st Lien Revolver

614,400

—

Quirch Foods Holdings LLC

1st Lien Delayed Draw Term Loan

1,209,254

1,209,254

Radiate Holdco LLC

1st Lien Delayed Draw Term Loan

—

10,000,500

Recorded Books Inc (RB Media)

1st Lien Delayed Draw Term Loan

20,969

390,213

Recorded Books Inc (RB Media)

1st Lien Revolver

270,854

987,009

Resistance Holdings Inc

1st Lien Revolver

1,258,941

—

RKG Newco LLC

1st Lien Revolver

935,449

—

SBP Holdings LP

1st Lien Delayed Draw Term Loan

1,989,772

2,074,454

SBP Holdings LP

1st Lien Revolver

838,328

838,328

Shrieve Chemical Co LLC

1st Lien Revolver

363,484

363,484

Sintec Media NYC Inc

1st Lien Revolver

197,884

419,049

Smarsh Inc

1st Lien Delayed Draw Term Loan

367,709

472,634

Smarsh Inc

1st Lien Revolver

119,734

144,941

Speedstar Holding LLC

1st Lien Delayed Draw Term Loan

—

1,601,589

Telestream 2 LLC

1st Lien Revolver

361,966

425,843

TETRA Technologies Inc

1st Lien Delayed Draw Term Loan

—

5,984,764

TH Liquidating Trust

Trust Interest

285,563

285,563

USA Debusk LLC

1st Lien Delayed Draw Term Loan

—

2,655,600

USA Debusk LLC

1st Lien Revolver

336,905

614,355

Vantage Specialty Chemicals Inc

1st Lien Revolver

1,179,478

1,731,343

Vensure Employer Services Inc

1st Lien Delayed Draw Term Loan

280,134

89,078

Wrangler Topco, LLC

1st Lien Delayed Draw Term Loan

—

363,641

Wrangler Topco, LLC

1st Lien Revolver

1,502,990

1,502,990

Xactus LLC

1st Lien Revolver

479,141

718,711

Total

$

54,518,188

$

66,905,919

49


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

In the normal course of its operations, the Fund enters into contracts that contain a variety of representations and warranties which provide general indemnifications. The Fund’s maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Fund that have not yet occurred. However, based on experience, the Fund believes the risk of significant loss to be remote.

From time to time, the Fund and its affiliates are subject to litigation arising in the normal course of business, including with respect to our portfolio companies. The Fund and certain other funds managed by Silver Point and its affiliates were named as defendants in a lawsuit asserting tortious interference filed in a United States bankruptcy court. On February 19, 2025, the bankruptcy court issued a Report and Recommendation to the U.S. District Court for the Southern District of Texas recommending dismissal of the tortious interference claim. On December 8, 2025, the U.S. District Court entered an order dismissing the tortious interference claim. On January 6, 2026, the plaintiffs filed a notice of appeal of this order to the U.S. Court of Appeals for the Fifth Circuit. The appeal is currently pending with the Fifth Circuit and oral argument is scheduled for November 2, 2026. The Fund intends to vigorously defend these claims. At this time, the Fund cannot predict with a reasonable degree of certainty the likelihood of an unfavorable outcome; however the Adviser does not expect the results of any potential outcome, even if unfavorable, to be material to the Fund’s consolidated financial statements.

9.

Net Assets

The Fund is authorized to issue an unlimited number of common shares of beneficial interest at $0.001 per share par value. The Fund has entered into subscription agreements with investors, including affiliates of the Adviser, providing for the private placement of the Fund’s common shares (collectively “Capital Commitments”). Under the terms of the Capital Commitments, investors are required to fund capital contributions to purchase the Fund’s common shares up to the amount of their respective Capital Commitment on an as-needed basis each time a drawdown notice is delivered to investors. Drawdown notices will be delivered at least 10 calendar days prior to the date on which contributions will be due and drawdown amounts will generally be made pro rata, in accordance with Capital Commitments of all investors that have unfunded Capital Commitments (limited to the extent of an investor’s unfunded Capital Commitment).

As of September 30, 2026, the Fund had $648.2 million of total commitments, of which $7.5 million was unfunded. Total commitments of $25.9 million represent entities affiliated with the Adviser.

As of December 31, 2025, the Fund had $622.2 million of total commitments, of which $26.5 million was unfunded. Of the unfunded commitments, $25.0 million was not available to be called until January 1, 2026. Total commitments of $25.9 million represent entities affiliated with the Adviser.

Shares issued and outstanding as of September 30, 2026 and December 31, 2025 were 23,776,383 and 21,240,388, respectively. The aggregate interests of Shareholders affiliated with the Adviser was approximately 4% of the Fund as of September 30, 2026 and 4% as of December 31, 2025.

The following table summarizes activity in the number of shares issued during the nine months ended September 30, 2026:

Date

Shares Issued

Proceeds Received

Issuance Price per Share

January 2, 2026

357,654

$

10,000,000

$

27.96

February 2, 2026

358,038

$

10,000,000

$

27.93

March 2, 2026

359,066

$

10,000,000

$

27.85

April 1, 2026

182,017

$

5,000,000

$

27.47

May 1, 2026

182,749

$

5,000,000

$

27.36

June 1, 2026

182,815

$

5,000,000

$

27.35

The following table summarizes activity in the number of shares issued during the nine months ended September 30, 2025:

Date

Shares Issued

Proceeds Received

Issuance Price per Share

April 30, 2025

250

$

7,375

$

29.50

June 2, 2025

329,496

$

9,502,656

$

28.84

50


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

Distributions

The Board may, in its discretion, authorize the Fund to distribute ratably among the Shareholders of any class or series of shares in the Fund in accordance with the number of outstanding full and fractional shares of such class or series as the Board may deem proper or as may otherwise be determined in accordance with the governing documents of the Fund. Any such distribution may be made in cash or property (including without limitation any type of obligations of the Fund or any assets thereof) or shares of any class or series or any combination thereof. It is expected that the Board will authorize monthly distributions of the majority of the Fund’s net investment income. The Board may always retain such amount as it may deem necessary to pay the debts or expenses or meet other obligations of the Fund, or as it may otherwise deem desirable to use in the conduct of its affairs or to retain for future requirements or extensions of the business. The following table summarizes the Fund’s dividends declared for the nine months ended September 30, 2026:

Date Declared

Record Date

Payment Date

Type

Distribution per Share

Total Amount

January 29, 2026

January 31, 2026

February 27, 2026

Regular

$

0.24

$

5,207,028

February 27, 2026

February 28, 2026

March 30, 2026

Regular

$

0.24

$

5,315,761

March 25, 2026

March 31, 2026

April 30, 2026

Regular

$

0.24

$

5,425,192

April 28, 2026

April 30, 2026

May 28, 2026

Regular

$

0.24

$

5,492,834

May 26, 2026

May 29, 2026

June 25, 2026

Regular

$

0.24

$

5,561,045

June 23, 2026

June 30, 2026

July 28, 2026

Regular

$

0.24

$

5,629,627

July 23, 2026

July 31, 2026

August 25, 2026

Regular

$

0.24

$

5,654,886

August 20, 2026

August 31, 2026

September 24, 2026

Regular

$

0.24

$

5,680,490

September 23, 2026

September 30, 2026

October 29, 2026

Regular

$

0.24

$

5,706,332

The following table summarizes the Fund’s dividends declared for the nine months ended September 30, 2025:

Date Declared

Record Date

Payment Date

Type

Distribution per Share

Total Amount

February 11, 2025

December 31, 2024

February 12, 2025

Regular

$

0.66

$

12,179,459

February 11, 2025

December 31, 2024

February 12, 2025

Supplemental

$

0.04

$

738,149

April 28, 2025

March 31, 2025

April 29, 2025

Regular

$

0.66

$

12,179,459

April 28, 2025

March 31, 2025

April 29, 2025

Supplemental

$

0.04

$

738,149

April 28, 2025

April 25, 2025

April 29, 2025

Regular

$

0.24

$

4,428,894

August 6, 2025

August 15, 2025

September 1, 2025

Regular

$

0.46

$

8,640,397

September 29, 2025

September 30, 2025

October 31, 2025

Regular

$

0.76

$

14,461,509

51


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

Distribution Reinvestment Plan

The Fund has adopted a distribution reinvestment plan pursuant to which the Fund will reinvest all cash dividends declared by the Board on behalf of our shareholders who do not elect to receive their dividends in cash. As a result, if the Board authorizes, and the Fund declares, a cash dividend or other distribution, then shareholders who have not opted out of our distribution reinvestment plan will have their cash distributions automatically reinvested in additional shares. Shareholders who receive distributions in the form of common shares will be subject to the same tax consequences as if the distributions were received in cash.

The table below summarizes the number of common shares issued to shareholders through the Fund’s distribution reinvestment plan for the nine months ended September 30, 2026:

Declared Date

Record Date

Date Shares Issued

Shares Issued

December 27, 2025

December 31, 2025

January 2, 2026

97,906

January 29, 2026

January 31, 2026

February 2, 2026

95,020

February 27, 2026

February 28, 2026

March 2, 2026

96,894

March 25, 2026

March 31, 2026

April 1, 2026

99,826

April 28, 2026

April 30, 2026

May 1, 2026

101,463

May 26, 2026

May 29, 2026

June 1, 2026

102,942

June 23, 2026

June 30, 2026

July 1, 2026

105,246

July 23, 2026

July 31, 2026

August 1, 2026

106,686

August 20, 2026

August 31, 2026

September 1, 2026

107,672

September 23, 2026

September 30, 2026

October 1, 2026

109,153

The table below summarizes the number of common shares issued to shareholders through the Fund’s distribution reinvestment plan for the nine months ended September 30, 2025:

Declared Date

Record Date

Date Shares Issued

Shares Issued

August 6, 2025

August 15, 2025

September 1, 2025

244,829

September 29, 2025

September 30, 2025

October 1, 2025

298,694

Share Repurchase Program

At the discretion of the Board, the Fund intends to commence a share repurchase program following the second anniversary of the Liquidity Event in which it intends to repurchase up to 5% of the Fund’s common shares outstanding, either by number of common shares or aggregate NAV, as of the close of the previous calendar quarter; provided, however, during their commitment period, investors will be contractually prohibited from selling, assigning, transferring or otherwise disposing of their common shares, including pursuant to any tender offer by the Fund, or by requesting to tender their common shares. The Board may amend, suspend or terminate the share repurchase program or conduct additional repurchases of common shares in an amount greater than 5% of common shares at any time if in its reasonable judgment it deems such action to be in the Fund’s best interest and the best interest of its shareholders. As a result, share repurchases may not be available each quarter. The Fund intends to conduct such repurchase offers in accordance with the requirements of Rule 13e-4 promulgated under the Exchange Act and the 1940 Act.

To the extent the Fund offers to repurchase common shares in any particular quarter, the Fund expects to repurchase common shares pursuant to tender offers on or around the last business day of that quarter, using a purchase price equal to the NAV per share as of the last calendar day of the applicable quarter. In the event the amount of shares tendered exceeds the repurchase offer amount, common shares will be repurchased on a pro rata basis. All unsatisfied repurchase requests must be resubmitted in the next quarterly tender offer, or upon the recommencement of the share repurchase plan.

There have been no repurchases under the share repurchase program.

52


Silver Point Specialty Lending Fund

Notes to Consolidated Financial Statements (Unaudited)

10.

Financial Highlights

The following summarizes the financial highlights for the Fund:

For the Nine Months Ended September 30,

2026

2025

Per Share Data*(1)

Net asset value, beginning of period

$

27.96

$

29.53

Net investment income

2.33

2.39

Net realized gain (loss) and net change in unrealized appreciation (depreciation)

(1.22

)

(0.72

)

Total from operations

1.11

1.67

Dividends declared from net investment income

(2.16

)

(2.86

)

Total increase (decrease) in net assets

(1.06

)

(1.19

)

Net asset value, end of period

$

26.90

$

28.34

Shares outstanding, end of period

23,776,383

19,028,301

Total Return, based on net asset value(2)(6)

4.08

%

5.90

%

Ratios to average net assets(3)(5)

    Interest and financing related expenses

5.26

%

5.43

%

    Other operating expenses(7)(9)

2.26

%

2.20

%

    Incentive fee, net of clawback(6)

1.20

%

0.96

%

    Total expenses(9)

8.72

%

8.59

%

    Net investment income(3)(9)

11.76

%

11.28

%

Net assets, end of period

$

639,509,124

$

539,167,799

Portfolio turnover rate(4)

22.51

%

19.36

%

Weighted-average debt outstanding

$

581,200,000

$

471,117,494

Weighted-average interest rate on debt(8)

5.66

%

6.24

%

Weighted-average shares outstanding

22,821,203

18,610,157

(*) Totals may not foot due to rounding.

(1)

The per share data was derived by using the weighted average shares outstanding during the applicable period, except for net asset value and dividends declared which reflected the actual amount per share for the applicable period.

(2)

Total return is calculated as the change in net asset value during the respective periods, assuming dividends and distributions, if any, are reinvested in accordance with the Fund’s dividend reinvestment plan, divided by the beginning net asset value per share.

(3)

The net investment income ratio is presented after the effects of expenses (including interest and financing related expenses, the management fee and incentive fee, net of clawback).

(4)

Portfolio turnover is calculated as the lesser of (i) purchases of portfolio investments or (ii) the aggregate total of sales of portfolio investments plus any prepayments received, divided by average fair value of portfolio investments during the period.

(5)

Annualized, except for incentive fees.

(6)

Not annualized.

(7)

Other operating expenses exclude interest and financing related expenses and incentive fees.

(8)

Annualized.

(9)

Prior to any management fee waivers, the annualized other operating expenses, total expenses, and net investment income to average net assets for the period ended September 30, 2026, was 2.51%, 8.98%, and 11.50%, respectively. Prior to any management fee waivers, the annualized other operating expenses, total expenses, and net investment income to average net assets for the period ended September 30, 2025, was 2.34%, 8.74%, and 11.14%.

11.

Subsequent Events

Management has performed an evaluation of subsequent events and has determined that no additional items require adjustments to, or disclosure in, the consolidated financial statements other than those items described below.

On October 22, 2026, the Board declared a dividend of $0.24 per share, payable on or before November 30, 2026, for Shareholders of record on October 30, 2026.

On October 26, 2026, the Fund entered into Amendment No. 22 (the "Amendment") to the Revolving Credit Facility. The Amendment, among other things, increased the facility amount by $125 million to $375 million and provides for further increases to the facility amount up to a maximum of $425 million within 90 days of the effective date of the Amendment, subject to certain conditions.

On November 4, 2026, the Fund's 2026 Notes, which had an outstanding principal balance of $145 million, matured and were repaid in full.

53


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The information contained in this section should be read in conjunction with the consolidated financial statements and notes thereto appearing elsewhere in this report. Some of the statements in this report (including in the following discussion) contain forward-looking statements that involve risks and uncertainties, which relate to future events or the future performance or financial condition of Silver Point Specialty Lending Fund (the “Fund,” “we,” “us,” or “our”). Our actual results could differ materially from those anticipated by such forward-looking information including statements concerning:

•

our future operating results;

•

our business prospects and the prospects of our portfolio companies;

•

changes in the economy, including those caused by tariffs and trade disputes with other countries, changes in inflation and risk of recession;

•

risk associated with possible disruptions in our operations or the economy generally;

•

the impact of global health epidemics on our and our portfolio companies’ business and the global economy;

•

the effect of investments that we expect to make;

•

our contractual arrangements and relationships with third parties;

•

actual and potential conflicts of interest with our Adviser and its affiliates;

•

the dependence of our future success on the general economy and its effect on the industries in which we invest, including as a result of inflation;

•

the ability of our portfolio companies to achieve their objectives;

•

the use of borrowed money to finance a portion of our investments, including the consequences of interest rate increases;

•

the adequacy of our financing sources and working capital;

•

the timing of cash flows, if any, from the operations of our portfolio companies;

•

the ability of our Adviser to locate suitable investments for us and to monitor and administer our investments;

•

the ability of our Adviser and its affiliates to attract and retain highly talented professionals;

•

the consequences of the conflict between Russia and Ukraine, including international sanctions, the potential impact on inflation and increased disruption to supply chain;

•

our ability to qualify and maintain our qualification as a BDC; and

•

the effect of changes in laws or regulations affecting our operations or to tax legislation and its tax position.

We use words such as “may,” “will,” “should,” “expect,” “anticipate,” “project,” “estimate,” “intend,” “continue” or “believe” or the negatives thereof or other variations thereon or comparable terminology to identify forward-looking statements.

We have based the forward-looking statements included in this report on information available to us on the date of this report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we have filed or in the future may file with the Securities and Exchange Commission (the “SEC”), including annual reports on Form 10-K, registration statements on Form 10, quarterly reports on Form 10-Q and current reports on Form 8-K.

Overview

The Fund was originally formed on July 31, 2014 as a Delaware limited partnership and started operations on July 1, 2015. The Fund converted into a statutory trust organized under the laws of the State of Maryland on November 15, 2021. We have elected to be regulated as a BDC under the 1940 Act and intend to qualify as a RIC for U.S. federal income tax purposes. We are an “emerging growth company” under the JOBS Act. For so long as we remain an emerging growth company under the JOBS Act, we will be subject to reduced public company reporting requirements.

Investment Framework

We are a specialty finance company that is a closed-end management investment company. We have elected to be regulated as a BDC under the 1940 Act. Our investment objective is to achieve stable income generation with attractive risk-adjusted returns by investing primarily in U.S. middle market lending opportunities, and specialty asset based financings. We define “middle market companies” to generally mean companies with earnings before interest expense, income tax expense, depreciation and amortization (“EBITDA”) between $50 million and $200 million annually and/or enterprise value between $150 million and $2 billion at the time of investment. As of September 30, 2026, the portfolio median EBITDA for our portfolio companies was approximately $113.4 million. We may also, from time to time invest in larger or smaller companies. In seeking to achieve our investment objective, we may also invest across a broad range of industries. We will invest primarily in first-lien debt, but may also invest in second-lien debt, mezzanine and unsecured debt, equity, structured credit, and derivatives depending on the opportunity set and market environment.

54


We focus on U.S. middle market opportunities that have barriers to entry because they entail in-depth due diligence, valuation and collateral analyses; involve complexity; and require speed and certainty of execution and similar features that limit the participation of traditional financing sources. These opportunities are often less competitive and allow us to require more favorable structural and economic terms than available in broader public markets. In addition to investments in U.S. middle market companies, we may invest a portion of our capital in opportunistic investments, including, but not limited to, loans, debt securities (secured and unsecured) and equity. The proportion of these types of investments will change over time given our views on, among other things, the economic and credit environment in which we are operating.

Our Adviser believes the middle market lending environment is attractive throughout the credit cycle as a result of the following (i) growing demand for non-traditional lenders, (ii) trajectory of the middle market environment, (iii) dynamics of middle market lending conditions and (iv) the niches of the specialty lending market, on which we believe our Adviser has the credit expertise and sourcing relationships to capitalize. The reduced competition and barriers to entry within these deals may allow us to originate and purchase loans at premium economics and with better creditor protections than those available in the broader market.

If we are successful in achieving our investment objective, we believe that we will be able to provide our Shareholders with consistent dividend distributions and attractive risk-adjusted total returns, although there can be no assurances in this regard. Since we commenced investment operations on July 1, 2015, through September 30, 2026, we have invested approximately $4.5 billion in 322 portfolio companies, excluding any subsequent exits or repayments. As of September 30, 2026, the fair value of our portfolio was invested approximately 94.1% in first lien secured debt, 1.4% in second lien debt, 1.8% in unsecured debt, 1.7% in equity investments and 1.0% in other investments.

Relationship with our Adviser

Silver Point Specialty Credit Fund Management, LLC (the “Adviser”), a Delaware limited liability company and wholly owned subsidiary of Silver Point Capital, L.P. (“Silver Point”), serves as our investment adviser and administrator (see Note 3 to the consolidated financial statements for more details). Subject to the supervision of our Board of Trustees, our Adviser manages our day-to-day operations and provides us with investment advisory and management services. Our Adviser is responsible for sourcing, researching and structuring potential investments, monitoring portfolio companies, and providing operating and managerial assistance to us and to our portfolio companies as required. We believe our Adviser will be able to leverage Silver Point’s existing relationships across advisors, intermediaries, investment banks, financial sponsors, broker-dealers, lawyers, and investors to source attractive investment opportunities.

We seek to accomplish our investment objective through leveraging the Silver Point investment platform with $52.2 billion of investable assets (including leverage for applicable funds) and Silver Point’s significant credit investing expertise, which enables us to source and identify less competitive and/or mispriced market opportunities. We target secured, floating rate loans with stable income that are structured with significant downside protection, which we believe includes strong covenant packages and comprehensive collateral packages. We prioritize investments in first lien debt, which we believe offers more attractive risk-adjusted return characteristics.

We and our Adviser have obtained an exemptive order from the SEC to permit greater flexibility to negotiate the terms of co-investments if our Board of Trustees determines that it would be advantageous for us to co-invest with other affiliated funds managed by our Adviser or its affiliates in a manner consistent with our investment objectives, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors.

Key Components of Our Results of Operations

Investments

We focus primarily on targeting direct lending opportunities to U.S. middle market companies throughout the business cycle. Our level of investment activity can and does vary substantially from period to period depending on many factors, including the amount of debt and equity capital available to middle market companies, the level of merger and acquisition activity for such companies, the prevailing economic and market environment, the amount of capital we have available to us and the competitive environment for the type of investments we make.

As a BDC, we must not acquire any assets other than “qualifying assets” specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” Pursuant to rules adopted by the SEC, “eligible portfolio companies” include certain U.S. companies that do not have any securities listed on a national securities exchange and public companies whose securities are listed on a national securities exchange but whose market capitalization is less than $250 million.

Since formation, in excess of 70% of the Fund’s assets have been “qualifying assets” under Section 55(a) of the 1940 Act. As of September 30, 2026, the fair value of the Fund’s total assets was comprised of approximately 75.2% of “qualifying assets.”

55


Revenues

We generate revenue primarily in the form of interest income on the investments we hold and, to a lesser extent, capital gains on the sales of loans and debt and equity securities and dividend income on direct equity investments. In addition, we generate revenue in the form of commitment, origination, structuring or diligence fees, fees for providing managerial assistance, consulting fees and prepayment fees.

Interest and dividend income are recorded on an accrual basis. Loan origination fees, original issue discount and market discounts or premiums are capitalized, and we accrete or amortize such amounts to income. We record contractual prepayment premiums and the acceleration of unamortized premiums or discounts on loans and debt securities as income, which can cause investment income to vary quarter by quarter.

Interest on debt investments is generally payable monthly or quarterly. Some of our investments provide for deferred interest payments or PIK interest. The principal amount of debt investments and any accrued but unpaid interest generally becomes due at the maturity date. Generally a small but varied number of portfolio companies may make voluntary prepayments in any quarter, meaning that changes in the amount of prepayment fees received can vary significantly between periods and can vary without regard to underlying credit trends. Repayments of our debt investments can reduce interest income from period to period.

We recognize realized gains or losses on sales of investments based on the difference between the net proceeds from the disposition and the amortized cost basis of the investment at time of disposition, without regard to unrealized gains or losses previously recorded. We record changes in unrealized gain or loss on investments based on the current period changes in fair value of investments inclusive of the reversal of previously recorded unrealized gains or losses with respect to investments realized during the current period.

Expenses

Our primary operating expenses include interest and financing costs incurred from our credit facilities and the payment of fees to our Adviser under the Advisory Agreement. Additionally, we bear other costs and expenses of our operations, administration and transactions, including, but not limited to, the following:

•

investment advisory and management fees;

•

expenses, including travel expenses, incurred by our Adviser, or members of our investment team, or payable to third parties, in respect of prospective or consummated investments;

•

amounts payable to third parties relating to, or associated with, making or holding investments, including legal, tax, consulting and other professional expenses;

•

commissions and other compensation payable to brokers or dealers;

•

transfer agent and custodial fees;

•

certain taxes;

•

direct costs and expenses of administration, including audit, accounting, consulting and legal costs;

•

errors and omissions liability insurance for Trustees and officers and any other insurance premiums;

•

interest payable on debt incurred to finance our investments;

•

calculation of our net asset value (including the costs and expenses of any independent valuation firms);

•

Independent Trustee fees and expenses;

•

the costs of any reports, proxy statements or other notices to our Shareholders, the SEC and other regulatory authorities (including printing and mailing costs), the costs of any Shareholders’ meetings and the compensation of investor relations personnel responsible for the preparation of the foregoing and related matters; and

•

our fidelity bond.

We bear other costs and expenses of our operations and transactions in accordance with and as set forth in more detail in our Advisory Agreement (see Note 3 to the consolidated financial statements).

Use of Leverage

We are a party to debt financing arrangements that allow us to borrow money and lever our investment portfolio, subject to the limitations of the 1940 Act, with the objective of increasing our yield. This is known as “leverage” and could increase or decrease returns to our Shareholders. The use of leverage involves significant risks. As a BDC, pursuant to the 1940 Act, our total borrowings are limited. We are allowed to borrow amounts such that the ratio of our total assets (less total liabilities other than indebtedness represented by senior securities) to our total indebtedness represented by senior securities plus preferred shares, if any, is at or above 150% immediately after such borrowing. This means that we can borrow up to $2 for every $1 of investor equity. The amount of leverage that we employ will depend on our Adviser’s and our Board of Trustees’ assessment of market conditions and other factors at the time of any proposed borrowing.

56


Market Opportunity

We believe the middle market lending environment, and in particular our focus area within middle market lending, is attractive throughout the credit cycle as a result of a combination of the following:

Size of the Middle Market Environment and Resulting Demand for Capital. The middle market is a critical portion of the U.S. economy and serves an outsized role in terms of GDP and revenues. According to the National Center for The Middle Market's Mid-Year 2026 Middle Market Indicator, there are nearly 200,000 businesses in the U.S. middle market which represents one-third of private sector GDP and employment. Moreover, average year-over-year revenue growth in the middle market remained strong at 11.0%, with 82% of companies reporting top-line growth year-over-year. The Middle Market Indicator defines U.S. middle market companies as those with annual revenue between $10 million and $1 billion, significantly overlapping with our definition of U.S. middle market companies. The contribution from middle market companies to the economy has grown over time, and as the sector continues to expand, we believe there will be a similarly outsized need for capital. Historically, U.S. commercial and regional banks were traditional lenders to the middle market. However, regulatory and structural changes have taken place in the lending space that have resulted in less supply of capital for middle market companies from these traditional lenders. This has created an attractive lending opportunity for direct lenders to fill the void of traditional lenders.

Specialty Lending Market. We believe that middle market lending opportunities yield higher returns with better creditor protections when compared to broadly syndicated loan opportunities and that a unique opportunity exists for specialty lenders with differentiated sourcing channels and underwriting expertise to structure deals with more favorable terms than the broader market. We believe there persists a void in the market for deals where the borrower is in an industry or position that requires the lender to (i) conduct independent in-depth enterprise and collateral analysis and/or understand complexity, (ii) offer creative customized solutions and/or (iii) provide capital with speed and certainty of execution. We believe the reduced competition and barriers to entry within these deals allow us to originate loans at a risk-adjusted return premium to the broader market and to secure relatively stronger covenant packages, which provides our loans with significant downside protection.

Specialty Lending Expertise. Successfully lending within the middle market space requires a specialized skill set, particularly in assessing credit quality and risk, assessing business valuations, structuring and documentation, and asset management. Lenders in the middle market space have the ability to enhance value through intricate knowledge of capital structures and business dynamics, and through thoughtful structuring of financial covenants. Furthermore, lenders who engage in robust asset monitoring and management can successfully enhance returns throughout the business and credit cycle. We believe Silver Point is well-positioned to extract value from middle market opportunities given its platform, deep credit expertise, and experience managing portfolios of loans across cycles.

Attractive Opportunities to Invest in Senior Secured and Floating Rate Loans. We believe that opportunities to invest in senior secured loans are attractive because of the floating rate structure of most senior secured debt issuances and the defensive characteristics of these types of investments. We believe that floating rate debt investments can offer a superior return profile relative to fixed-rate investments, since floating rate structures are generally less susceptible to declines in value. In addition, senior secured debt possesses attractive defensive characteristics given its priority in payment relative to junior debt holders and equity holders.

Ability to invest throughout cycles including during periods of economic uncertainty. We believe that direct lending can offer attractive risk adjusted returns throughout cycles, as there is consistently a stream of borrowers that prioritize private credit for their capital needs. We have also found that times of increased volatility often results in a weakened capital base for new loan supply and an increase in lending opportunities that require private capital to be accretive solution providers. Given our capabilities and expertise in the direct lending market, having invested throughout cycles, including the Global Financial Crisis, we believe we have built an all-cycle business model and we are well positioned to take advantage of the opportunity set in any market environment.

Portfolio and Investment Activity

As of September 30, 2026 and December 31, 2025, we had investments in 104 and 109 portfolio companies, respectively, with an aggregate fair value of $1,160.7 million and $1,183.7 million, respectively. As of September 30, 2026 and December 31, 2025, our portfolio had an average portfolio company investment size of $11.2 million and $10.9 million based on fair value, respectively.

57


The table below summarizes our investments as of September 30, 2026 and December 31, 2025:

September 30, 2026

December 31, 2025

($ in millions)

Amortized
Cost

Fair
Value

Percentage of
Total Fair
Value

Amortized
Cost

Fair
Value

Percentage of
Total Fair
Value

First-lien debt

$

1,134.9

$

1,092.6

94.1

%

$

1,140.3

$

1,118.4

94.5

%

Second-lien debt

16.7

16.0

1.4

%

22.2

18.1

1.5

%

Unsecured debt

8.9

20.6

1.8

%

14.6

21.3

1.8

%

Equities and warrants

34.7

19.5

1.7

%

26.4

13.2

1.1

%

Other investments

18.8

12.0

1.0

%

18.6

12.7

1.1

%

Total

$

1,214.0

$

1,160.7

100.0

%

$

1,222.1

$

1,183.7

100.0

%

The following table summarizes the performing and non-accrual investments, based on fair value and amortized cost, as of September 30, 2026 and December 31, 2025:

September 30, 2026

December 31, 2025

($ in millions)

Amortized Cost

Fair Value

Amortized Cost

Fair Value

Performing

$

1,176.1

96.9

%

$

1,146.4

98.8

%

$

1,172.9

96.0

%

$

1,160.3

98.0

%

Non-accrual(1)

37.9

3.1

%

14.3

1.2

%

49.2

4.0

%

23.4

2.0

%

Total

$

1,214.0

100.0

%

$

1,160.7

100.0

%

$

1,222.1

100.0

%

$

1,183.7

100.0

%

(1)

Loans are generally placed on non-accrual status when there is reasonable doubt that the principal or interest will be collected in full and the accrued interest is reversed against interest income (see Note 2 to the consolidated financial statements for more details).

For the three months ended September 30, 2026, we funded an aggregate principal amount of $91.1 million. We funded $77.2 million in 8 new portfolio companies and $13.9 million in existing portfolio companies. For this period, the weighted average term for investments in new portfolio companies was 3.5 years. For the same period, we received $(73.7) million of aggregate repayments, paydowns and sales.

For the three months ended September 30, 2025, we funded an aggregate principal amount of $197.2 million. We funded $147.7 million in 10 new portfolio companies and $49.5 million in existing portfolio companies. For this period, the weighted average term for investments in new portfolio companies was 4.5 years. For the same period, we received $(35.0) million of aggregate repayments, paydowns and sales.

58


Our investment activity for the three months ended September 30, 2026 and 2025 is presented below:

For the Three Months Ended September 30,

($ in millions)

2026

2025

Investment funded:

New purchases

$

77.2

$

147.7

Follow-ons

13.9

49.5

Total

$

91.1

$

197.2

Investments funded(1):

First-lien debt

$

91.0

$

197.2

Second-lien debt

—

—

Unsecured debt

—

—

Equities and warrants

—

—

Other investments

0.1

—

Total

$

91.1

$

197.2

Investments sold or repaid(1):

First-lien debt

$

(73.7

)

$

(32.4

)

Second-lien debt

—

—

Unsecured debt

—

—

Equities and warrants

—

(0.1

)

Other investments

—

(2.5

)

Total

$

(73.7

)

$

(35.0

)

Number of new investment commitments in new portfolio companies

8

10

Average new investment fundings in new portfolio companies

$

9.7

$

14.8

Weighted average term (years) for new investments in new portfolio companies

3.5

4.5

Percentage of new floating rate debt investments at fair value

75.1

%

94.6

%

Percentage of new fixed rate debt investments at fair value

24.9

%

5.4

%

Weighted average yield of new investments at fair value

11.6

%

10.5

%

(1)

Excluding non-cash additions or disposals as a result of restructures, if any.

The weighted average yields and interest rates of our debt investments at fair value, as of September 30, 2026 and December 31, 2025 were as follows:

September 30,
2026

December 31,
2025

Weighted average yield of portfolio

11.0

%

9.6

%

Weighted average yield of performing debt investments

11.4

%

9.9

%

Weighted average interest rate of performing debt investments

10.0

%

9.7

%

Weighted average spread over SOFR of floating rate performing investments

5.8

%

5.9

%

Results of Operations

For the three and nine months ended September 30, 2026 and 2025

Operating results for the three and nine months ended September 30, 2026 and 2025 were as follows:

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

($ in millions)

2026

2025

2026

2025

Total investment income

$

32.5

$

26.9

$

95.8

$

80.6

Less: Net expenses

14.0

12.7

42.7

36.2

Net investment income

18.5

14.2

53.1

44.4

Net realized gain (loss)

(13.2

)

(0.2

)

(15.2

)

(13.4

)

Net change in unrealized appreciation (depreciation)

5.2

(0.1

)

(12.6

)

0.0

Net increase (decrease) in net assets resulting from operations

$

10.5

$

13.9

$

25.3

$

31.0

59


Investment Income

Investment income for the three and nine months ended September 30, 2026 and 2025 was as follows:

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

($ in millions)

2026

2025

2026

2025

Interest income, excluding PIK interest

$

30.8

$

25.7

$

90.9

$

76.4

PIK interest income

1.5

1.2

4.0

4.2

Dividend income

0.1

—

0.1

—

Other income

0.1

0.0

0.8

0.0

Total investment income

$

32.5

$

26.9

$

95.8

$

80.6

Our average investment portfolio size based on fair value was $1,154.5 million and $1,009.5 million for the three months ended September 30, 2026 and 2025, respectively. Our average investment portfolio size based on fair value was $1,161.6 million and $950.3 million for the nine months ended September 30, 2026 and 2025, respectively.

For the three months ended September 30, 2026, total investment income of $32.5 million increased by approximately $5.6 million compared to $26.9 million for the three months ended September 30, 2025, primarily due to an increase in interest income (excluding PIK) of $5.1 million. The increase in interest income (excluding PIK) was primarily due to the increase in the average size of our portfolio.

For the nine months ended September 30, 2026, total investment income of $95.8 million increased by approximately $15.2 million compared to $80.6 million for the nine months ended September 30, 2025, primarily due to an increase in interest income (excluding PIK) of $14.5 million. The increase in interest income (excluding PIK) was primarily due to the increase in the average size of our portfolio.

Expenses

Operating expenses for the three and nine months ended September 30, 2026 and 2025 were as follows:

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

($ in millions)

2026

2025

2026

2025

Interest and financing expenses

$

8.0

$

7.7

$

24.6

22.0

Management fee (net of waiver)

1.6

1.4

4.8

3.6

Income incentive fee

2.6

2.0

7.5

6.8

Incentive compensation clawback

—

—

—

(1.5

)

Professional fees

0.7

0.5

2.1

2.2

Administration fees

0.6

0.5

2.0

1.5

Trustee fees

0.1

0.1

0.2

0.3

Other general and administrative expenses

0.4

0.5

1.5

1.3

Net expenses

$

14.0

$

12.7

$

42.7

$

36.2

For the three months ended September 30, 2026, total expenses of $14.0 million increased by approximately $1.3 million compared to $12.7 million for the three months ended September 30, 2025. Interest and financing expenses for the three months ended September 30, 2026 increased $0.3 million over the same period in prior year, primarily due to the increase in average principal amount of our outstanding debt, which was partially offset by base rate declines contributing to the decrease in weighted average borrowing costs of approximately 39 basis points. Additionally, for the three months ended September 30, 2026, Management fee (net of waiver) increased by approximately $0.2 million and Income Incentive Fee increased by approximately $0.6 million over the same period in the prior year.

For the nine months ended September 30, 2026, total expenses of $42.7 million increased by approximately $6.5 million compared to $36.2 million for the nine months ended September 30, 2025. Interest and financing expenses for the nine months ended September 30, 2026 increased by $2.6 million over prior period, primarily due to the increase in average principal amount of our outstanding debt, which was partially offset by base rate declines contributing to the decrease in weighted average borrowing costs of approximately 58 basis points. Additionally, for the nine months ended September 30, 2026, Management fee (net of waiver) increased by approximately $1.2 million and Income Incentive Fee increased by approximately $0.7 million over prior period, primarily as a result of the new advisory agreement that became effective May 1, 2025.

60


Net Realized Gain (Loss) and Net Change in Unrealized Appreciation (Depreciation)

The following table summarizes the net realized gain (loss) and net change in unrealized appreciation (depreciation) for the three months ended September 30, 2026 and 2025:

For the Three Months Ended September 30,

For the Nine Months Ended September 30,

($ in millions)

2026

2025

2026

2025

Net realized gain (loss):

Investments

$

(12.5

)

$

0.1

$

(16.7

)

$

(11.2

)

Foreign currency (“FX”) transactions and FX forward contracts

(0.6

)

(0.3

)

1.8

(2.2

)

Interest rate swaps

(0.1

)

—

(0.3

)

0.0

Total net realized gain (loss)

(13.2

)

(0.2

)

$

(15.2

)

$

(13.4

)

Net change in unrealized appreciation (depreciation):

Investments

3.1

(0.9

)

$

(15.0

)

$

0.3

Translation in FX and FX forward contracts

1.3

0.8

1.2

(0.1

)

Interest rate swaps

0.8

—

1.2

(0.2

)

Total net change in unrealized appreciation (depreciation)

$

5.2

$

(0.1

)

$

(12.6

)

$

0.0

Net Realized Gain (Loss)

For the three months ended September 30, 2026 and 2025, net realized gain (loss) on investments was $(12.5) million and $0.1 million, respectively. For the three months ended September 30, 2026, the net realized gain (loss) was primarily driven by two portfolio companies with respective losses greater than ($1.0) million. For the three months ended September 30, 2025, there was no significant net realized gains (losses) on investments.

For the nine months ended September 30, 2026 and 2025, net realized gain (loss) on investments was $(16.7) million and $(11.2) million, respectively. For the nine months ended September 30, 2026, the net realized gain (loss) was primarily driven by three portfolio companies with respective losses greater than ($1.0) million. For the nine months ended September 30, 2025, the net realized gain (loss) was primarily driven by three portfolio companies with respective losses greater than ($1.0) million.

Net Change in Unrealized Appreciation (Depreciation)

We fair value our portfolio investments quarterly and any changes in fair value are recorded as unrealized appreciation or depreciation. Upon exiting an investment, we reverse the previously recorded unrealized appreciation or depreciation and recognize realized gain or loss, if any.

For the three months ended September 30, 2026, net change in unrealized appreciation (depreciation) on investments was $3.1 million, primarily driven by portfolio company specific developments partially offset by general spread widening in the market. We had gross unrealized appreciation (including reversal of previously recognized unrealized depreciation associated with disposals) of $19.4 million, primarily driven by four portfolio companies with respective unrealized appreciation above $1.0 million; we had gross unrealized depreciation of $(16.3) million, primarily driven by four portfolio companies with respective unrealized depreciation above $(1.0) million.

For the three months ended September 30, 2025, net change in unrealized appreciation (depreciation) on investments was $(0.9) million. We had gross unrealized appreciation of $7.6 million, primarily driven by three portfolio companies with respective unrealized appreciation above $1.0 million; we had gross unrealized depreciation of $(8.5) million, primarily driven by three portfolio companies with respective unrealized depreciation above $(1.0) million.

For the nine months ended September 30, 2026, net change in unrealized appreciation (depreciation) on investments was $(15.0) million, primarily driven by general spread widening in the market. We had gross unrealized appreciation (including reversal of previously recognized unrealized depreciation associated with disposals) of $22.2 million, primarily driven by seven portfolio companies with respective unrealized gains greater than $1.0 million; we had gross unrealized depreciation of $(37.2) million, primarily driven by nine portfolio companies with respective unrealized depreciation above $(1.0) million.

For the nine months ended September 30, 2025, net change in unrealized appreciation (depreciation) on investments was $0.3 million. We had gross unrealized appreciation of $23.8 million, primarily driven by seven portfolio companies with respective unrealized appreciation above $1.0 million; we had gross unrealized depreciation of $(23.5) million, primarily driven by six portfolio companies with respective unrealized depreciation above $(1.0) million.

61


Income Taxes, Including Excise Taxes

The Fund elected to be treated, and intends to qualify annually, as a RIC, as defined under Subchapter M of the Code. To qualify for tax treatment as a RIC, the Fund must, among other requirements, distribute to its shareholders, in each taxable year, generally at least 90% of its investment company taxable income, as defined by the Code, and net tax-exempt income for that taxable year. To maintain its tax treatment as a RIC, the Fund intends, among other things, to make the requisite distributions to its shareholders, which generally relieve the Fund from corporate-level U.S. federal income taxes.

Depending on the level of taxable income earned in a tax year, the Fund may carry forward taxable income (including net capital gains, if any) in excess of current year dividend distributions into the next tax year and pay a nondeductible 4% U.S. federal excise tax on such taxable income, as required. To the extent that the Fund determines that its estimated current year taxable income will exceed its estimated current year dividend distributions, the Fund will accrue excise tax on the estimated excess taxable income.

Derivatives and Hedging

We have designated certain interest rate swaps to be in a hedge accounting relationship associated with our fixed rate debt and we also use interest rate swaps to reduce the interest rate risk exposure of certain fixed rate investments. We also entered into foreign currency forward contracts to manage the foreign currency exposure in our non-U.S. dollar denominated investments. See Note 2 and Note 7 to the consolidated financial statements for more details regarding the accounting policies and additional disclosure for derivative instruments. See Note 6 to the consolidated financial statements for additional disclosure regarding the carrying value of the hedged debt.

Financial Condition, Liquidity and Capital Resources

Our liquidity and capital resources are derived primarily from proceeds from net investor capital contributions/equity issuances, advances from our credit facilities and cash flows from operations. The primary uses of our cash and cash equivalents are investments, costs of operations, debt service, repayment and other financing costs and distributions to investors.

We may from time to time enter into additional credit facilities, increase the size of existing facilities or issue debt and convertible debt securities. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions and other factors. As of September 30, 2026 and December 31, 2025, our asset coverage ratio was 214% and 199%, respectively. We have carefully considered our unfunded portfolio commitments for the purpose of planning our capital resources and liquidity including our financial leverage. As of September 30, 2026 and December 31, 2025, our unfunded portfolio commitments were approximately $54.5 million and $66.9 million, respectively. Further, we maintain sufficient cash, cash equivalents and borrowing capacity to cover any short term funding requirements.

Cash as of September 30, 2026, taken together with cash available from our credit facilities, is expected to be sufficient for our investing activities and to conduct our operations in the near term. As of September 30, 2026, we had approximately $140.6 million of availability on our third-party debt facilities, subject to asset coverage limitations.

As of September 30, 2026, we had $46.7 million in cash and cash equivalents, restricted cash and cash equivalents, and foreign cash held at banks. During the nine months ended September 30, 2026, cash provided by operating activities was $36.9 million, primarily driven by payments for the purchase of investments of $(261.5) million offset by proceeds from sales, paydowns and resolutions of investments of $264.7 million, other operating activity of $15.2 million, net change in unsettled transactions of $(0.5) million and an increase in net assets resulting from operations of $25.3 million. Lastly, cash used in financing activities was $(24.2) million, primarily due to net proceeds from debt borrowings and principal repayments of $(41.7) million and new issuance of common shares of $45.0 million offset by dividends paid of $(24.2) million.

Contractual Obligations

As of September 30, 2026, our contractual payment obligations are as follows:

Payments Due by Period

($ in millions)

Total

Less than
1 year

1-3 years

3-5 years

After
5 years

2024 CLO

$

304.0

$

—

$

—

$

—

$

304.0

2026 Notes

145.0

145.0

—

—

—

2055 Promissory Notes

1.5

—

—

—

1.5

Revolving Credit Facility

109.4

—

—

109.4

—

Total Contractual Obligations

$

559.9

$

145.0

$

—

$

109.4

$

305.5

62


2021 Debt Securitization

On September 9, 2021, the Fund completed a $400 million term debt securitization (the “2021 Debt Securitization”) and the Fund owned $112 million of Class D and Subordinated Notes. The debt offered in the 2021 Debt Securitization (the “2021 CLO”) was issued by Silver Point SCF CLO I, Ltd., a wholly-owned, consolidated subsidiary of the Fund, and was backed by a diversified portfolio of senior secured bonds and loans and second lien loans (see Note 6 to the consolidated financial statements for more details).

2024 Debt Securitization

On September 26, 2024, the Fund completed a $428 million term debt securitization (the “2024 Debt Securitization”) and the Fund owns $124 million of Class D and Subordinated Notes. The 2024 Debt Securitization is commonly referred to as a “CLO Reset”, in which the 2021 CLO was reset with a new capital structure and reinvestment period. The debt offered in the 2024 Debt Securitization (the “2024 CLO”) was issued by Silver Point SCF CLO IV, Ltd., a wholly-owned, consolidated subsidiary of the Fund, and was backed by a diversified portfolio of senior secured bonds and loans and second lien loans (see Note 6 to the consolidated financial statements for more details). The 2024 CLO consists of the following:

September 30, 2026

($ in millions)

Total Principal
Amount
Committed

Principal
Amount
Outstanding

Coupon

Interest
Rate

Class A-1 Loans

$

100.0

$

100.0

S+1.72%

5.47

%

Class A-1a Notes

115.5

115.5

S+1.72%

5.47

%

Class A-1b Notes

16.5

16.5

5.10%

5.10

%

Class A-2 Notes

16.0

16.0

S+1.95%

5.70

%

Class B Notes

24.0

24.0

S+2.10%

5.85

%

Class C Notes

32.0

32.0

S+2.70%

6.45

%

Total 2024 CLO

$

304.0

$

304.0

5.60

%

2026 Notes

On November 4, 2021, the Fund placed $145 million aggregate principal amount of notes that mature on November 4, 2026 (the “2026 Notes”). The 2026 Notes were issued in two tranches, with $100 million of tranche A notes funded on November 4, 2021 and $45 million of tranche B notes funded on January 21, 2022. The 2026 Notes bear interest at a rate of 4.00% per year, payable semi-annually on November 4 and May 4, of each year, commencing on May 4, 2022. The 2026 Notes are governed by a purchase agreement, dated November 4, 2021, by and among the Fund and the purchasers. In connection with the 2026 Notes, the Fund entered into interest rate swaps and applied hedge accounting for the designated hedge relationship between the 2026 Notes and the swaps. As a result of these swaps, the Fund’s effective interest rate on the 2026 Notes is SOFR plus 13 basis points during the swaps’ outstanding period (see Note 6 to the consolidated financial statements for more details).

Revolving Credit Facility

On October 17, 2017 and amended on April 14, 2023, Specialty Credit Facility, LLC, a wholly-owned subsidiary of the Fund, entered into a secured revolving credit facility (the “Revolving Credit Facility”) with Deutsche Bank AG, as facility agent (the “Facility Agent”) and U.S. Bank National Association as collateral agent (the “Collateral Agent”).

As of September 30, 2026, the commitment under the Revolving Credit Facility was $250 million and amounts drawn under the Revolving Credit Facility bore interest at 3-month SOFR plus a margin of 1.70% per annum. We also pay a commitment fee of 0.40% per annum on any undrawn amount. Amounts borrowed under the Revolving Credit Facility are secured by the assets of the borrower (see Note 6 to the consolidated financial statements for more details).

2055 Promissory Notes

On April 30, 2025, the Fund issued $1.5 million in aggregate principal of promissory notes (the “2055 Promissory Notes”). The Fund pays interest on the principal amount of the 2055 Promissory Notes at a rate of 12% per annum, payable annually in arrears. The 2055 Promissory Notes mature on April 30, 2055 and may be prepaid by the Fund at any time, in whole or in part, provided that (i) the Fund will pay on the date of such prepayment all accrued and unpaid interest due on such prepaid principal amount to and including the date of prepayment and (ii) if the prepayment occurs within twenty-four months after the issue date of the 2055 Promissory Notes, the Fund will pay a one-time premium.

63


Unfunded Capital Commitments

We began accepting subscription agreements with investors, providing for the private placement of the Fund’s common shares (collectively “Capital Commitments”). Under the terms of the Capital Commitments, investors are required to fund capital contributions to purchase the Fund’s common shares up to the amount of their respective Capital Commitment on an as-needed basis each time a drawdown notice is delivered to investors.

As of September 30, 2026, the Fund had $7.5 million of unfunded capital commitments (see Note 9 to the consolidated financial statements for more details).

Distributions

We intend to pay monthly dividends to our Shareholders out of assets legally available for distribution. All dividends will be paid at the discretion of our Board of Trustees and will depend on our earnings, financial condition, compliance with applicable BDC regulations and such other factors as our Board of Trustees may deem relevant from time to time (see Note 9 to the consolidated financial statements for more details).

Unfunded Portfolio Commitments

From time to time, the Fund may enter into commitments to fund investments. Such commitments are incorporated into the Fund’s assessment of its liquidity position. The Fund’s senior secured revolver commitments are generally available on a borrower’s demand. The Fund’s senior secured delayed draw term loan commitments are generally available on a borrower’s demand and, once drawn, generally have the same remaining term as the associated loan agreement. Undrawn senior secured delayed draw term loan commitments generally have a shorter availability period than the term of the associated loan agreement.

As of September 30, 2026 and December 31, 2025, we had the following commitments to fund investments in current portfolio companies:

($ in millions)

September 30,
2026

December 31,
2025

First Lien Secured Debt

$

54.2

$

66.6

Other Investments

0.3

0.3

Total Portfolio Company Commitments

$

54.5

$

66.9

We seek to carefully consider our unfunded portfolio company commitments for the purpose of planning our ongoing financial leverage. Further, we consider any outstanding unfunded portfolio company commitments we are required to fund within the 150% asset coverage limitation. As of September 30, 2026, we believe we had adequate financial resources to satisfy the unfunded portfolio company commitments, with cash and cash equivalents on hand and availability under the Revolving Credit Facility.

Other Commitments and Contingencies

Contracts

We have entered into two contracts under which we have future commitments: the Advisory Agreement (see Note 3 to the consolidated financial statements) and the sub-administration agreement. Payments under the Advisory Agreement are equal to (1) a percentage of the Fund’s net assets on the last day of each calendar quarter, (2) a two-part incentive fee and (3) reimbursements equal to an amount that the Administrator incurs for costs and expenses and the Fund’s allocable portion of overhead incurred by our Adviser in performing its obligations as Administrator under the Advisory Agreement. Either party may terminate the Advisory Agreement without penalty upon at least 60 days’ written notice to the other.

Financial Instruments

We may become a party to financial instruments with off-balance sheet risk in the normal course of our business to meet the financial needs of our portfolio companies. These instruments may include commitments to extend credit and involve, to varying degrees, elements of liquidity and credit risk in excess of the amount recognized in the balance sheet.

64


Critical Accounting Estimates

The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Changes in the economic environment, financial markets, and any other parameters used in determining such estimates could cause actual results to differ. In addition to the discussion below, our critical accounting policies are further described in the notes to our consolidated financial statements.

Valuation of Investments and Derivative Contracts

The Board of Trustees designated the Adviser as the Fund’s valuation designee pursuant to Rule 2a-5 under the 1940 Act, which establishes requirements for determining fair value in good faith for purposes of the 1940 Act. Accordingly, the Adviser has appointed its BDC Valuation Committee with the responsibility for fair value determinations pursuant to valuation procedures adopted for the Fund. The Board of Trustees oversees the Adviser in its role as valuation designee in accordance with the requirements of Rule 2a-5 under the 1940 Act.

Investments and derivative contracts are valued in good faith by the Adviser, as the Fund’s valuation designee, at fair value pursuant to the valuation policy, which considers quotations provided by independent pricing sources, when such quotations are available and deemed reliable. The Fund conducts this valuation process on a quarterly basis.

Investments that are not listed on an exchange but are actively traded over-the-counter are generally valued at the representative “bid” quotation if held long and the representative “ask” quotation if held short or, in the case of equities that trade in over-the-counter marketplaces, at the last deemed reliable sale price provided by independent pricing sources. Derivative contracts not listed on an exchange are generally valued through industry-standard valuation models using inputs obtained from pricing vendors and from the relevant derivative contract.

The estimated fair value of financial instruments is based upon available information and may not be the amount that the Fund would realize in a current transaction or might be ultimately realized, since such amounts depend on future circumstances, and the differences could be material.

In accordance with the authoritative guidance on fair value measurements and disclosures under U.S. GAAP, the Fund discloses the fair value of its investments according to a hierarchy that prioritizes the inputs used to measure the fair value. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices on a securities exchange in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (level 3 measurements). In accordance with U.S. GAAP, these inputs are summarized in the three broad levels listed below:

Level 1: Inputs that reflect unadjusted quoted prices on a securities exchange in active markets for identical assets or liabilities;

Level 2: Inputs other than quoted prices on a securities exchange that are observable for the asset or liability either directly or indirectly in active markets, or unadjusted prices on a securities exchange in markets that are not considered to be active;

Level 3: Significant inputs that may be unobservable or inputs, including market quotations other than quoted prices on a securities exchange, in markets that are not considered to be active.

Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions including assumptions about risk. Inputs may include price information, volatility statistics, specific and broad credit data, liquidity statistics and other factors. An investment’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes “observable” requires judgment by the Adviser. The Adviser considers observable data to be that market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by multiple independent sources that are actively involved in the relevant market. The categorization of an investment within the hierarchy is based upon the pricing transparency of the investment and does not necessarily correspond to the Adviser’s perceived risk of that instrument.

In determining an instrument’s placement within the hierarchy, the Adviser separates the Fund’s investment portfolio into two categories: investments and derivative contracts. Each of these categories can further be divided between assets and liabilities and further by investment type.

Investments whose values are based on the unadjusted quoted prices on a securities exchange in active markets for identical assets or liabilities are classified within Level 1.

Investments that are valued based on dealer quotations or alternative pricing sources supported by observable inputs are generally classified within level 2. These may include certain bonds or bank loans.

65


Derivative contracts can be exchange-traded or privately negotiated over-the-counter (“OTC”). OTC derivatives, including foreign currency forward contracts and interest rate swaps are generally valued using observable inputs. In instances where models are used, the value of an OTC derivative depends upon the contractual terms of, and specific risks inherent in the instrument as well as the availability and reliability of observable inputs. OTC derivatives are typically classified within level 2 of the fair value hierarchy depending on their liquidity or the observability of their inputs.

Investments classified within level 3 have significant unobservable inputs. Level 3 instruments may include certain bank loans, trust interests, private equity and real estate properties. When observable prices are not available for these investments, one or more valuation techniques (e.g., market approach or income approach) for which sufficient and reliable data is available may be used. Within level 3, the use of the market approach technique generally consists of using comparable market data, while the use of the income approach technique generally consists of the net present value of estimated future cash flows, adjusted as appropriate for liquidity, credit, market and/or other factors. Quotations provided by independent pricing sources may also be considered, if available and deemed reliable, in determining the value of level 3 investments.

The inputs used in estimating the value of level 3 investments that are not valued using quotations provided by independent pricing sources may include but are not limited to the original transaction price, recent transactions in the same or similar instruments, completed or pending third party transactions in the underlying investment or comparable issuers, subsequent rounds of financing, recapitalizations and other transactions across the capital structure, offerings in the equity or debt capital markets, discount rates, durations and changes in financial ratios or cash flows. Comparable public companies may also be identified based on industry, size, strategy, etc. and a trading multiple or yield is determined for each comparable company. Additionally, level 3 investments may also be adjusted to reflect illiquidity and/or non-transferability, with the amount of such discount estimated in the absence of market information. Assumptions used due to the lack of observable inputs may significantly impact the resulting fair value and therefore the Fund’s consolidated results of operations.

See Note 2 and Note 5 to the consolidated financial statements for more information on our valuation process, as well as key assumptions and inputs used in valuation of level 3 investments period over period.

Recent Developments

On October 22, 2026, the Board declared a dividend of $0.24 per share, payable on or before November 30, 2026, for Shareholders of record on October 30, 2026.

On October 26, 2026, the Fund entered into Amendment No. 22 (the "Amendment") to the Revolving Credit Facility. The Amendment, among other things, increased the facility amount by $125 million to $375 million and provides for further increases to the facility amount up to a maximum of $425 million within 90 days of the effective date of the Amendment, subject to certain conditions.

On November 4, 2026, the Fund's 2026 Notes, which had an outstanding principal balance of $145 million, matured and were repaid in full.

66


Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are subject to financial market risks, including but not limited to changes in interest rates, foreign currency rates and the valuations of our investment portfolio.

Interest Rate Risk

Interest rate sensitivity refers to the change in our earnings that may result from changes in the level of interest rates. Because we expect to fund a portion of our investments with borrowings, our net investment income is expected to be affected by the difference between the rate at which we invest and the rate at which we borrow. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income.

We regularly measure our exposure to interest rate risk. We assess interest rate risk and manage our interest rate exposure on an ongoing basis by comparing our interest rate sensitive assets to our interest rate sensitive liabilities.

As of September 30, 2026, approximately 92.2% of our total debt investments at fair value (or 92.1% of our performing debt investments) bore floating interest rates. From time to time, the Fund seeks to mitigate interest rate risk associated with fixed rate investments by entering into interest rate swaps. With the impact of the interest rate swaps, approximately 95.7% of our performing debt investments based on fair value were effectively floating rate investments as of September 30, 2026. Our Revolving Credit Facility and a majority of the 2024 CLO also bear floating interest rates; in connection with our fixed-rate 2026 Notes, we entered into fixed-to-floating interest rate swaps under a designated hedge accounting relationship, in order to align the interest rates of our liabilities with our investment portfolio (see Note 6 to the consolidated financial statements for more details).

Assuming that our consolidated balance sheet as of September 30, 2026 were to remain constant and that we took no actions to alter our existing interest rate sensitivity, the following table shows the annualized impact of hypothetical base rate changes in interest rates (considering interest rate caps and floors, if any, for floating rate instruments):

September 30, 2026

Basis Point Change

Change in
Interest Income

Change in
Interest Expense
(1)

Change in
Net Investment
Income
(2)

($ in millions)

Up 300 basis points

$

33.1

$

(16.3

)

$

16.8

Up 200 basis points

22.1

(10.8

)

11.3

Up 100 basis points

11.0

(5.4

)

5.6

Up 50 basis points

5.5

(2.7

)

2.8

Down 50 basis points

(5.4

)

2.7

(2.7

)

Down 100 basis points

(10.7

)

5.4

(5.3

)

Down 200 basis points

(20.7

)

10.8

(9.9

)

Down 300 basis points

(29.4

)

16.3

(13.1

)

(1)

Includes the impact of effective hedge through interest rate swaps associated with the 2026 Notes.

(2)

Excludes the impact of income based incentive fees. See Note 3 to the consolidated financial statements for more details on fees.

Although we believe that this analysis is indicative of our existing sensitivity to interest rate changes, it does not adjust for changes in the credit market, credit quality, the size and composition of the assets in our portfolio and other business developments that could affect our net investment income. Accordingly, we cannot assure you that actual results would not differ materially from the analysis above.

We may in the future hedge against interest rate fluctuations by using hedging instruments such as additional interest rate swaps, futures, options and forward contracts. While hedging activities may mitigate our exposure to adverse fluctuations in interest rates, certain hedging transactions that we may enter into in the future, such as interest rate swap agreements, may also limit our ability to participate in the benefits of changes in interest rates with respect to our portfolio investments.

67


Currency Risk

From time to time, we may make investments that are denominated in a foreign currency. These investments are translated into U.S. dollars at each balance sheet date, exposing us to movements in foreign exchange rates. We may employ hedging techniques to minimize these risks, but we cannot assure you that such strategies will be effective or without risk to us. We may seek to utilize instruments such as, but not limited to, forward contracts to seek to hedge against fluctuations in the relative values of our portfolio positions from changes in currency exchange rates. We also have the ability to borrow in certain foreign currencies under our Revolving Credit Facility. Instead of entering into a foreign exchange forward contract in connection with loans or other investments we have made that are denominated in a foreign currency, we may borrow in that currency to establish a natural hedge against our loan or investment. To the extent the loan or investment is based on a floating rate other than a rate under which we can borrow under our Revolving Credit Facility, we may seek to utilize interest rate derivatives to hedge our exposure to changes in the associated rate.

Valuation Risk

We have invested, and plan to continue to invest, primarily in illiquid debt of private companies. Most of our investments will not have a readily available market price, and we value these investments at fair value as determined in good faith in accordance with our valuation policy. There is no single standard for determining fair value. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. If we were required to liquidate a portfolio investment in a forced or liquidation sale, we may realize amounts that are different from the amounts presented and such differences could be material.

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

In accordance with Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q and determined that our disclosure controls and procedures are effective as of the end of the period covered by the Quarterly Report on Form 10-Q.

(b) Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a‑15(f) and 15d‑15(f) under the Exchange Act) that occurred during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

68


PART II—OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. We and our Adviser are also subject to extensive regulation, which may result in regulatory proceedings or investigations against us or our Adviser, respectively. Except as described below, neither we nor the Adviser are currently subject to any material legal proceedings.

The Fund and certain other funds managed by Silver Point and its affiliates were named as defendants in a lawsuit asserting tortious interference filed in a United States bankruptcy court. On February 19, 2025, the bankruptcy court issued a Report and Recommendation to the U.S. District Court for the Southern District of Texas recommending dismissal of the tortious interference claim. On December 8, 2025, the U.S. District Court entered an order dismissing the tortious interference claim. On January 6, 2026, the plaintiffs filed a notice of appeal of this order to the U.S. Court of Appeals for the Fifth Circuit. The appeal is currently pending with the Fifth Circuit and oral argument is scheduled for November 2, 2026. The Fund intends to vigorously defend these claims. At this time, the Fund cannot predict with a reasonable degree of certainty the likelihood of an unfavorable outcome; however the Adviser does not expect the results of any potential outcome, even if unfavorable, to be material to the Fund’s consolidated financial statements.

Item 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the risk factors discussed below and contained in “Item 1A. Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 18, 2026 (our “Form 10-K”), each of which could materially affect our business, financial condition or future results. The risks described in our Form 10-K are not the only risks facing the Fund. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities

Except as described and as previously reported by the Fund on its current reports on Form 8-K, the Fund did not sell any securities during the quarter ended September 30, 2026 that were not registered under the Securities Act.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

During the three months ended September 30, 2026, no director or executive officer of the Fund adopted or terminated a “Rule 10b5–1 trading arrangement” or “non-Rule 10b5–1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

69


Item 6. Exhibits

The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:

Exhibit

Number

Description

3.1(a)

Second Amended and Restated Declaration of Trust (incorporated by reference to Exhibit 3.1 to the Fund’s current report on Form 8K filed on May 6, 2025).

3.1(b)

Certificate of Amendment to Second Amended and Restated Declaration of Trust (incorporated by reference to Exhibit 3.1 to the Fund’s current report on Form 8-K (File No. 000-56533) filed on January 2, 2026).

3.2

Second Amended and Restated By-Laws (incorporated by reference to Exhibit 3.2 to the Fund’s current report on Form 8K filed on May 6, 2025).

10.1

Fourth Amended and Restated Investment Advisory Agreement (incorporated by reference to Exhibit 10.2 to the Fund’s current report on Form 8K filed on May 6, 2025).

31.1

Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

31.2

Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

32.1

Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

101.INS

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

101.SCH

Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Documents

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

* Filed herewith.

70


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Silver Point Specialty Lending Fund

Date: November 6, 2026

By:

/s/ Anthony DiNello

Anthony DiNello

Chief Executive Officer (Principal Executive Officer)

Date: November 6, 2026

By:

/s/ Jesse Dorigo

Jesse Dorigo

Chief Financial Officer (Principal Financial Officer)

71


来源:SEC EDGAR · 本站存档